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vAbstract
Past epidemiologic studies have claimed that birthweight, body mass index, and
childhood growth are associated with childhood wheezing disorders although the
findings are inconsistent. The aim of this thesis was to investigate the effects of
birthweight body mass index and childhood growth on wheezing disorders through
meta-analyses of past epidemiologic studies and using contemporary cohort data.
An online search of published papers linking childhood wheezing disorders with
birthweight, BMI, and growth was carried out using EMBASE and Medline medical
research databases. Risk estimates were pooled using a random-effects method. Data
from 13,734 Born in Bradford (BiB) cohort children were used to investigate the
incidence and burden of allergic diseases, and the effects of birthweight on
wheezing disorders. Data of 1,598 BiB1000 children were used to investigate the
effects of weight at the age of 3 years and childhood growth on wheezing disorders.
Birthweight was categorised using the World Health Organisation and Centre for
Disease Prevention and Control guidelines. Weight Standardised Scores were
derived using World Health Organisation growth standards. Body mass index was
categorised based on Centre for Disease Prevention and Control guideline.
Based on a total of 77 studies that comprised more than 3 million children, the
summary risk estimates indicated that low birthweight children have an increased
risk of wheezing disorders when compared with the normal birthweight children. In
addition, underweight children have a reduced risk of wheezing disorders whilst
overweight and obese children have an increased risk when compared with normal
body mass index children.
Based on the cohort data, the results indicate that the burden of allergic conditions is
higher than previously reported in earlier studies. In addition, there is an increased
risk of wheezing disorders for low birthweight, slow growth during the first three
months, and fast growth between 3 and 12 months.
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1CHAPTER 1
INTRODUCTION
1.1 What are allergic diseases?
Allergic diseases are inflammatory reaction of body cells mainly caused by
abnormal immune system response to harmless environmental antigens or allergens
(Warner and Warner, 2002; Galli et al., 2008; Grammatikos, 2008).When an
allergen or foreign substance enters or makes direct contact with the body, the
immune system reacts by mobilizing immunoglobulin E (IgE) and other T-cell
populations as a process of normal defence mechanism (Kabesch and Von Mutius,
2002; Galli et al., 2008). In most people, this is a normal process by which the body
protects against some parasitic infections, however, in those who are susceptible, the
body overreacts or becomes hypersensitive, including to harmless substances, which
then leads to allergic reactions (Grammatikos, 2008). This immediate reaction
results in an acute inflammation around the area of insult that subsides in a short
period of time if the exposure is transient. However, if the exposure persists, it can
develop into chronic inflammation, that is, chronic allergic disease (Galli et al.,
2008).
The primary cause of allergic diseases is unknown; however, genetic and
environmental factors may play a key role (Grammatikos, 2008). The common
substances that provoke allergic reactions are pollen, dust mites, foods such as nuts
and peanuts, drugs and some organic compounds from plants (Galli et al., 2008).
Some of the signs and symptoms of allergic reactions are wheezing, cough and
shortness of breath, runny nose, itchy and watery eyes, skin rashes or eczema,
vomiting and diarrhoea (Stanley, 1952; Galli et al., 2008).
In children, the common allergic disorders are asthma, rhinitis and eczema (Asher et
al., 1995; Asher et al., 2006). Asthma is defined as a chronic disease of the passage
of airways, characterised by smooth muscle contraction, accumulation of mucous
and debris in the lumen, vascular congestion and airway wall oedema which leads to
breathlessness and wheezing (Roche and Jeffery, 2002). Rhinitis is an inflammation
of the inside part of the nose characterised by a runny nose, stiffness and sneezing in
the absence of cold or flu (Asher et al., 1995). Eczema can be defined as a dry skin
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flexural areas in the absence of external causes (Asher et al., 1995).
1.2 Prevalence and burden of childhood allergic diseases
Childhood allergic diseases are global health problem and their prevalence was
observed to rise in the last decades (Masoli et al., 2004; Asher et al., 2006; Pearce et
al., 2007). Based on self-reported symptoms, the International Study of Asthma and
Allergies in Childhood (ISAAC) reported that the global prevalence of asthma,
rhinitis and eczema for 6-7 age group during 2002-2003 was 12.6% (range =2.8–
37.6%), 8.5% (range = 2.2–24.2%) and 8.9% (range =2–22.3%) , respectively
(Asher et al., 2006). The respective prevalence for the 13-14 age groups was 14.1%
(range = 3.4–31.2%), 14.8% (range = 4.5–45.1%) and 8.1% (range = 1.4–21.8%).
The UK was among the highest affected countries in the world with 12-months
period prevalence of 20.9%, 10.1% and 16% for asthma, rhinitis and eczema
symptoms in the 6-7 age group. The respective prevalence for the 13-14 age group
was 24.7% 15.3% and 14.7% (Asher et al., 2006).
In a recent retrospective cohort study of 43, 473 children using the national General
Practice Research Database (GPRD), 18-years period prevalence of asthma, eczema
and rhinitis in the UK was 22.9%, 36.5% and 11.4%, respectively (Punekar and
Sheikh, 2009). The same study also estimated that, in 2008, there were 3.7 million,
2.2 million and 0.8 million under 18 years of age children diagnosed with eczema,
asthma and rhinitis, respectively.
In the UK, it is estimated that 1 in 5 and 1 in 11 children suffer from eczema
(Eczema-UK, 2015) and asthma (Asthma-UK, 2014), respectively. Although figures
for eczema and rhinitis are not available, there were 1.1 million childhood asthma
cases, and around 25,000 emergency hospital admissions in 2012 (Asthma-UK,
2014). It is also estimated that the National Health Service (NHS) spends £1 billion
a year treating and caring for childhood and adult asthma cases (Asthma-UK, 2014).
Confirmation of rhinitis and eczema cases in young and under-five children may not
be difficult, however, diagnosis of asthma is problematic because ‘wheezing’ which
is the key symptom of asthma can also occur due to other causes such as,
developmental anomalies (e.g. polyps), recurrent aspiration (e.g. gastroesophageal
reflex), perinatal disorders (e.g. congenital infection), genetic disorders (e.g. cystic
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although there are various asthma confirmatory tests available (Bush and Fleming,
2015), young children can be less cooperative in participating in such tests that may
lead to an under-diagnosis of true asthma cases. Therefore, the word ‘asthma’ may
not be an adequate term for what can be described as a spectrum of respiratory
problems.
1.3 Childhood wheezing disorders
Childhood wheezing disorders comprise a variety of respiratory problems that share
a common symptom—wheezing (Silverman, 2002). Wheezing disorders can be
categorised into a variety of phenotypes based on the temporal pattern and duration
of wheeze (Brand et al., 2008). Based on temporal patterns, wheezing disorders can
be: a) episodic, often related with viral cold or b) multiple-trigger where wheezing
occurs between episodes and shows exacerbations of symptoms during episodes due
to triggers other than cold (e.g. tobacco smoke). Based on the duration, wheezing
disorders can be: a) transient where wheezing symptoms occur before the age of
three years and disappear by the age of six; b) persistent where wheezing symptoms
start before the age of three years and continue to manifest until the age six and
afterwards; or c) late-onset where wheezing symptoms start after the age of three
years (Brand et al., 2008).
1.3.1 Contributing factors for childhood wheezing disorders
Although childhood wheezing disorders are diverse, the biological contributing
factors can be broadly categorised into three: anatomical and physiological
development, inflammatory response, and smooth muscle remodelling.
1.3.1.1 Anatomical and physiological development
Anatomical development of the lungs starts from the embryonic phase (0-7 weeks
gestation) and continues until postnatal phase (up to 18 months after birth) (Hislop
and Pandya, 2002). Each anatomical component of the lung has its own timetable of
development although they are not independent to each other (Hislop and Pandya,
2002). At the time of birth, the lungs need to have enough number of alveoli in order
to carry out air breathing and gas exchange functions which may not be the case for
babies with intrauterine growth restriction and born premature (Willet and Sly,
2002).
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birthweight (Jaddoe et al., 2008) due to constriction of utero-placental circulation
induced by nicotine (Willet and Sly, 2002). Lower birthweight babies are likely to
have smaller lungs and lower number of alveoli, which in turn could cause breathing
difficulty and wheezing symptoms (Hislop and Pandya, 2002). Babies with less
structurally developed lungs would also be more likely to have respiratory infections
that can lead to wheezing symptoms (Hislop and Pandya, 2002).
1.3.1.2 Inflammatory response
Inflammation is a protective reaction of any vascularised tissue of the body against
foreign substances (Grigg, 2002). In response to inhaled antigens, a cascade of
inflammatory process takes place (Renauld, 2001). First, CD4+ helper T cells
produce interleukins (IL-4, IL-5, IL-9, and IL-13). Second, naive T-cells differentiate
into Th2 cells and stimulate B-cells to produce IgE antibodies in response to IL-4.
Fourth, the IgEs bind with mast cells. Finally, the mast cells release histamines and
inflammatory cells (prostaglandins and leukotrienes) that cause bronchospasm and
inflammation of the airways, respectively. At the same time, inflammatory cells
such eosinophils are pulled towards the area of insult by the chemotactic factors
released by mast cells (Renauld, 2001).
During the inflammatory reaction, airway tissue damage occurs mainly due to the
presence of excess cytokines in the lung tissues (Holt, 2002). As a consequence to
the tissue damage and inflammatory process, the airways become congested and
narrow which then can lead to transient or persistent wheezing symptoms, based on
the duration of the exposure (Balfour-Lynn and Openshaw, 2002).
1.3.1.3 Smooth muscle remodelling
The function of the airways is to regulate the flow of gas exchange and prevent
harmful substances from reaching the air sacks (Renauld, 2001; Hislop and Pandya,
2002; Roche and Jeffery, 2002). However, this protective mechanism of the lung
tissues may also cause damage to the tissues themselves.
As a healing process, damaged (injured) epithelial tissues are infiltrated by
neutrophils and later by lymphocyte and macrophages in order to eradicate the dead
cells before the process of repairing of tissues takes places (Roche and Jeffery,
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formation of collagen and scar, and contraction of the surrounding tissues (Roche
and Jeffery, 2002). Inflammation and remodelling are part of the healing process, in
which the structure and function of the tissues is restored in the end. In wheezing
disorders cases, however, both the inflammation and remodelling processes persist
(Renauld, 2001; Roche and Jeffery, 2002; Galli et al., 2008).
The aftermath of the incessant inflammation and remodelling process is that the
airways become thickened (Renauld, 2001), and much of the elasticity of the smooth
muscles is reduced (Renauld, 2001; Roche and Jeffery, 2002) which then can lead to
wheezing symptoms.
1.3.2 Hypotheses for the association of birthweight, body mass index
and growth patterns with childhood wheezing disorders
1.3.2.1 Birthweight
Results from previous meta-analyses suggest that low birthweight is associated with
wheezing disorders (Mu et al., 2014; Xu et al., 2014) although the mechanism of this
relationship is less understood. However, it is reported that low birthweight children
have increased risk of lower respiratory infections (Jackson et al., 2013; Lu et al.,
2013). It was also suggested that low birthweight children could be susceptible to
infectious diseases due to alteration in their immune function (Raqib et al., 2007).
Thus, it is possible that low birthweight children experience more viral respiratory
infections than normal birthweight children due to either an immune function
alteration or having lungs that can not carry out their function of air exchange and
protection against harmful substance properly. Viral respiratory infections especially
bronchiolitis from respiratory syncytial virus (RSV) and rhinovirus (RV) can
develop into recurrent wheezing or childhood wheezing disorders (Singh et al.,
2007; Sly et al., 2008). Recurrent viral infections can also cause damage to the
respiratory airway tissues that can lead to stiffness of mucosal muscles and lack of
elasticity, which then cause wheezing symptoms (Balfour-Lynn, 1996).
1.3.2.2 Body mass index
There are three potential mechanisms that may explain the association between body
mass index (BMI) and wheezing disorders. First, overweight or obesity, due to the
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diaphragm and the airways which can lead to breathing difficulty and wheezing
symptoms (Sontag, 2000). Second, obesity may cause gastro-oesophageal reflux and
that the gastric content of the reflux may cause infection and inflammation of the
airway that may then lead to wheezing symptoms (Sontag, 2000).
Third, overweight or obese people have excess pro-inflammatory hormones (e.g.
adipokines) in their blood circulation (Guler et al., 2004; Castro-Rodríguez, 2007;
Farah and Salome, 2012 ). This suggests that overweight or obesity is an
inflammatory state where the cascading of inflammatory process can trigger
asthmatic symptoms (Guler et al., 2004; Castro-Rodríguez, 2007; Farah and Salome,
2012 ).
1.3.2.3 Childhood growth patterns
The effect of growth patterns on wheezing disorders could perhaps be explained by
effects of birthweight and BMI in combination. Growth starts from prenatal period
and those who had adverse events during this period will most likely be low
birthweight babies which then become susceptible to respiratory infections (Jackson
et al., 2013; Lu et al., 2013). Postnatally, babies also may falter from normal growth
to become obese which then leads to wheezing symptoms (Guler et al., 2004;
Castro-Rodríguez, 2007; Farah and Salome, 2012 ).
1.3.3 The risk factors for wheezing disorders
The primary cause of wheezing disorders is not known, however, a combination of
genetic predisposition with exposure to allergens are described to be the main risk
factors (Grammatikos, 2008; WHO, 2013). Previous observational epidemiologic
studies have also reported that factors such as low birthweight (Mu et al., 2014; Xu
et al., 2014), overweight and obesity (Chen et al., 2013; Egan et al., 2013), fast
growth during early age (Rzehak et al., 2013), family asthma (Lim et al., 2010),
maternal smoking (Burke et al., 2012), breast feeding (Scholtens et al., 2009), child
and family feeding habits (Chatzi et al., 2007), number of siblings (parity) and live
births (McKeever et al., 2001), socioeconomic status (Kozyrskyj et al., 2010),
gestational age (Jaakkola et al., 2006), gender (Osman et al., 2007) and ethnicity
(Netuveli et al., 2005; Akinbami et al., 2014) are linked with the risk of wheezing
disorders.
71.4 The Born in Bradford cohort project
The Born in Bradford (BiB) cohort study is based at the Bradford Institute for
Health Research (BIHR) office, Braford Royal Infirmary, in Bradford. The study
covers the Bradford district in West Yorkshire North of England with a total area of
around 143 square miles. The district includes 30 electoral Wards with a population
of around half a million residents mainly White British and Pakistani (mostly from
Mirpuri region of Pakistan) (Raynor, 2008).
The district’s population is younger than the national average (Raynor, 2008); and,
while only around 18% of the residents are Pakistani origin (Wright et al., 2013),
around 44% babies born in the district are from Pakistani origin mothers (Raynor,
2008).
Bradford district is among the most deprived cities in the United Kingdom and is
known for its high childhood morbidity and twice the national average infant
mortality (BDIMC, 2007; BDIMC, 2014). Babies born to Pakistani origin mothers
are twice as likely as to die during their first year when compared with babies born
from white mothers (BDIMC, 2007).
The BiB project was established in 2007 in response to the concern about the high
childhood morbidity and infant mortality in the district (Wright et al., 2013). The
aim of the project was to examine the impact of genetic, nutritional, environmental,
behavioural and social factors on child health and development, and adult life
(Wright et al., 2013).
1.5 Motivation for this thesis
1.5.1 Contemporary birth cohort data
In the UK, there are birth cohorts such as: Avon Longitudinal Study of Parents and
Children (ALSPAC) cohort (Boyd et al., 2012), the Manchester Asthma and Allergy
Study (MAAS) cohort, (Custovic et al., 2002), and the Millennium Cohort study
(Dex and Joshi, 2005). However, in these cohorts, minority ethnic groups are
underrepresented and much of the diseases outcome data are collected through
questionnaires. Therefore, comparative statistical analyses among different ethnic
groups could be under powered. In addition, data collected through questionnaires
are also prone to recall and measurement error biases.
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population (i.e. Pakistani and white British origin), and all child anthropometric
measurements are collected by trained workers. In addition, the project also provides
a unique opportunity for utilising primary care data in SystmOne (http://www.tpp-
uk.com/products/systmone), that is, electronic patient record (i.e. disease and drug
prescription information). Therefore, any comparative analyses among the two
ethnicities using the BiB cohort data will provide strong statistical power. Results
based on the cohort data will also be less prone to recall and measurement error
biases.
1.5.2 The requirement for update
The effects of birthweight on childhood wheezing disorders have been extensively
studied although results remained inconsistent (Chatkin and Menezes, 2005). Until
March 2015, 83 studies that investigated birth weight and childhood wheezing disorders
were published. However, only 20% of them contributed to the last two systematic reviews
and meta-analyses (Flaherman and Rutherford, 2006; Mu et al., 2014).
Previous observational epidemiologic studies also suggested that overweight/obesity
and childhood asthma are associated although results remain inconsistent. Meta-
analyses were carried out in the past, however, one of the meta-analyses is too old
(Flaherman and Rutherford, 2006), and the other two recent meta-analyses focused
only on cohort studies, though not all previous cohort studies were included (Chen et
al., 2013; Egan et al., 2013).
Therefore, there is a need to carry out an up-to-date investigation of the association
of birthweight and BMI with childhood wheezing disorders through a systematic
review and meta-analysis of past epidemiologic studies.
1.5.3 The need to use novel statistical analytic techniques
Even though a large volume of research has been carried out on childhood wheezing
disorders and modifiable risk factors, the accuracy and precision of the findings may
be questionable. This is because, rigorous thought and proper planning prior to data
analysis was lacking in the past studies. For instance, critical thinking of what
variables to include and exclude was rarely in evidence. Most publications consider
all variables entered into the model as potential confounders although the term
confounding strictly refers to a variable causally related with but not directly
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consequence of including a variable which is directly affected by an exposure is
shown to exhibit a reversal effect, leading to incorrect effect estimates and erroneous
inferences (Tu et al., 2005). In order to minimise biases due to such problems, one
has to use novel tools, Direct Acyclic Graphs (DAGs), in order to properly identify
confounding and confounders (Greenland et al., 1999; Shrier and Platt, 2008).
Childhood weight change and growth patterns have been reported as predictors of
health during childhood and adult life (Eriksson et al., 2003; Hardy et al., 2004;
Baker et al., 2007; Eriksson et al., 2007; Owen et al., 2009; Halldorsson et al.,
2011 ). However, much of the evidence is based on multiple regression models,
which are prone to collinearity problems caused by the repeated weight
measurements that can lead to biased coefficient estimates (Duncan and Duncan,
2004; Tu et al., 2013). To avoid such collinearity problem, generalized estimating
equations (Ballinger, 2004; Hwang and Takane, 2005), multilevel linear models
(Bryk and Raudenbush, 1987) or latent growth models (Muthen, 2001; Duncan and
Duncan, 2004; Muthén, 2004) are recommended.
1.6 Aims of this thesis
This thesis mainly focuses on the investigation of the effects of birthweight, BMI,
and childhood growth through systematic review and meta-analysis of past
observational epidemiologic studies and using BiB cohort data. In so doing, the
thesis has the following aims:
 To conduct an up-to-date systematic review and meta-analysis of studies
on the effects of birthweight, BMI, and growth on childhood wheezing
disorders;
 To investigate the incidence and burden of childhood wheezing
disorders, eczema and rhinitis in the BiB cohort population; and,
 To investigate the effects of birthweight, weight at the age of 3 years and
childhood growth on childhood wheezing disorders in the BIB cohort.
1.7 Structure of this thesis
The thesis is structured in four parts. Chapter 1 forms the first which provided a
summary background for the thesis.
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Chapter 2 forms part 2, presents the summary of past epidemiologic studies that
investigated the effects of birthweight, BMI and childhood growth patterns on
wheezing disorders through systematic literature reviews and meta-analyses.
Methods for literature search, data extraction and standardisation are described.
Finally, summary results for each of the anthropometric measures (i.e. birthweight,
BMI and growth patterns) are presented, followed by discussions of the results and
concluding remarks.
Part three consists of Chapters 3, 4 and 5. Chapter 3 discusses methodological issues
in research and details the materials and methodologies used in a series of analyses
using the BiB cohort data, namely: the incidence and burden of allergic conditions;
describing growth patterns of white British and Pakistani children; and investigating
the effects of birthweight, weight at the age of 3 years and childhood growth
patterns on wheezing disorders. In Chapter 4, results for each analyses carried out in
chapter 3 are presented and described in detail; and Chapter 5 includes discussions
of the results in Chapter 4 together with conclusions.
Final part consists of Chapter 6 and presents a summary of the key findings from the
past (i.e. systematic review and meta-analysis) and current (i.e. results from the BiB
cohort data) epidemiological research and highlights areas for further investigation.
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CHAPTER 2
SYSTEMATIC REVIEW AND META-ANALYSIS
2.1 Chapter overview
This chapter investigated the effects of birthweight, BMI and childhood growth
patterns on childhood wheezing disorders using past observational epidemiologic
studies’ data. In section 2.2, a brief introductory discussion of systematic review and
meta-analysis methods (i.e. fixed-effect and random-effects) is presented.
In section 2.3; a critique of past systematic reviews and meta-analyses of
birthweight and childhood wheezing disorders is presented. Then, methods used and
results are presented. The section then ends with critical discussion of the results and
concluding remarks.
Likewise, section 2.4 presents a critique of past systematic reviews and meta-
analyses of BMI and childhood wheezing disorders, and a detailed description of
methods and results, and a critical discussion of the findings. Finally, in section 2.5,
a descriptive summary and discussion of childhood growth patterns and childhood
wheezing disorders studies is presented.
2.2 Overview of systematic review and meta-analysis
Systematic literature review is a process that includes systematically locating,
appraising, selecting, and synthesising data from past literature with an aim of
creating generalisations or answering a research question (Hedges, 2009a). Meta-
analysis is a process of statistically synthesising or combining results from past
studies (Hedges, 2009a). There are two types of modelling approaches in meta-
analysis, that is, fixed-effect or random-effects (Borenstein et al., 2009a; Hedges,
2009b ).
Under fixed-effect modelling, the analyst only wants to make inferences in the
effect-size parameter of the included studies (Hedges, 2009b). The assumption is
that there is one true effect which underlines all the studies in the analysis and that
all differences in the observed effects are due to sampling error within each study
(Borenstein et al., 2009a). Therefore, the relationship between the observed effect
and unknown true effect can be written as:
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Yi = θ + εi (2.1)
where Yi and εi are the individual observed effect and the sampling error for study
(i), respectively, and theta (θ) is the unknown true effect or population mean 
(Borenstein et al., 2009a). In order to obtain the most precise estimation of the
population effect size, a weighted mean is calculated where the weight assigned to
each of the studies is the inverse of that study’s variance (Borenstein et al., 2009a;
Shadish and Haddock, 2009). So, the weight given to each study in a fixed-effect
meta-analysis (Wfi) is:
(2.2)
where VYi is the within-study variance, that is, the sampling error for study (i).
Therefore the weighted mean (or the summary risk estimate) can be calculated as:
where M is the summary risk estimate, Wfi is the fixed effect weight assigned for
study (i), Yi is the observed effect size for study (i). The variance of the summary
effect is estimated as:
(2.4)
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Under random-effects modelling, the assumption is that the true effects of studies
are not identical but randomly distributed (Borenstein et al., 2009a). Therefore, we
would have two sources of variation, that is, the within-study (sampling error) and
the between-study variation. Then, equation 2.1 is written as
Yi = µ + ζi + εi (2.5)
Where Yi is the observed effect and mu (µ) is the mean of the distribution of true
effects among a population of studies; and zeta (ζ) is the difference between true 
study and population effect (i.e. between-study error), and epsilon (ε) is the 
difference between the observed study effect and the unknown true study effect
(within-study error). Subsequently, equation 2.2 is modified as:
(2.6)
Where Wri and 2 are the random effects assigned weight for study i and the
between-study variation, respectively. The between-study variance and is estimated
as:
(2.7)
where Wfi is weight from the fixed-effect inverse variances, Q is the heterogeneity
test statistic, k is the number of studies and k-1 is the degrees of freedom (df). Once
the weights given to each study are calculated, the summary effect and its variance
are estimated as in the fixed-effect model (Borenstein et al., 2009a; Shadish and
Haddock, 2009).
The choice between the fixed-effect and random-effects meta-analyses depends on
the assumption about the studies and the generalisation that one wants to make from
2
1


Yi
ir V
W
















i
i
if
i
if
if w
w
w
kQ
2
2 )1(
14
the results (Borenstein et al., 2009a; Hedges, 2009b). Suppose that in scenario (a), a
big interventional study is planned with 5000 participants. However, due to
personnel and logistics, it is decided that the study be split into 10 studies. It is also
decided that the results of each study are to be aggregated for a summary effect size.
In this circumstance, it can be assumed that all the studies included are functionally
identical, so a fixed-effect meta-analysis is the plausible method (Borenstein et al.,
2009a).
In scenario (b), suppose that there are 10 studies to be conducted in different
countries or continents by different researchers and there is a plan to aggregate the
results for a summary effect size. It is very unlikely that the studies will be
functionally identical so one cannot calculate a common effect size. Hence, in this
scenario, a random-effects meta-analysis becomes more sensible choice (Borenstein
et al., 2009a). In scenario (b), based on the summary effect size, one can also make
generalisations about other populations, but not in scenario (a).
The ultimate aim of performing a meta-analysis is not only to calculate summary
effect size, but also, to assess the variation of the effect sizes of studies
(heterogeneity), and identify its sources (Borenstein et al., 2009c). There are two
sources of variation or heterogeneity of effect sizes, that is, true variation and
random error. The task is to isolate the true heterogeneity and quantify it. There are
three tools to identify heterogeneity: (a) the Q statistic that measures the weighted
squared deviations; (b) the tau-squared (τ2) that measures the between study
variance and (c) the I2 which is the ratio of true heterogeneity to the total observed
variation. Once the presence of true heterogeneity is confirmed, its sources are
investigated through (a) a subgroup analysis where the mean effect size for different
subgroups are compared (Borenstein et al., 2009e) or (b) meta-regression where the
relationship between study level covariates and the effect size are assessed (Lau et
al., 1998; Borenstein et al., 2009d).
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2.3 Birthweight and wheezing disorders
2.3.1 Critique of past systematic reviews and meta-analyses
The effects of birthweight on childhood wheezing disorders have been extensively
studied although results remained inconsistent (Chatkin and Menezes, 2005).
Syntheses of studies have been carried out in the past (Flaherman and Rutherford,
2006; Mu et al., 2014; Xu et al., 2014), however, the results were inconsistent and
the methodologies applied by the authors were less rigorous. For example, in a
meta-analysis of 9 observational epidemiologic studies, it was reported that there
was an increase of 20% (RR=1.2, 95% CI : 1.1 to 1.3) in childhood asthma risk for
high birthweight children (Flaherman and Rutherford, 2006). However, the studies
included in this meta-analysis of high birthweight and childhood asthma used a
variety of definitions for high birthweight and risk estimations. One of the studies
used 3.8kg (Schwartz et al., 1990), four used 4.0kg (Fergusson et al., 1997; Gregory
et al., 1999; Leadbitter et al., 1999; Bolte et al., 2004) and another used 4.5kg (Sin et
al., 2004) as cut-off points for high birthweight, whilst three others used different
birthweight measurements (Rasanen et al., 2000; Xu et al., 2002; Yuan et al., 2003);
four used relative risk (Schwartz et al., 1990; Fergusson et al., 1997; Yuan et al.,
2002; Sin et al., 2004) and five used odds ratios (Gregory et al., 1999; Leadbitter et
al., 1999; Rasanen et al., 2000; Xu et al., 2002; Bolte et al., 2004) which could
potentially affect the summary risk estimates.
From a meta-analysis of nine studies, Mu et al. (2014) also reported that low
birthweight increases the risk of asthma by 28% (OR=1.28 , 95% CI: 1.09 to 1.50)
and 34% (OR=1.34, 95% CI:1.13 to1.60) for studies that used two and three
birthweight categories respectively. However, the population’s age and birthweight
categorisation were not consistent across the studies included. For example, one of
the studies used data-driven quartile birthweight categories (Taveras et al., 2006),
another had a mixture of child and adult populations (Gregory et al., 1999), and
three others were treated as adult studies (Steffensen et al., 2000; Yuan et al., 2002;
Remes et al., 2008) although the participants were children. And also, one other
included study (Rona et al., 1993) used ‘asthma attack’ as an outcome measure for
asthma while this may underestimate the true number of cases as many asthmatics
may not experience any ‘attack’ at all.
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2.3.2 Sythematic literature review methods
2.3.2.1 Literature Search Strategy
The reviews were carried out in accordance with the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009)
whilst a protocol was also registered with PROSPERO (Mebrahtu et al., 2014).
Online search was carried out using the EMBASE and MEDLINE databases. Prior
to the searches, a list of terms and phrases was constructed. Table 2.1 gives the
details of terms and phrases used for the literature search.
2.3.2.2 Inclusion criteria
Eligible papers were those published as an article, in English, and reported original
research about the effects of birthweight on wheezing disorders in children 0-19
years of age. No lower limit for a time of publication was set. However, the
literature covered the period to March 2015. Case-control, cohort, and cross-
sectional studies were included.
2.3.2.3 Exclusion criteria
Papers were excluded if:
a) Birthweight was modelled as a continuous variable as an assumption was
made that the risk of outcome (wheezing disorder) is higher in the lower and
higher ends of weight bands. Thus, ‘standard’ categorical variable of
birthweight was considered to be more appropriate than its continuous
format;
b) Authors claimed birthweight was included in their analyses but no
comparison group or risk estimates were presented in text or table of the
papers;
c) Authors used data-driven multiple categories of birthweight that cannot be
converted into the ‘standard’ categories;
d) Studies included an adult population with no separate data available for
children and adolescents; and,
e) Authors used data-driven multiple birthweight categories and if the number
of categories presented were generally too few (<4) to allow combination
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with studies through estimating nonlinear dose-response curves (Orsini et al.,
2012).
Table 2.1 Terms and phrases used during literature search
2.3.2.4 Data extraction
For the studies that were eligible to be included in the meta-analyses, the following
characteristics were extracted:
a) Authors’ name;
b) Year of publication;
c) Country of study;
d) Study design;
e) Sample size;
f) Study age group and gender;
g) Diagnosis (outcome) terms;
h) Birthweight categories;
i) Birthweight categorisation methods;
j) Outcome and exposure ascertainment methods; and,
k) Risk estimates.
Birthweight
1 birthweight
2 low birthweight
3 high birthweight
4 Birth weight
5 low birth weight
6 high birth weight
7 childhood asthma
8 wheez*
9 wheezing disorders
10 asthm*
11 Asthma in children
12 Childhood wheez*
13 1-6/or
14 7-12/or
15 13-14/and
16 limit 15 to English language
N.B: First literature search was conducted on 3rd March 2014 and was updated on 8th April 2015.
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2.3.2.5 Data standardisation
Exposure variable
Authors of the included studies used four types of exposure categorisation
techniques. For comparability and not to lose data due to variation in categorisation
methods, standardisation was undertaken.
a) Where authors assumed the Centre for Disease Prevention and Control
(CDC, 2009) and ‘recent’ World Health Organisation method (WHO, 2014)
that categorises birthweight as low (<2.5kg), normal (2.5-4.0kg) and high
(>4.0kg) or the ‘old’ WHO method (Kramer, 1987) that categorises low
(<2.5kg) and normal (≥2.5kg), the reported adjusted risk estimates and data 
on the number of cases and non-cases of each weight comparison group were
combined for meta-analysis without any change;
b) Where authors adopted two or three birthweight categories with Centre for
Disease Prevention and Control (CDC) or World Health Organisation
method (WHO) ‘normal’ category as a reference and where the number of
participants in each category were available, the stratum based number of
cases and non-cases were aggregated before being combined with the other
studies for meta-analysis of unadjusted risk estimates;
c) Where authors adopted two or three birthweight categories with the CDC or
WHO normal category as a reference and provided adjusted risk estimates,
the stratum based risk estimates were aggregated using recommendations
from Hamling et al. (2008) before being combined with the other studies for
meta-analysis of adjusted risk estimates, and
d) Where authors adopted data-driven multiple categories that could not be
converted to either of the standard formats, the risk estimates were compiled
in a table for descriptive analysis.
Outcome variable
Study authors used one or multiple outcome terms in their reporting. Again, for
comparability among studies, where authors used a single outcome, for example,
asthma or wheezing, the quoted outcome term by the author and its risk estimate
were assumed for analysis. However, where authors used multiple outcome terms,
the term that was highest in the hierarchy and its risk estimate were assumed for
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analysis. For example, if asthma and wheezing were used together, asthma was
preferred over wheezing.
2.3.2.6 Quality assessment
Papers included in the review and meta-analysis were assessed for risks of bias
using the Newcastle-Ottawa quality assessment scale (Wells et al., 2000),
see Appendix A , Appendix B and Appendix C for details on scoring guidelines
used. Table 2.3 gives the details of studies with respective scores.
2.3.2.7 Statistical analysis
Where meta-analyses were carried out, random-effects models were preferred as an
assumption was made that the studies were not functionally identical and the aim of
the meta-analyses were to generalise about other populations in different parts of the
world (Borenstein et al., 2009b). Estimates were pooled using the DerSimonian and
Laird method (DerSimonian and Laird, 1986).
If studies presented stratum-specific estimates (e.g. by gender), then to provide
correct measures of heterogeneity, the risk estimates were aggregated using fixed-
effect models before being combined with the other studies for meta-analyses of
adjusted risk estimates in a random-effects model. Likewise, where authors reported
the number of cases and non-cases in each stratum, the total number of cases and
non-cases were aggregated before being combined with the other studies for meta-
analyses of unadjusted risk estimates of all studies.
To quantify between-study heterogeneity, the Cochrane Q-test (Whitehead and
Whitehead, 1991) and the I2 measure of the proportion of the total heterogeneity
explained by between study variation (Higgins and Thompson, 2002) were used.
Sub-group meta-analyses and sensitivity analysis of adjusted and unadjusted risk
estimates were performed on nine covariates (study characteristics) in order to
assess the robustness of the risk associations and levels of between-study
heterogeneities.
Where summary risk estimate results showed significant variation (heterogeneity),
in order to account for the sources of between-study heterogeneity, meta-regression
(Lau et al., 1998; Borenstein et al., 2009d) of adjusted and unadjusted risk estimates
were performed using Restricted Maximum Likelihood (REML).
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In investigating evidence of publication bias and small study effects, symmetry
funnel plots and bias test models (Egger et al., 1997; Sterne et al., 2001) were used.
All meta-analyses were carried out in Stata software version 12 (StataCorp, 2011).
The fixed- and random-effects models were carried out using ‘metan’ command.
Likewise, meta-regression, bias test and funnel plot models were performed using
‘metareg’,’metabias’, and ‘metafunnel’ Stata commands, respectively.
Five per cent significance levels and 95% confidence intervals were adopted
throughout.
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2.3.3 Results
2.3.3.1 Literature search
A total of 1,830 papers were recovered from EMBASE and Medline collectively. Of
the total, 83 papers were read in full. Out of the 83 papers, 52 reported either the risk
estimates or number of cases and non-cases of wheezing disorders in each exposure
group and were included in the review (Figure 2.1). Then, 38 of the total 52 studies
either used the standard birthweight categories or presented data that were
convertible to the standard formats and were included in the meta-analysis
(Table 2.2).
Eleven of the 52 studies used data-driven birthweight categories which were found
to be inconvertible into the standard formats but can be re-grouped into two or three
categories (Gold et al., 1999; Yuan et al., 2003; Sin et al., 2004; Mai et al., 2007;
Garcia-Marcos et al., 2008; Davidson et al., 2010; Jeong et al., 2010; Brew et al.,
2012; Lu et al., 2012; Mathew et al., 2012; Nuolivirta et al., 2012), see Appendix
D . A further three studies were also not combined due to the use of asthma
admission as outcome term (Kiechl-Kohlendorfer et al., 2007; Liu et al., 2014 ), and
pooled data from different continents and presented a summary risk estimate
(Mitchell et al., 2014).
The 38 studies were from Europe (18), Americas (12), Asia (5) and Oceania (3).
Only 1 study was classified as a case-control while the 37 were cohort (i.e.,
retrospective and prospective) studies. The sample population of 31 studies ranged
between 1,085 and 764,207 while 7 studies had <1,000 participants each.
2.3.3.2 Quality of studies
With a maximum score of 9 points available for each article, of the 38 included in
the meta-analysis: 14 scored 7-9 (>75%), 18 scored 5-6 (50-75%), and 6 scored ≤4 
(<50%) and their risks of biases can be interpreted as ‘low’, ‘moderate’ and ‘high’
respectively (Table 2.3). The quality of the studies can be categorised as high,
medium and low for quality scores of 7-9/9, 5-6/9 and ≤4/9, respectively. 
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Figure 2.1 Birthweight and wheezing disorders literature search flow chart
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Table 2.2 Characteristics of birthweight and wheezing disorders studies included in the meta-analysis
Author , year, region Study
design
Sample size Participants’ age and
gender
Outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure
categories
Weitzman et al. (1990), USA RC 2,927 2-5 years mixed asthma parent parent <2.5 kg and ≥2.5kg 
Seidman et al. (1991), Israel* RC 19,772 17 years boys asthma e-records e-records <2.5 kg, 2.5-4.0kg, and >4.0kg
Arshad et al. (1993), UK PC 1,215 2 years mixed asthma physician no mention <2.5 kg and ≥2.5kg 
Azizi et al. (1995), Malaysia CC 359 1 month-5 years mixed asthma physician no mention <2.5 kg and ≥2.5kg 
Lewis et al. (1995), UK* RC 12,577 5 years mixed wheezing parent e-records <2.5 kg, 2.5-4kg, and >4.0kg
Lewis et al. (1996), UK* RC 18,835 16 years mixed wheezing parent e-records <2.5 kg and ≥2.5kg  
Schaubel et al. (1996), Canada RC 16,207 1-4 years mixed asthma e-records e-records <2.5kg and ≥2.5kg 
Sears et al. (1996), New Zealand* PC 1,037 18 years mixed asthma physician e-records <2.5 kg, 2.5-4kg, and >4.0kg
Fergusson et al. (1997), New Zealand* RC 888 16 years mixed asthma e-records e-records <2.5 kg, 2.5-4kg, and >4.0kg
Lilljeqvist et al. (1997), Norway* RC 569 7-10 years mixed asthma parent e-records <2.5 kg, 2.5-4kg, and >4.0kg
Slezak et al. (1998), USA* RC 847 3-5 years mixed asthma parent no mention ≤2.5kg and >2.5kg 
Wjst et al. (1998), Germany RC 2,470 5-14 years mixed asthma parent parent <2.5 kg and ≥2.5kg 
Leadbitter et al. (1999), New Zealand* PC 735 13 years mixed asthma physician e-records <2.5 kg, 2.5-4kg, and >4.0kg
Rasanen et al. (2000) Finland* RC 4,502 16 years mixed asthma parent parent <2.5kg and ≥2.5kg 
Steffensen et al. (2000), Denmark* PC 4,795 18 years boys asthma physician e-records <2.5 kg, 2.5-4kg, and >4.0kg
Annesi-Maesano et al. (2001), UK RC 4065 0-18 years mixed asthma parent parent <2.5 kg and ≥2.5kg 
Brooks et al. (2001), USA* RC 8,071 3 years mixed asthma parent e-records <2.5 kg and ≥2.5kg 
Ronmark et al. (2002), Sweden RC 3,247 7-8 years mixed asthma parent e-records <2.5 kg and ≥2.5kg 
Anand et al. (2003), UK RC 256 15 years mixed asthma e-records e-records <2.5 kg and ≥2.5kg 
Benicio et al. (2004), Brazil RC 1,085 6-59 months mixed wheezing parent no mention <2.5 kg and ≥2.5kg 
Bolte et al. (2004), Germany* RC 715 5-7 years mixed asthma parent e-records <2.5 kg, 2.5-4kg, and >4.0kg
Al-Kubaisy et al. (2005), Iraq CC 2,262 6-12 years mixed asthma parent parent <2.5 kg and ≥2.5kg 
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Author , year, region Study
design
Sample size Participants’ age and
gender
Outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure
categories
Bernsen et al. (2005), Netherlands* RC 1,710 6 years mixed asthma e-records e-records <2.5kg and ≥2.5kg 
Nepomnyaschy and Reichman (2006),
USA
RC 1,803 3 years mixed asthma parent e-records <2.5 kg and ≥2.5kg 
Remes et al. (2008), Finland* RC 4,660 16 years mixed asthma parent no mention <2.5kg and ≥2.5kg 
Ortqvist et al. (2009), Sweden* RC 10,570 9-12 years mixed asthma parent e-records <2.5kg and ≥2.5kg 
Xu et al. (2009), USA RC 2,409 1-5 years mixed asthma parent no mention <2.5kg, 2.5–4.0kg, and >4.0 kg
Midodzi et al. (2010), Canada PC 8,397 4-5 years mixed asthma physician e-records <2.5 kg and ≥2.5kg 
Bjerg et al. (2011), Sweden RC 2,996 11-12 years mixed asthma parent no mention <2.5 kg and ≥2.5kg 
Mogensen et al. (2011), Sweden* PC 1784 13-14 years mixed asthma parent e-records <2.5kg and ≥2.5kg 
Suglia et al. (2011), USA RC 1,815 3 years mixed asthma parent parent <2.5kg and ≥2.5kg 
To et al. (2012), Canada* RC 687,194 6 years mixed asthma e-records e-records <2.5kg and ≥2.5kg 
Wang et al. (2012), Taiwan RC 78,011 13-16 years mixed asthma parent e-records <2.5 kg and ≥2.5kg 
Kallen et al. (2013), Sweden* RC 764,207 2-11 years mixed asthma e-records e-records <2.5 kg, 2.5-4kg, and >4.0kg
Miyake and Tanaka (2013), Japan RC 2004 3 years mixed asthma parent e-records <2.5 kg and ≥2.5kg 
Yang et al. (2013), USA RC 3,933 7 years mixed asthma e-records e-records <2.5 kg and ≥2.5kg 
Granell et al. (2014), UK PC 4,778 7 years mixed asthma e-records parent <2.5 kg and ≥2.5kg 
Reis et al. (2015), Brazil RC 1,468 1-4 years mixed asthma parent parent <2.5 kg and ≥2.5kg 
PC=prospective cohort; RC=retrospective cohort; CC=case-control; * = regrouped birthweight categories; mixed=included both genders.
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Table 2.3 Risk of bias assessment table using Newcastle-Ottawa quality assessment scale for birthweight and wheezing disorder
studies included in the meta-analysis
Author , year, region Study title Selection Comparability outcome
Weitzman et al, 1990, USA Racial, social, and environmental risks for childhood asthma   
Seidman et al, 1991, Israel Is low birth weight a risk factor for asthma during adolescence?   
Arshad et al, 1993, UK The effect of genetic and environmental factors on the prevalence
of allergic disorders at the age of two years
  
Azizi et al, 1995, Malaysia Indoor Air Pollution and Asthma in Hospitalized Children in a
Tropical Environment
Lewis et al, 1995, UK Prospective study of risk factors for early and persistent wheezing
in childhood
  
Lewis et al, 1996, UK Study of the aetiology of wheezing illness at age 16 in two national
British birth cohorts
  
Schaubel et al, 1996, Canada Neonatal characteristics as risk factors for preschool asthma   
Sears et al, 1996, New Zealnd Parental and neonatal risk factors for atopy, airway hyper-
responsiveness, and asthma
  
Fergusson et al, 1997, New
Zealand
Perinatal factors and atopic disease in childhood   
Lilljeqvist et al, 1997, Norway Low birthweight, environmental tobacco smoke, and air pollution:
Risk factors for childhood asthma?
 
Slezak et al, 1998, USA Asthma prevalence and risk factors in selected Head Start sites in
Chicago
  
Wjst et al, 1998, Germany Pulmonary function in children with initial low birth weight   
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Author , year, region Study title Selection Comparability outcome
Leadbitter et al, 1999, New
Zealand
Relationship between foetal growth and the development of asthma
and atopy in childhood
  
Rasanen et al, 2000, Finland Perinatal risk factors for asthma in Finnish adolescent twins   
Steffensen et al, 2000,
Denmark
Low birth weight and preterm delivery as risk factors for asthma
and atopic dermatitis in young adult males
  
Annnesi-maesano et al, 2001, In utero and perinatal complications preceding asthma   
Brooks et al, 2001, USA Impact of low birth weight on early childhood asthma in the United
States
  
Ronmark et al, 2002, Sweden Incidence rates and risk factors for asthma among school children:
A 2-year follow-up Report from the Obstructive Lung Disease in
Northern Sweden (OLIN) studies
  
Anand et al, 2003, UK Lung function and respiratory health in adolescents of very low
birth weight
  
Benicio et al,2004, Brazil Wheezing conditions in early childhood: prevalence and risk factors
in the city of Sao Paulo, Brazil
  
Bolte et al, 2004, Germany The relation of markers of foetal growth with asthma, allergies and
serum immunoglobulin E levels in children at age 5-7 years
  
Al-kubaisy et al, 2005, Iraq Risk factors for asthma among primary school children in Baghdad,
Iraq

Bernsen et al, 2005,
Netherlands
Perinatal characteristics and obstetric complications as risk factors
for asthma, allergy and eczema at the age of 6 years
  
Nepomnyaschy et al, 2006,
USA
Low birthweight and asthma among young urban children   
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Author , year, region Study title Selection Comparability outcome
Remes et al, 2008, Finland High birth weight, asthma and atopy at the age of 16 years   
Ortqvist et al, 2009, Sweden Familial factors do not confound the association between birth
weight and childhood asthma
  
Xu et al, 2009, USA The effects of birthweight and breastfeeding on asthma among
children aged 1-5 years
  
Midodzi et al,2010, Canada Early Life Factors Associated with Incidence of Physician-
diagnosed Asthma in Preschool Children: Results from the
Canadian Early Childhood Development Cohort Study
  
Bjerg et al, 2011, Sweden A strong synergism of low birth weight and prenatal smoking on
asthma in schoolchildren
  
Mogensen et al 2011, Sweden Association between childhood asthma and ADHD symptoms in
adolescence – a prospective population-based twin study
  
Suglia et al, 2011, USA Asthma and obesity in three-year-old urban children: Role of sex
and home environment
  
To et al, 2012, Canada Is large birth weight associated with asthma risk in early
childhood?
  
Wang et al ,2012, Taiwan Joint effects of birth outcomes and childhood body mass index on
respiratory symptoms
  
Kallen et al, 2013, Sweden Association between preterm birth and intrauterine growth
retardation and child asthma
  
Miyake et al, 2013, Japan Lack of relationship between birth conditions and allergic disorders
in Japanese children aged 3 years
  
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Author , year, region Study title Selection Comparability outcome
Yang et al,2013, USA Population-based study on association between birth weight and
risk of asthma: A propensity score approach
  
Grannel et al, 2014, UK Effects of BMI, Fat Mass, and Lean Mass on Asthma in Childhood:
A Mendelian Randomization Study
  
Reis et al, 2015, Brazil Prevalence and risk factors for wheezing in Salvador, Brazil: A
population-based study
  
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2.3.3.3 Meta-analysis
Low birthweight
A total of 31 studies contributed data on the number of cases and non-cases of
childhood wheezing disorders that included 1,425,480 children. An overall risk
estimate of the studies that compared <2.5kg and ≥2.5kg of birthweight groups 
showed that there was a significant increased odds of wheezing disorders (OR=
1.55, 95% CI: 1.35 to 1.79, P<0.01) for <2.5kg birthweight (Figure 2.2). There was
substantial heterogeneity among the studies (I2 = 81%, 95% CI: 72% to 87%). A
further meta-analysis of 11 studies that comprised 105,071 children and provided
adjusted odds ratios for the same birthweight comparison groups also showed an
increase of wheezing disorder risk by 63% (OR=1.63, 95% CI: 1.32 to 2.01, P<0.01)
for the <2.5kg birthweight children (Figure 2.3)
Figure 2.2 Summary unadjusted odds ratios of wheezing disorders for low
(<2.5kg) compared with normal (≥2.5kg) birthweight categories 
Heterogeneity chi-squared = 107 (df = 20) p < 0.001, I2 = 81% (95% CI: 72% to 87%), and the estimate of between-study
variance Tau-squared = 0.06.
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Figure 2.3 Summary adjusted odds ratios of wheezing disorders for low (<2.5kg)
compared with normal (≥2.5kg) birthweight categories  
Heterogeneity chi-squared = 23 (df = 10) p = 0.01, I2 = 57% (95% CI: 16% to 78%), and the estimate of between-study
variance Tau-squared = 0.06.
A summary risk estimate of 10 studies that provided data on 2.5-4.0kg and <2.5kg
birthweight comparison groups showed that there is a significant increase in
wheezing disorders risk for the <2.5kg birthweight children (OR=1.37, 95% CI: 1.05
to 1.79, P=0.02), and the between-study variation was very high (I2=83%, 95% CI:
68 % to 89%), see Figure 2.4. There was not enough data to carry out meta-analysis
of adjusted risk estimates for these birthweight comparison groups—only one study
contributed (Xu et al., 2009).
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Figure 2.4 Summary unadjusted odds ratios of wheezing disorders for low
(<2.5kg) compared with normal (2.5-4.0kg) birthweight categories
Heterogeneity chi-squared = 50 (df = 9) p < 0.001, I2 = 83% (95% CI: 68 % to 89%), and the estimate of between-study
variance Tau-squared = 0.09.
High birthweight
A total of 10 studies provided data on the number of cases and non-cases of
wheezing disorders for 2.5-4.0kg and >4.0kg birthweight comparison groups
(Figure 2.5). The overall odds ratio of childhood wheezing disorders for the >4.0kg
birthweight was 1.02 (95% CI: 0.99 to 1.04, P=0.13), which was not significantly
different from 1. There was no significant heterogeneity among the studies’ odds
ratio estimates (I2 = 0%, 95% CI: 0 to 45%). When further investigated if the non-
significant heterogeneity was due to the presence of Kallen et al’s study (Kallen et
al., 2013) that has dominated the pooled risk estimate, both the summary risk
estimate and the level of heterogeneity remained stable (OR=1.03, 95% CI:0.92 to
1.15 ; Q=6 (df = 8), P = 0.63, I2= 0%). There was not enough data to carry out meta-
analysis of adjusted risk estimates for these birthweight comparison groups—only
one study contributed (Xu et al., 2009).
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Figure 2.5 Summary unadjusted odds ratios of wheezing disorders for high
(>4.0kg) compared with normal (2.5-4.0kg) birthweight categories
Heterogeneity chi-squared = 6 (df = 9) p = 0.73, I2 = 0% (95% CI: 0% to 45%) and the estimate of between-study variance
Tau-squared = 0.00.
2.3.3.4 Subgroup analyses
Low birthweight and wheezing disorders
Subgroup meta-analyses of 21 studies that compared the low (<2.5kg) and normal
(≥2.5kg) birthweight categories showed that the summary risk estimates remained
significant in all subgroups of the a priori defined covariates, except if wheezing
was used as an outcome term or diagnosis was reported by a parent or the studies
were low quality (Table 2.4). When the same analysis was carried out on the studies
that reported adjusted odds ratios for the same birthweight comparison groups, there
was no statistically significant risk of association between low birthweight and
wheezing disorders only if birthweight was extracted from e-records or the study age
group were ‘five years and above’ or the studies were high quality (Table 2.5). The
between group heterogeneities in the unadjusted odds ratios were significant except
when for the outcome terms used (Table 2.4). In the adjusted odds ratios, the
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between group heterogeneity was significant for outcome and exposure
ascertainment, age group and study period (Table 2.5).
A further subgroup analyses of 10 studies that contributed data on the wheezing
disorder cases and non-cases in the low (<2.5kg) and normal (2.5kg-4.0kg)
birthweight groups were performed. The results showed inconsistent risk of
association among subgroups of all the predefined study characteristics. For
example, there was no significant association between low birthweight and
wheezing disorders if studies used asthma as an outcome term or sample size of less
than 1000 was used or studies were published before 2000 (Table 2.6). The between
and within group heterogeneities were significant in most of the study
characteristics.
34
Table 2.4 Subgroup analysis of unadjusted odds ratio of wheezing disorders for
normal (≥2.5kg) compared with low birthweight (<2.5kg) categories 
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.56 (1.34 to 1.82) 19 83% <0.01 0.82
Wheezing 1.50 (0.95 to 2.39) 2 63% 0.1
Outcome ascertainment
E-records 1.64 (1.15 to 2.36) 5 86% <0.01 <0.01
Parent 1.49 (1.26 to 1.77) 15 70% <0.01
Physician 2.09 (1.69 to 2.59) 1 -
Exposure ascertainment
E-records 1.52 (1.29 to 1.78) 13 83% <0.01 0.01
Parent 1.48 (0.87 to 2.53) 4 86% <0.01
No mention 1.79 (1.32 to 2.42) 4 24% 0.27
Age during diagnosis
Five years and above 1.41 (1.21 to 1.63) 13 74% <0.01 <0.01
Under five years 1.56 (1.12 to 2.19) 5 73% 0.02
Mixed (0-19 years) 2.14 (1.77 to 2.57) 3 0% 0.75
Sample size
1000+ 1.53 (1.33 to 1.76) 20 81% <0.01 0.03
<1000 3.46 (1.49 to 8.04) 1 -
Study period
<2000 1.76 (1.23 to 2.51) 4 74% <0.01 <0.01
2000+ 1.51 (1.30 to 1.76) 17 81% <0.01
Study type
Cohort 1.51 (1.32 to 1.72) 20 77% <0.01 <0.01
Case-control 2.41 (1.89 to 3.07) 1 -
Study quality score c
High (7-9/9) 1.63 (1.22 to 2.18) 7 90% <0.01 <0.01
Medium (5-6/9) 1.41 (1.24 to 1.61) 11 23% 0.22
Low (≤4/9) 1.90 (0.90 to 3.98) 3 91% <0.01
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Table 2.5 Subgroup analysis of adjusted odds ratios of wheezing disorders for
normal (≥2.5kg) compared with low (<2.5kg) birthweight categories  
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.59 (1.28 to 1.98) 10 57% 0.01 0.13
Wheezing 2.09 (1.24 to 3.53) 1 -
Outcome ascertainment
Parent 1.53 (1.24 to 1.89) 9 55% 0.02 0.02
Physician 2.52 (1.50 to 4.23) 2 0% 0.06
Exposure ascertainment
E-records 1.21 (0.96 to 1.52) 4 33% 0.21 <0.01
Parent 1.71 (1.29 to 2.89) 2 0% 0.42
No mention 2.14 (1.65 to 2.79) 5 0% 0.93
Age during diagnosis
Five years and above 1.11 (0.93 to 1.32) 2 0% 0.58 <0.01
Under five years 1.63 (1.11 to 2.40) 4 57% 0.07
Mixed (0-19 years) 1.85 (1.49 to 2.31) 5 0% 0.85
Sex
Boys 1.52 (1.13 to 2.04) 1 - - 0.59
Both 1.67 (1.30 to 2.14) 10 61% <0.01
Sample size
1000+ 1.56 (1.24 to 1.97) 9 59% <0.01 0.06
<1000 2.01 (1.36 to 3.09) 2 0% 0.82
Study period
<2000 2.16 (1.59 to 2.93) 4 0% 0.83 <0.01
2000+ 1.44 (1.15 to 1.81) 7 56% 0.34
Study type
Cohort 1.60 (1.29 to 1.99) 10 58% 0.01 0.21
Case-control 2.19(1.09 to 4.4) 1 -
Study quality score c
High (7-9/9) 1.42 (0.80 to 2.54) 2 81% 0.02 <0.01
Medium (5-6/9) 1.70 (1.41 to 2.03) 9 11% 0.34
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Table 2.6 Subgroup analysis unadjusted odds ratios of wheezing disorders for
normal (2.5-4.0kg) compared with low (<2.5kg) birthweight categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.33 (0.95 to 1.85) 9 75% <0.001 <0.01
Wheezing 1.34 (1.14 to 1.59) 1 -
Outcome ascertainment
E-records 1.50 (0.98 to 2.30) 3 81% <0.01 <0.01
Parent 1.61 (1.16 to 2.24) 4 51% 0.1
Physician 0.49 (0.13 to1.89) 3 78% 0.01
Exposure ascertainment
0.9E-records 1.27 (0.93 to 1.72) 9 84% <0.001
No mention 1.93 (1.37 to 2.72) 1 -
Age during diagnosis
Five years and above 1.10 (0.76 to 1.59) 8 66% <0.01 <0.01
Mixed (0-19 years) 1.96 (1.87 to 2. 04) 2 0% 0.9
Gender
Mixed 1.32 (0.94 to 1.85) 8 84% <0.001 0.04
Boys 1.44( 1.12 to 1.87) 2 0% 0.71
Sample size
1000+ 1.62 (1.29 to 2.02) 5 82% <0.001 0.01
<1000 0.61 (0.20 to 1.91) 5 75% 0.03
Study period
<2000 1.00 (0.62 to 1.63) 6 76% <0.01 <0.01
2000+ 1.95(1.85 to 2.05) 4 0.6% 0.39
Study quality score c
High (7-9/9) 1.14 (0.75 to 1.74) 6 81% <0.001 0.01
Medium (5-6/9) 1.56 (1.10 to 2.21) 2 70% 0.06
Low (≤4/9) 0.86 (0.03 to 23.90) 2 88% <0.01
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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High birthweight and wheezing disorders
Subgroup meta-analyses of 10 studies that contributed data on the cases and non-
cases of wheezing disorders in the high (>4.0kg) and normal (2.5-4.0kg) birthweight
categories showed that the risk of association was not significant across all
categories of the predefined study characteristics and the study quality (Table 2.7).
Both the within and between group heterogeneities were insignificant.
Table 2.7 Subgroup analysis of unadjusted odds ratios of wheezing disorders for
normal (2.5-4.0kg) compared with high birthweight (>4.0kg) categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.02 (0.99 to 1.04) 9 0% 0.69 0.45
Wheezing 1.08 (0.93 to1.26) 1 0% 0.73
Outcome ascertainment
E-records 1.02 (0.99 to1.04) 3 0% 0.69 0.82
Parent 1.06 (0.89 to1.25) 4 5% 0.36
Physician 1.04 (0.80 to1.36) 3 0% 0.40
Exposure ascertainment
E-records 1.02 (1.00 to1.04) 9 0% 0.80 0.22
No mention 0.74 (0.44 to1.23) 1
Age during diagnosis
Five years and above 1.04 (0.93 to1.17) 8 0% 0.73 0.66
Mixed (0-19 years) 0.96 (0.76 to1.22) 2 34% 0.22
Gender
Boys 0.97(0.79 to1.20) 2 0% 0.38 0.66
Mixed 1.02 (1.00 to1.04) 8 0% 0.64
Sample size
1000+ 1.02 (0.99 to1.04) 5 0% 0.55 0.78
<1000 1.02(1.00 to1.04) 5 0% 0.55
Study period
<2000 1.04 (0.92 to1.17) 6 0% 0.51 0.75
2000+ 1.02 (0.99 to1.04) 4 0% 0.63
Study quality score c
High (7-9/9) 1.02 (0.99 to 1.04) 3 0 0.54 0.54
Medium (5-6/9) 1.01 (0.89 to 1.15) 4 0 0.42
Low (≤4/9) 1.26 (0.87 to 1.82) 3 0 0.65
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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2.3.3.5 Meta-regression analysis
Birthweight and wheezing disorders
Investigating the sources of between-study heterogeneities of the unadjusted low
birthweight odds ratios showed that 64% (adjusted R-squared=64%, P=0.04) of the
variance was explained by the a priori selected covariates in the <2.5kg and ≥2.5kg 
birthweight comparisons. However, none of the variance was explained by the a
priori selected covariates in the adjusted <2.5kg and ≥2.5kg and the unadjusted 
<2.5kg and 2.5-4.0kg birthweight comparisons (Table 2.8). No further investigation
of between-study heterogeneity (i.e. meta-regression analysis) was carried out for
the high (>4.0kg) and normal (2.5-4.0kg) birthweight categories’ odds ratios as there
was no statistically significant variation among the studies (Table 2.8).
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Table 2.8 Meta-regression analysis of odds ratios of wheezing disorders for low
compared with normal birthweight categories
Study characteristics Coefficient (95% CI) P-value
Unadjusted odds ratios for normal (≥2.5kg) versus low (<2.5kg)  
Outcome terms used (ref=asthma) -0.14 (-0.58 to 0.31) 0.53
Outcome ascertainment (ref=physician) -0.03 (-0.27 to 0.22) 0.83
Exposure ascertainment (ref=e-records) 0.01 (-0.19 to 0.21) 0.91
Age during diagnosis (ref=five and above) 0.24 (0.05 to 0.44) 0.02
Sample size (ref=less than 1000) -1.00 (-2.02 to 0.02) 0.05
Study period (ref=before 2000) -0.19 (-0.53 to 0.14) 0.24
Study type (ref=cohort) 0.65 (0.16 to 1.14) 0.01
Overall (adjusted R-squared) = 64%) 0.04
Adjusted odds ratios for normal (≥2.5kg) versus low (<2.5kg)
Outcome terms used (ref=asthma) -0.54 (-2.62 to 1.54) 0.38
Outcome ascertainment (ref=physician) -0.08 (-1.23 to 1.07) 0.78
Exposure ascertainment (ref=e-records) 0.82 (-0.83 to 2.48) 0.17
Age during diagnosis (ref=five and above) -0.24 (-1.19 to 0.72) 0.40
Sex (ref=mixed) 0.55 (-0.60 to 1.71) 0.18
Sample size (ref=less than 1000) 0.01 (-1.65 to 1.67) 0.98
Study period (ref=before 2000) 0.58 (-1.54 to 2.70) 0.36
Study type (ref=cohort) -0.07 (-3.04 to 2.91) 0.93
Overall (adjusted R-squared) = 0%) 0.28
Unadjusted odds ratios for normal (2.5-4.0kg) versus low (<2.5kg)*
Outcome ascertainment (ref=physician) 0.86 (-0.42 to 2.15) 0.12
Exposure ascertainment (ref=e-records) -0.44 (-2.00 to 1.12) 0.44
Age during diagnosis (ref=five and above) 0.52 (-1.37 to 2.41) 0.44
sex (ref=mixed) 1.21 (-2.08 to 4.5) 0.33
Sample size (ref=less than 1000) -0.01 (-2.70, 2.68) 0.99
Study period (ref=before 2000) 0.20 (-1.93, 2.31) 0.79
Overall (adjusted R-squared= 0%) 0.42
*: outcome terms was dropped due to collinearity.
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2.3.3.6 Investigating biases (small study effects)
Birthweight and wheezing disorders
The funnel plots showed no evidence of asymmetry for the high (>4.0kg versus 2.5-
4.0kg) birthweight unadjusted odds ratios (Figure 2.6C). However there was some
evidence of asymmetry for the low birthweight (2.5kg versus ≥2.5kg and <2.5kg 
versus 2.5-4.0kg) unadjusted odds ratio estimates (Figure 2.6A and Figure 2.6B) and
low birthweight (2.5kg versus ≥2.5kg) adjusted odds ratio estimates (Figure 2.6D).
This was also reflected in Egger’s tests (Table 2.9), with no evidence of small-study
effects for Figure 2.6C (p=0.99), but some evidence for Figure 2.6A (p=0.04),
Figure 2.6B (p=0.02) and Figure 2.6D (p=0.02).
Figure 2.6 Egger’s funnel plots of birthweight and wheezing disorder studies
(A) <2.5kg (low) versus ≥2.5kg (normal) birthweight ;(B) <2.5kg (low) versus 2.5-4.0kg (normal) birthweight ; (C) >4.0kg 
(high) versus 2.5-4.0kg (normal) birthweight and (D) <2.5kg (low) versus ≥2.5kg (normal) birthweight risk estimate funnel 
plots. Unadjusted odds ratio in A, B, and C, and adjusted risk estimates in D. In all funnel plots, the middle solid line is the
summary odds ratio estimate and the two diagonal dotted lines are the 95% confidence limits around the summary odds ratio,
and the slant solid lines in figures A, B and D are the fitted regression lines for Egger’s small-study effect test. Note that the
fitted regression line in C is exactly aligned to and obscured by the middle solid line.
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Table 2.9 Egger’s test of bias for small study effects in birthweight and wheezing
disorders studies
Parameter Coefficient (95% CI) P-value
Unadjusted odds ratios for normal (≥2.5kg) versus low (<2.5kg)  
Slope 0.21 (0.10 to 0.32) <0.01
Bias 1.32 (0.07 to 2.58) 0.04
Adjusted odds ratios for normal (≥2.5kg) versus low (<2.5kg)
Slope -0.01 (-0.32 to 0.30) 0.92
Bias 2.09 (0.51 to 3.67) 0.02
Unadjusted odds ratios for normal (2.5-4.0kg) versus low (<2.5kg)
Slope 0.70 (0.60 to 0.80) <0.01
Bias -1.90 (-3.40 to -0.40) 0.02
Unadjusted odds ratios for normal (2.5-4.0kg) versus high (>4.0kg)
Slope 0.12 (-0.01 to 0.05) 0.17
Bias 0.002 (-0.73 to 0.73) 0.99
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2.3.4 Discussion
2.3.4.1 Key findings
This meta-analysis is the most recent comprehensive analysis as it includes 77
studies published until March 2015. The results showed that low birthweight
(defined as <2.5kg) children have an increased risk of wheezing disorders when
compared to the normal birthweight children (defined as ≥2.5) based on unadjusted 
(OR= 1.55, 95% CI: 1.35 to 1.79) and adjusted (OR=1.63, 95% CI: 1.32 to 2.01)
estimates. If the low birthweight are compared with those of 2.5-4.0kg birthweight
children, there is a 37% increase of wheezing disorders risk (unadjusted OR=1.37,
95% CI: 1.05 to 1.79) although it must be considered that there was a significant
between-study heterogeneity and some evidence of small study effects or
publication bias. However, there is a weak evidence to suggest that high birthweight
(defined as >4.0kg) children have increased odds of wheezing disorders (unadjusted
OR=1.02, 95% CI: 0.99 to 1.04, P=0.13), when compared to the normal birthweight
(defined as 2.5-4.0kg).
2.3.4.2 Results in context of previous reviews and meta-analyses
The unadjusted pooled risk estimates for low birthweight are moderately higher than
those of a recent meta-analysis by Mu et al. (2014) that reported unadjusted ORs of
1.28 (95% CI: 1.09 to 1.50) and 1.34 (95% CI: 1.13 to 1.60) for studies that used
two (i.e. <2.5 versus ≥2.5kg) and three (i.e. <2.5 versus 2.5-4.0kg) birthweight 
categories respectively. However, some studies included in their meta-analysis were
not consistent had adult population, and the fact that more studies were included in
this study than theirs may have possibly influenced the difference in robustness of
the summary risk estimates. Xu et al. (2014) also reported a RR of 1.15 (95% CI:
1.08 to 1.22) for low birthweight children. However, birthweight categories and risk
reporting methods were not consistent across the studies included their meta-
analysis so their results may not be comparable with this meta-analysis’s findings.
The unadjusted summary risk of association between high birthweight and wheezing
disorders was not statistically significant in contrast to a previous meta-analysis by
Flaherman and Rutherford (2006) that reported a 20% increase of asthma risk (RR=
1.2; 95% CI: 1.1 to 1.3). However, it must be noted that the studies included in the
previous meta-analysis had used different cut-off points and measurement types for
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high birthweight, and risk estimation methods (relative risk and odds ratio).
Combining studies with different cut-off points may under or overestimate the
summary risk estimate. Likewise, combining relative risks and odd ratios may have
a similar effect in common diseases (McNutt et al., 2003; Viera, 2008).
The studies that were not included in this meta-analysis reported inconsistent risk of
association for the low birthweight categories (Appendix D ), although a recent
ISAAC Phase III study that used similar birthweight categories has reported an odds
ratio of 1.20 (95%: 1.12 to 1.30) for low birthweight (Mitchell et al., 2014).
However, the majority of the studies reported no risk of association for the high
birthweight group, agreeing with the findings of this meta-analysis.
Based on the pooled odds ratio results, the adjusted and unadjusted summary odds
ratios for two and three birthweight categories were similar. This may strongly
suggest that low birthweight is an independent risk factor for childhood wheezing
disorders although it must be noted that there are also some evidence of bias in the
funnel plots and Egger’s tests of bias (Egger et al., 1997; Sterne et al., 2001) which
may indicate that there was potential publication bias for studies that showed no
significant risk of association (Sterne and Habord, 2004).
Based on the heterogeneity measures (Q-test and I2), there was a considerable level
of between-study variation in the low birthweight unadjusted risk estimates although
this could be due to high precision or high sample size of studies included in this
meta-analysis (Rücker et al., 2008) as illustrated in the forest plot (Figure 2.2). The
studies were mostly precise and had narrow confidence intervals. However, there
was no significant heterogeneity among the unadjusted risk estimates of high
birthweight and asthma and this could be due to having less precise risk estimates
with wider confidence intervals as demonstrated by the forest plot (Figure 2.5).
2.3.4.3 Strengths and weaknesses
This work has limitations and results should be interpreted cautiously. First, in the
low birthweight and overweight summary risk estimates, there was a significant and
substantial level of between-study variation that was not explained by the a priori
selected covariates. Second, there is also some evidence of funnel plot asymmetry
which may indicate a potential small study effect such as potential publication bias
(Egger et al., 1997). Third, as in any systematic review and meta-analysis, a
44
possibility of potentially relevant studies being missed cannot be ruled out. Fourth,
the results are based on epidemiologic observational studies and are solely
dependent on the quality of the primary studies included.
The strength of this work is that it was possible to produce consistent risk estimates
due to the use of harmonised data. Combining adjusted risk estimates was a primary
choice among previous authors. This technique may, however, under or
overestimate the association between exposure and outcome variables due to
exclusion of studies that used non-standard weight categories or combining all
irrespective of the type of exposure categorisation method used. In order to improve
validity of the summary risk estimates, data harmonisation techniques were
implemented and more studies were included than if previous authors’ techniques
were used. Most importantly, it was possible to produce more consistent summary
risk estimates of birthweight (i.e., low and high birthweight) on wheezing disorders
than if results of studies were to be combined irrespective of cut-off points as used
by previous authors. The other strength of this work is also that it was possible to
extract and analyse both adjusted and unadjusted risk estimates, which can be used
as an internal validation to each other.
In conclusion, the results show that there is strong evidence that suggests low birth
(<2.5kg) is a risk factor for wheezing disorders during childhood and adolescence.
However, there is weak evidence for an increase of asthma or wheezing disorders
risk for high birthweight children.
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2.4 BMI and wheezing disorders
2.4.1 Critique of past systematic reviews and meta-analyses
Previous observational epidemiologic studies suggest that overweight/obesity and
childhood asthma are associated. However, an inconsistency in the results remains.
A meta-analysis of four observational epidemiologic studies reported a 50%
(RR=1.50, 95% CI: 1.2 to 1.8) increased risk of childhood asthma for overweight
(Flaherman and Rutherford, 2006). However, the included studies used a variety of
risk estimate definitions: three used odds ratios (Castro-Rodriguez et al., 2001;
Chinn and Rona, 2001; Xu et al., 2002) and another used relative risk (Gilliland et
al., 2003).
Results from a recent meta-analysis of 6 cohort studies by Chen et al. (2013)
reported relative risks of 1.19 (95% CI: 1.03 to 1.37) and 2.02 (95% CI: 1.16 to 3.5)
for childhood asthma in those who were overweight and obese respectively. In a
meta-analysis of 6 prospective studies, it was also reported that there is a 35%
(RR=1.35, 95% CI: 1.15 to 1.58) and 50% (RR=1.50, 95% CI: 1.22 to 1.83) increase
in risk of childhood asthma for overweight and obesity respectively (Egan et al.,
2013). However, the age of study populations, Body Mass Index (BMI)
categorisations, and risk estimate definitions were not consistent across the studies
included in the two meta-analyses. For example, in the meta-analysis by Egan et al.
(2013), one study used data-driven quintile BMI categories, (Gold et al., 2003)
whilst the other two studies used only high risk children, (Zhang et al., 2010; Ho et
al., 2011), two used relative risk, (Gilliland et al., 2003; Gold et al., 2003) one used
hazard ratios (Mannino et al., 2006), and the other three used odds ratio (Mamun et
al., 2007; Zhang et al., 2010; Ho et al., 2011) as risk estimate definitions. Likewise,
in the meta-analysis by Chen et al. (2013), one study included adult population
(Burgess et al., 2007), and another used bronchitis as the outcome variable instead of
asthma or wheezing symptoms (Lee et al., 2013).
Combining studies that include child and adult populations, use non-standard and
inconsistent BMI categories and a variety of risk estimate definitions in a meta-
analysis may bias the summary risk estimates. For example, suppose that two studies
used 30th centile, three used 10th centile and four other used 5th centile as cut-off
points for underweight. Then, it becomes difficult to combine these 9 studies in a
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meta-analysis as the cut-off points used are not equivalent. The last group used a
standard BMI cut-off point for underweight (5th centile) and the other two groups
used cut-off points of convenience where some individuals grouped as underweight
in these studies have normal BMI according to the standard BMI categorisation
methods. Similarly, although the estimates from odds ratios and relative risks are
similar when the disease is rare (<10%), they diverge as the prevalence increases
(McNutt et al., 2003; Viera, 2008), potentially biasing the summary risk estimates
derived from combined odds ratios and relative risks.
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2.4.2 Sythematic literature review methods
2.4.2.1 Literature Search Strategy
The reviews were carried out in accordance with the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009).
Online searches were carried out using the EMBASE and MEDLINE databases.
Table 2.10 gives the details of terms and phrases used for the literature search.
2.4.2.2 Inclusion criteria
Eligible papers were those published as an article, in English, and reported original
research about the effects of BMI on wheezing disorders in children 0-19 years of
age. No lower limit for a time of publication was set. However, the literature search
covered the period to March 2015. Case-control, cohort, and cross-sectional studies
were included.
2.4.2.3 Exclusion criteria
Papers were excluded if:
a) BMI was modelled as a continuous variable as an assumption was made that
the risk of outcome (wheezing disorder) is higher in the lower and higher
ends of BMI bands. Thus, ‘standard’ categorical variable BMI was
considered to be more appropriate;
b) Authors claimed BMI was included in their analyses but no comparison
group or risk estimates were presented in text or table of the papers;
c) Authors used data-driven multiple categories of BMI that cannot be
converted into the ‘standard’ categories;
d) Studies included an adult population with no separate data available for
children and adolescents; and,
e) Authors used data-driven multiple BMI categories and if the number of
categories presented were generally too few (<4) to allow combination with
studies through estimating nonlinear dose-response curves (Orsini et al.,
2012).
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Table 2.10 Terms and phrases used during literature search
2.4.2.4 Data extraction
For the studies that were eligible to be included in the meta-analyses, the following
characteristics were extracted:
a) Authors’ name;
b) Year of publication;
c) Country of study;
d) Study design;
e) Sample size;
f) Study age group and gender;
Body mass index
1 BMI
2 Current weight
3 Child weight
4 Child BMI
5 Child obesity
6 Obes* adj2 children
7 underweight
8 overweight
9 Child* obesity
10 Child* growth
11 High BMI
12 High weight
13 Low BMI
14 Asthm*
15 Wheez*
16 wheezing
17 Wheezing disorders
18 Asthma in children
19 Childhood asthma
20 Childhood wheez*
21 1-13/or
22 14-20/or
23 21-22/and
24 Limit 23 to English language
N.B: First literature searches were conducted on 4th June 2014. Updated was carried out on 8th April 2015.
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g) Diagnosis (outcome) terms;
h) Body mass index (exposure) categories;
i) Body mass index categorisation methods;
j) Outcome and exposure ascertainment methods; and,
k) Risk estimates.
2.4.2.5 Data standardisation
Exposure variable
Data on exposure variable varied according to the cut-off points of BMI categories
adopted by authors:
a) The CDC: <5th centile, ≥5th and <85th centiles, ≥ 85th and <95th centiles, and
≥95th centile for underweight, normal, overweight, and obese categories
respectively (CDC, 2014);
b) The International Obesity Task Force (IOTF): Age and sex specific cut-off
points that are extrapolated from the adult BMI cut-offs of 18.5kg/m2,
25kg/m2, and 30kg/m2 for underweight, overweight, and obesity
respectively (Cole et al., 2000; Cole et al., 2007);
c) The WHO: 85th-95th (1SD+) and ≥95th (2SD+) centiles for overweight and
obese, respectively (NOO, 2011); and,
d) Data-driven multiple BMI categories.
For comparability and not to lose data due to variation in categorisation methods,
data were standardised as follows:
a) Where authors used one of the standard category methods (CDC, IOTF or
WHO), the reported adjusted risk estimates and data on the number of cases
and non-cases of each BMI comparison group were combined for meta-
analysis without any change;
b) Where authors adopted data-driven BMI categories with the CDC, IOTF or
WHO normal category as a reference and where the number of participants
in each category was available, the stratum based number of cases and non-
cases were aggregated before being combined with the other studies for
meta-analysis of unadjusted risk estimates; and,
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c) Where authors adopted two or three birthweight categories with CDC, IOTF
or WHO normal category as a reference and provided adjusted risk
estimates, the stratum based risk estimates were aggregated using from
Hamling et al. (2008) method before being combined with the other studies
for meta-analysis of adjusted risk estimates.
Outcome variable
Study authors used one or multiple outcome terms. Thus, for comparability among
studies, where authors used a single outcome, for example, asthma or wheezing, the
quoted outcome term by the author and its risk estimate were assumed for analysis.
However, where authors used multiple outcome terms, the term that was highest in
the hierarchy and its risk estimate were assumed for analysis. For example, if asthma
and wheezing were used together, asthma was preferred over wheezing.
2.4.2.6 Quality assessment
Papers included in the review and meta-analysis were assessed for risks of bias
using the Newcastle-Ottawa quality assessment scale (Wells et al., 2000),
see Appendix A , Appendix B and Appendix C for details on scoring guidelines
used.
2.4.2.7 Statistical analysis
Random effects models were adopted in pooling estimates using the DerSimonian
and Laird method (DerSimonian and Laird, 1986). If studies presented stratum-
specific estimates (e.g. by gender), then to provide correct measures of
heterogeneity, the risk estimates were aggregated using fixed-effect models before
being combined with the other studies for meta-analyses of adjusted risk estimates in
a random-effects model. Likewise, if the number of cases and non-cases in each
stratum were reported, the total number of cases and non-cases were aggregated
before being combined with the other studies for meta-analyses.
The Cochrane Q-test (Whitehead and Whitehead, 1991) and the I2 (Higgins and
Thompson, 2002) were used in estimating between-studies heterogeneity. Sub-group
meta-analyses and sensitivity analyses were performed in order to assess the
robustness of the risk associations and levels of between-study heterogeneities
within a covariate. Then, meta-regression (Lau et al., 1998; Borenstein et al., 2009d)
51
of risk estimates were performed if a covariate showed significant heterogeneity
among its levels.
Publication bias and small study effects were investigated using symmetry funnel
plots and bias test models (Egger et al., 1997; Sterne et al., 2001). All meta-analyses
were carried out in Stata software version 12 (StataCorp, 2011).
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2.4.3 Results
2.4.3.1 Literature search
A total of 4,013 papers were retrieved from EMBASE and Medline. Of these, 91
were read in full. Out of the 91 papers, 45 were included in the review (Figure 2.7).
A total of 39 studies that reported either the risk estimates or number of cases and
non-cases of wheezing disorders in each exposure group were included in the meta-
analysis (Table 2.11). Results from six studies were not combined with the other
studies for meta-analysis as they used slightly different centile cut-off points (von
Kries et al., 2001; Mai et al., 2007; Okabe et al., 2011; Okabe et al., 2012; Mitchell
et al., 2013; Willeboordse et al., 2013).
The 39 studies were from Europe (12), Americas (18), Asia (7) and Oceania (2). The
studies were cross-sectional (25), case-control (2) and cohort (12). Only 5 of 39
studies involved a sample population of <1000 each.
2.4.3.2 Quality of studies
Out of the total 39 studies included in the meta-analysis: twenty-five scored 7-9,
thirteen scored 5-6, and their risks of biases can be interpreted as ‘low’ and
‘moderate’ respectively (Table 2.12).
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Figure 2.7 Body mass index and wheezing disorders literature search flow chart
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Table 2.11 Characteristics of BMI and wheezing disorders studies included in the meta-analysis
Author , year, region Study
design
Sample
size
Participants age
and gender
outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure categories
Gennuso et al. (1998), USA CC 171 4-16 years mixed asthma e-records e-records overweight: 85th-95th and obesity: ≥95th
centile
Chinn and Rona (2001), UK PC 4,743 9 years mixed asthma parent trained IOTF cut-offs for underweight, overweight,
and obese.
Rodríguez et al. (2002), USA CS 12,388 2 months-16 years
mixed
asthma parent no mention overweight: ≥85th centile
Gilliland et al. (2003), USA PC 3,792 7-18 years mixed asthma child trained overweight: 85th-95th and obese:≥95th
centile
Bibi et al. (2004), Israel CS 5,984 8 years mixed asthma parent trained non-obese≤ 95th and obese:≥95th centile
Cassol et al. (2005), Brazil CS 4,010 13-14 years mixed asthma child trained underweight: <5th overweight: 85th-95th
and obese:≥95th centile
Saha et al. (2005), USA RC 2,544 5-18 years mixed asthma e-records e-records overweight: 85th-95th and obese:≥95th
centile
Wickens et al. (2005), New
Zealand
CS 1,287 11-12 years mixed asthma parent trained IOTF cut-offs for underweight, overweight,
and obese.
Kwon et al. (2006), USA CS 853 2-11 years mixed asthma parent no mention underweight: <5th , overweight: 85th-95th
and obese:≥95th centile
Shamssain (2006), UK CS 7,000 5-16 years mixed asthma parent no mention IOTF cut-offs for underweight, overweight,
and obese.
Van De Ven et al. (2006),
Netherlands
CS 10,087 12-14 years mixed asthma parent parent IOTF cut-offs for underweight, overweight,
and obese.
Davis et al. (2007), USA CS 471,969 12-18 years mixed asthma child child underweight: <5th , overweight: 85th-95th
and obese:≥95th centile
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Author , year, region Study
design
Sample
size
Participants age
and gender
outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure categories
Tollefsen et al. (2007), Norway PC 1,477 17-19 mixed wheezing child trained overweight: ≥85th centile
Tsai et al. (2007), Taiwan CS 2,218 11-12 years mixed asthma child e-records underweight: <5th , overweight: 85th-95th
and obese:≥95th centile
Vargas et al. (2007), USA CC 2,053 3-5 years mixed asthma parents e-records overweight: 85th-95th and obese:≥95th
centile
Garcia-Marcos et al. (2008),
Spain
CS 874 6-8 years mixed asthma parent trained overweight: >85th centile
Jacobson et al. (2008), USA CS 517 1-5 years mixed asthma parent trained overweight: 85th-95th and obese:≥95th
centiles
Kusunoki et al. (2008), Japan CS 45,520 7-15 years mixed asthma parent e-records overweight: 85th-95th and obese:≥95th
centiles
Ahmad et al. (2009), USA CS 63,981 7-17 years mixed asthma parent parent CDC: obese≥95th centiles
He et al. (2009), China CS 2,179 8-13 years mixed asthma parent no mention IOTF cut-offs for underweight, overweight,
and obese.
Kuschnir and da Cunha (2009),
Brazil
CS 2,858 13-14 years mixed asthma trained trained underweight: <5th and overweight:≥85th
centiles
Scholtens et al. (2009),
Netherlands
PC 3,756 8 years mixed asthma parent parent overweight: ≥85th centile
Tai et al. (2009), Australia CS 1,509 4-5 years mixed asthma trained trained IOTF cut-offs for overweight, and obese.
Tsai and Tsai (2009), Taiwan CS 1,329 10-12 years
mixed
asthma child child underweight: <5th , overweight: 85th-95th
and obese:≥95th centiles
Vazquez-Nava et al. (2010),
Mexico
RC 1,160 4-5 years mixed asthma parent trained underweight: <5th , overweight: 85th-95th
and obese:≥95th centiles
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Author , year, region Study
design
Sample
size
Participants age
and gender
outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure categories
Visness et al. (2010), USA CS 16,074 2-19 years mixed asthma parent and child trained overweight: 85th-95th and obese:≥95th
centiles
Cibella et al. (2011), Italy CS 708 10-16 years mixed asthma child trained overweight: ≥85th centile
Matos et al. (2011), Brazil PC 1,129 4-12 years mixed asthma parent trained overweight: 1SD+
Suglia et al. (2011),USA PC 1,815 3 years mixed asthma parent trained underweight: <5th , overweight: 85th-95th
and obese:≥95th centiles
Yao et al. (2011),Taiwan CS 5,351 4-18 years mixed asthma parent trained IOTF cut-offs for overweight, and obese.
Black et al. (2012) USA* RC 681,122 6-19 years mixed asthma e-records e-records underweight: <5th, overweight: 85th-95th,
and obese:≥95th centiles
Magnusson et al. (2012),
Sweden
PC 2,075 8 years mixed asthma parent e-records overweight: ≥85th centile
Noal et al. (2012), Brazil PC 4,441 11-15 years mixed wheezing parent trained overweight: 1SD+ and obese: 2SD+
Guibas et al. (2013), Greece CS 1,626 2-5 years mixed asthma parent trained IOTF cut-offs for overweight, and obese.
Guibas et al. (2013), Greece CS 2,015 9-13 years mixed asthma parent trained IOTF cut-offs for overweight, and obese.
Silva et al. (2013), Brazil CS 1,500 6-12 years mixed wheezing parent trained overweight: ≥85th centile
Yiallouros et al. (2013),
Cyprus*
CS 10,981 7-17 years mixed asthma parent and child trained overweight:>1SD+
Granell et al. (2014), UK PC 4,835 7-9 years mixed asthma parent trained IOTF cut-offs for overweight and obese.
Wang et al. (2014) China CS 30,056 2-14 years mixed asthma parent trained underweight: <5th , overweight: 85th-95th
and obese:≥95th centiles
CC= Case-control, CS=Cross-sectional, PC=Prospective Cohort, RC=Retrospective Cohort, mixed=included both genders; *=regrouped
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Table 2.12 Risk of bias assessment table using Newcastle-Ottawa quality assessment scale for BMI and wheezing disorder studies
included in the meta-analysis
Author , year, region Study title Selection Comparability Outcome
Gennuso et al, 1998,
USA
The relationship between asthma and obesity in urban minority children and
adolescents
  
Chinn et al, 2001, UK Can the increase in body mass index explain the rising trend in asthma in
children?
  
Rodríguez et al, 2002,
USA
Identification of population subgroups of children and adolescents with high
asthma prevalence: Findings from the third national health and nutrition
examination survey
  
Gilliland et al, 2003,
USA
Obesity and the risk of newly diagnosed asthma in school-age children   
Bibi et al, 2004, Israel The relationship between asthma and obesity in children: Is it real or a case
of over diagnosis?
  
Cassol et al, 2005, Brazil Prevalence and severity of asthma among adolescents and their relationship
with the body mass index
  
Saha et al, 2005, USA Individual and neighbourhood-level factors in predicting asthma   
Wickens et al, 2005,
New Zealnd
Obesity and asthma in 11-12 year old New Zealand children in 1989 and
2000
  
Kwon et al, 2006, USA Childhood asthma and extreme values of body mass index: The Harlem
Children's Zone Asthma Initiative
  
Shamssain et al, 2006,
UK
The association between overweight and respiratory symptoms in
schoolchildren
  
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Author , year, region Study title Selection Comparability Outcome
Van De Ven et al, 2006,
Netherlands
Atopic diseases and related risk factors among Dutch adolescents   
Davis et al, 2007, USA An association between asthma and BMI in adolescents: results from the
California Healthy Kids Survey
  
Tollefsen et al, 2007,
Norway
Female gender is associated with higher incidence and more stable
respiratory symptoms during adolescence
  
Tsai et al, 2007, Taiwan Associations of BMI, TV-watching time, and physical activity on respiratory
symptoms and asthma in 5th grade schoolchildren in Taipei, Taiwan
  
Vargas et al, 2007, USA Relationship of body mass index with asthma indicators in Head Start
children
  
Garcia-Marcos et al,
2008, Spain
Percent body fat, skin-fold thickness or body mass index for defining
obesity or overweight, as a risk factor for asthma in schoolchildren: which
one to use in epidemiological studies?
  
Jacobson et al, 2008,
USA
Asthma, body mass, gender, and Hispanic national origin among 517
preschool children in New York City
  
Kusunoki et al, 2008,
Japan
Obesity and the prevalence of allergic diseases in schoolchildren   
Ahmad et al, 2009, USA Association between Obesity and asthma in US children and adolescents   
He et al, 2009, China Respiratory health in overweight and obese Chinese children   
Kuschnir 2009, Brazil Association of overweight with asthma prevalence in adolescents in Rio de
Janeiro, Brazil
  
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Author , year, region Study title Selection Comparability Outcome
Scholtens et al, 2009,
Netherlands
Overweight and changes in weight status during childhood in relation to
asthma symptoms at 8 years of age
  
Tai et al, 2009, Australia Association between asthma symptoms and obesity in preschool (4-5 year
old) children
  
Tsai et al, 2009, Taiwan The association of BMI and sedentary time with respiratory symptoms and
asthma in 5th grade schoolchildren in Kaohsiung, Taiwan
  
Vazquez-Nava et al,
2010, Mexico
Association between obesity and asthma in preschool Mexican children   
Visness et al, USA, 2010 Association of Childhood Obesity With Atopic and Nonatopic Asthma:
Results From the National Health and Nutrition Examination Survey 1999–
2006
  
Cibella et al, 2011, Italy A cross-sectional study assessing the relationship between BMI, asthma,
atopy, and eNO among schoolchildren
  
Matos et al, 2011, Brazil Overweight, asthma symptoms, atopy and pulmonary function in children of
4-12 years of age: findings from the SCAALA cohort in Salvador, Bahia,
Brazil
  
Suglia et al, 2011, USA Asthma and obesity in three-year-old urban children: Role of sex and home
environment
  
Yao et al, Taiwan, 2011 Associations of age, gender, and BMI with prevalence of allergic diseases in
children: PATCH study
  
Black et al, 2012, USA Higher prevalence of obesity among children with asthma   
Magnusson et al, 2012,
Sweden
Early childhood overweight and asthma and allergic sensitization at 8 years
of age
  
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Author , year, region Study title Selection Comparability Outcome
Noal et al, 2012, Brazil Is obesity a risk factor for wheezing among adolescents? A prospective
study in southern Brazil
  
Guibas et al, 2013,
Greece
The obesity-asthma link in different ages and the role of Body Mass Index in
its investigation: Findings from the Genesis and Healthy Growth Studies
  
Silva et al, 2013, Brazil Prevalence of Wheezing and its Association with Body Mass Index and
Abdominal Obesity in Children
  
Yiallourous, 2013,
Cyprus
Associations of body fat percent and body mass index with childhood
asthma by age and gender
  
Grannel et al, 2014, UK Effects of BMI, Fat Mass, and Lean Mass on Asthma in Childhood: A
Mendelian Randomization Study
  
Wang et al, 2014, China Gender-specific differences in associations of overweight and obesity with
asthma and asthma-related symptoms in 30,056 children: result from 25
districts of North-eastern China
  
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2.4.3.3 Meta-analysis
Underweight
A total of 7 studies presented data on the number of cases and non-cases of
wheezing disorders in underweight and normal BMI groups comprising a total of
772,040 children (Figure 2.8). The summary risk estimate of the studies showed that
there was a significant decrease odds of wheezing disorders (OR= 0.85, 95% CI:
0.75 to 0.97; P=0.02) for the underweight children (Figure 2.8). However, there was
considerable heterogeneity among the studies (Q=29, df =6, P<0.01; I2=79%, 95%
CI: 58% to 89%). When the same analysis was performed on four studies (Chinn
and Rona, 2001; Wickens et al., 2005; Tsai et al., 2007; Tsai and Tsai, 2009) that
provided adjusted risk estimates, the overall was odds ratio was 0.96 (95% CI: 0.75
to 1.23; P=0.75) with no heterogeneity among studies (Q=2, d.f=3, P=0.65; I2=0%),
see Figure 2.9.
Figure 2.8 Summary unadjusted odds ratios of wheezing disorders for
underweight compared with normal BMI categories
Heterogeneity chi-squared = 29 (df = 6) p < 0.001, I2 =79% (95% CI: 58% to 89%), and the estimate of between-study
variance Tau-squared = 0.01.
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Figure 2.9 Summary adjusted odds ratios of wheezing disorders for underweight
compared with normal BMI categories
Heterogeneity chi-squared = 2 (df = 3) p = 0.65, I2 =0%, and the estimate of between-study variance Tau-squared < 0.001.
Overweight
A total of 30 studies presented data on the number of cases and non-cases of
wheezing disorders in the overweight and normal BMI groups that included a total
of 1,079,732 children (Figure 2.10). The summary of the odds ratio showed that
there was a significant increased risk of wheezing disorders (OR= 1.22, 95% CI:
1.16 to 1.28; p<0.001), see Figure 2.10. There was a considerable heterogeneity
among the studies (Q=78, df = 29; I2 = 63%, 95% CI: 45% to 75%). When further
analysis was carried out on 21 studies that presented adjusted risk estimates of
overweight on childhood wheezing disorders, the summary risk estimate was
slightly accentuated (OR=1.31, 95% CI: 1.20 to 1.43, P<0.01) whereas the between-
study heterogeneity substantially decreased (Q=27, df=20, P=0.12; I2=27%, 95% CI:
0.0 to 57%), see Figure 2.11.
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Figure 2.10 Summary unadjusted odds ratios of wheezing disorders for overweight
compared with normal BMI categories
Heterogeneity chi-squared = 78 (df = 29) p < 0.001, I2 = 63% (95% CI: 45% to 75%), and the estimate of between-study
variance Tau-squared = 0.004.
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Figure 2.11 Summary adjusted odds ratios of wheezing disorders for overweight
compared with normal BMI categories
Heterogeneity chi-squared = 27 (df = 20) p = 0.13, I2 = 26% (95% CI: 0% to 57%), and the estimate of between-study variance
Tau-squared = 0.01.
Obesity
A total of 22 studies presented data on the number of cases and non-cases of
wheezing disorders in the normal and obese groups that comprised 1,007,418
children (Figure 2.12). The overall risk estimate showed that there was a significant
increase in the risk of wheezing disorders for obesity (OR=1.46, 95% CI: 1.36 to
1.57), see Figure 2.12. There was a substantial heterogeneity among the studies (Q=
113, df = 21; I2 = 82%, 95% CI: 73% to 87%). However, when the analysis was
repeated on the adjusted risk estimate of obesity on wheezing disorders available
from 16 studies (Figure 2.13), the heterogeneity was attenuated (Q=28, d.f=14,
P=0.02; I2=49%, 95% CI: 8% to 72%) whilst the summary risk estimate slightly
increased (OR=1.61, 95% CI: 1.43 to 1.82).
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Figure 2.12 Summary unadjusted odds ratios of wheezing disorders for obese
compared with normal BMI categories
Heterogeneity chi-squared = 113 (df = 21), p < 0.001, I2 = 82% (95% CI: 73% to 87%), and the estimate of between-study
variance Tau-squared = 0.009.
Figure 2.13 Summary adjusted odds ratios of wheezing disorders for obese BMI
compared with normal BMI categories
Heterogeneity chi-squared = 28 (df = 14), p = 0.02, I2 = 49% (95% CI: 8% to 72%), and the estimate of between-study
variance Tau-squared = 0.02.
Overall
Tai et al
Guibas et al
Guibas et al
Chin et al
Vargas et al
Noal et al
Visness et al
Bibi et al
Kwon et al
Shamssain
Study
Grannel et al
Yao et al
Davies et al
Gilliland et al
Cassol et al
Vazquez-Nava et al
Saha et al
Black et al
Jacobson et al
He et al
Gennuso et al
Wang et al
2009
2013
2013
2001
2007
2012
2010
2004
2006
2006
Year .
2014
2011
2007
2003
2005
2010
2005
2012
2008
2009
1998
2014
1.47 (1.37, 1.58)
2.60 (1.62, 4.18)
1.22 (0.52, 2.90)
1.15 (0.75, 1.77)
2.40 (1.30, 4.43)
0.90 (0.60, 1.35)
1.94 (1.60, 2.36)
1.50 (1.32, 1.70)
2.05 (1.42, 2.95)
2.07 (1.40, 3.05)
1.28 (1.00, 1.65)
OR (95% CI)
1.91 (1.27, 2.89)
1.52 (1.13, 2.06)
1.28 (1.25, 1.31)
1.33 (0.92, 1.93)
1.17 (0.82, 1.66)
1.17 (0.65, 2.11)
1.68 (1.35, 2.09)
1.44 (1.41, 1.46)
1.25 (0.62, 2.50)
1.82 (0.70, 4.70)
3.39 (1.49, 7.73)
1.29 (1.14, 1.46)
56/83
6/148
32/107
13/79
31/346
217/473
381/3025
36/302
58/188
89/332
Obese
30/145
57/435
11354/52808
36/392
40/258
20/352
193/751
19921/147008
16/118
5/149
26/36
327/4233
521/1175
54/1619
369/1362
184/2425
142/1435
936/3080
922/10529
352/5682
85/479
1261/5680
Normal
502/4187
339/3746
58810/333494
203/2869
431/3169
29/594
227/1332
38287/389465
21/188
36/1945
46/106
1351/22119
1.5 2 4
Overall
Noal et al
Guibas et al
Yao et al
Guibas et al
Bibi et al
Suglia et al
Visness et al
Ahmad et al
Chin et al
Vazquez-Nava et al
He et al
Tsai et al
Tsai et al
Wickens et al
Wang et al
Study
2012
2013
2011
2013
2004
2011
2010
2009
2001
2010
2009
2007
2009
2005
2014
Year .
1.61 (1.43, 1.82)
1.82 (1.30, 2.54)
1.69 (1.14, 2.50)
1.52 (1.12, 2.06)
1.54 (0.85, 2.80)
1.92 (1.39, 2.66)
2.26 (1.55, 3.30)
1.68 (1.33, 2.12)
1.35 (1.20, 1.52)
4.48 (2.32, 8.65)
1.16 (0.65, 2.08)
1.35 (0.24, 7.45)
1.56 (1.16, 2.09)
1.78 (1.09, 2.91)
1.39 (0.89, 2.17)
1.24 (1.00, 1.53)
ES (95% CI)
1.4 2 4 8
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2.4.3.4 Subgroup analyses
Underweight and wheezing disorders
Subgroup meta-analyses of underweight risk estimates on childhood wheezing
disorders from 7 studies showed that the strength of the risk estimates remained
stable across each subgroup of the predefined covariates or study characteristics.
However, the risk of wheezing disorders significantly reduced if BMI was
categorised using CDC or IOTF, age group was ‘Five years and above’, sample size
was >1000, three BMI categories were used during analysis. No subgroup analysis
was conducted for adjusted odds ratios as the studies contributed were few.
The heterogeneities within each subgroup of the covariates were significant; and,
except for the covariate ‘exposure categorisation method’, the heterogeneities
between subgroups of the covariates were not significant (Table 2.13).
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Table 2.13 Subgroup analysis of unadjusted odds ratios of wheezing disorders for
underweight compared with normal BMI categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome ascertainment
E-records/trained 1.08(0.64 to 1.8) 2 88% <0.01 0.06
Child 0.87 (0.83 to 0.91) 1 - -
Parent 0.81 (0.50 to1.31) 4 81% <0.01
Exposure ascertainment
E-records/trained 0.84 (0.62 to 1.15) 5 85% <0.001 0.27
Child 0.87 (0.83 to 0.91) 1 - -
No mention 1.42 (0.69 to 2.89) 1 - -
Exposure categorisation method
CDC 0.90 (0.82 to 0.97) 5 62% 0.03 <0.001
IOTF 0.45 (0.33 to 0.61) 1 - -
WHO 0.82 (0.57 to 1.18) 1 - -
Age during diagnosis
Five years and above 0.84 (0.74 to 0.96) 6 82% <0.001 0.17
Mixed (0-19 years) 1.42 (0.69 to 2.90) 1 - -
Sample size
<1000 1.42 (0.69 to 2.89) 1 - - 0.17
1000+ 0.84 (0.74 to 0.96) 6 82% <0.001
Study Design
cohort 0.62 (0.34 to 1.17) 2 94% <0.001 0.12
Cross-sectional 0.85 (0.75 to 0.97) 5 59% 0.05
Number of BMI categories
Three 1.09 (0.62 to 1.91) 2 79% 0.03 0.07
Four 0.81 (0.71 to 0.93 5 81% <0.01
Study quality scorec
High (7-9/9) 0.89 (0.66 to 1.19) 6 83% <0.01 0.44
Medium (5-6/9) 0.87 (0.83 to 0.91) 1 - -
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Overweight and wheezing disorders
When subgroup meta-analysis of the 30 studies that presented wheezing disorder
risks of overweight by the predefined study characteristics was carried out, except
for the IOTF categorisation method and papers published before 2000 that were not
statistically significant, the strength and direction of the summary risk estimates in
each subgroup remained stable. The within subgroup heterogeneity was not
significant for the wheezing outcome term, e-records outcome ascertainment,
parental exposure ascertainment, WHO BMI categorisation method, sample size less
than 1000, and case-control study design while it was significant for the rest of the
subgroups. Except for outcome and exposure ascertainment, age group during
diagnosis, sample size, and study design subgroups, there was no significant
heterogeneity between subgroups of the other covariates (Table 2.14).
Subgroup analyses of 21 studies that presented adjusted odds ratio of wheezing
disorders for overweight, except if outcome was ascertained by a child, WHO BMI
categorisation was used, ‘under five’ age group, or four BMI categories were used
during analysis, there was a significant increase of the risk across all subgroups of
the a priori selected study characteristics. The between subgroup heterogeneities
were all in insignificant (Table 2.15).
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Table 2.14 Subgroup analysis of unadjusted odds ratios of wheezing disorders for
overweight compared with normal BMI categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.22 (1.16 to 1.28) 28 65% <0.01 0.44
wheezing 1.23 (1.05 to 1.42) 2 0% 0.5
Outcome ascertainment
E-records/trained 1.19 (1.05 to 1.36) 5 40% 0.16 0.01
Child 1.30 (1.05 to 1.60) 4 64% 0.04
Parent 1.25 (1.14 to 1.38) 21 64% <0.01
Exposure ascertainment
E-records/trained 1.21 (1.13 to 1.30) 25 58% <0.01 <0.01
child 1.13 (1.11 to 1.15) 1 - -
Parent 1.54 (1.32 to 1.80) 2 0% 0.77
No mention 1.38 (1.01 to 1.88) 2 42% 0.18
Exposure categorisation method
CDC 1.24 (1.17 to 1.30) 18 66% <0.01 0.76
IOTF 1.06 (0.88 to 1.29) 9 72% <0.01
WHO 1.21 (1.06 to 1.39) 3 0% 0.98
Age during diagnosis
Five years and above 1.21 (1.15 to 1.27) 18 65% <0.01 0.03
Mixed (0-19 years) 1.21 (1.07 to 1.37) 12 55% 0.01
Sample size
<1000 1.57 (1.10 to 2.23) 5 37% 0.17 0.01
1000+ 1.21 (1.15 to 1.27) 25 63% <0.01
Study period
<2000 1.06 (0.46 to 2.42) 1 - - 0.84
2000+ 1.22 (1.17 to 1.28) 29 64% <0.01
Study design
Cohort 1.23 (1.08 to 1.41) 9 67% <0.01
Case-control 1.45 (1.03 to 2.05) 2 0% 0.41 0.17
Cross-sectional 1.24 (1.15 to 1.34) 19 66% <0.01
Number of BMI Categories
Two 1.48 (1.19 to 1.84) 7 78% 0.07
Three 1.23 (1.13 to 1.33) 18 35% <0.01 0.01
Four 1.15 (1.09 to 1.21) 5 74% <0.01
Study quality score c
High (7-9/9) 1.21 (1.13 to 1.30) 20 55% <0.01 0.07
Medium (5-6/9) 1.34 (1.15 to 1.56) 10 73% <0.01
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Table 2.15 Subgroup analysis of adjusted odds ratios of wheezing disorders for
overweight compared with normal BMI categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.32 (1.20 to 1.45) 18 33% 0.08 0.90
wheezing 1.28 (1.00 to 1.63) 3 0% 0.47
Outcome ascertainment
Child 1.20 (0.85 to 1.70) 3 45% 0.16 0.58
Parent 1.32 (1.21 to 1.45) 18 27% 0.14
Exposure ascertainment
E-records/trained 1.27(1.17 to 1.38) 18 19% 0.22 0.13
Parent 1.62(1.18 to 2.22) 1 - -
No mention 1.20 (0.28 to 5.24) 2 51% 0.15
Exposure categorisation method
CDC 1.38 (1.22 to 1.56) 14 45% 0.03 0.92
IOTF 1.23 (1.07 to 1.40) 6 0% 0.65
WHO 1.28 (0.90 to 1.83) 1 - -
Age during diagnosis
Five years and above 1.30 (1.12 to 1.52) 11 52% 0.02 0.35
Mixed (0-19 years) 1.33 (1.20 to 1.47) 9 0% 0.83
Under five 1.36 ( 0.88 to 2.10) 1 - -
Sample size
<1000 1.59 (1.09 to 2.32) 2 0% 0.98 0.21
1000+ 1.30 (1.18 to 1.42) 19 30% 0.11
Study design
Cohort 1.43 (1.22 to 1.68) 7 4% 0.40
Case-control 1.27 (1.15 to 1.39) 14 27% 0.17 0.07
Number of BMI Categories
Two 1.48 (1.16 to 1.89) 7 67% 0.01
Three 1.32 (1.19 to 1.45) 10 0% 0.94 0.42
Four 1.18 (0.96 to 1.47) 4 21% 0.28
Study quality score c
High (7-9/9) 1.20 (1.12 to 1.29) 14 0% 0.51 <0.01
Medium (5-6/9) 1.71 (1.42 to 2.05) 7 0% 0.80
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Obesity and wheezing disorders
Subgroup meta-analysis of 22 studies that presented the number of wheezing
disorders cases and non-cases in the obese and normal BMI groups showed that
except for the case-control study design subgroup, significant increase of risk was
observed in all subgroups of the a priori selected study characteristics (Table 2.16).
The same analysis on 15 studies that presented adjusted odds ratios also showed that
except in the unknown BMI measurement source (no mention) and sample size of
<1000 groups, there was a significant increase of wheezing disorders risk across all
subgroups of the predefined study characteristics (Table 2.17).
In the unadjusted odds ratios analyses, the within subgroup heterogeneities were
significant except for the outcome ascertainment through a child, exposure
ascertainment not mentioned, IOTF BMI categorisation method, and sample size
less than 1000 subgroups; and, the between subgroup heterogeneities were
significant except for the sample size covariate (Table 2.16). In addition, except for
the type of study design, no significant heterogeneity between subgroups was
observed in the adjusted OR analyses results (Table 2.17)
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Table 2.16 Subgroup analysis of unadjusted odds ratios of wheezing disorders for
obese compared with normal BMI categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.44 (1.34 to 1.55) 21 80% <0.01 0.01
Wheezing 1.94 (1.60 to 2.36) 1 - -
Outcome ascertainment
E-records/trained 1.81 (1.39 to 2.36) 4 75% 0.01 <0.01
Child 1.28 (1.25 to 1.31) 3 0% 0.86
Parent 1.51 (1.33 to 1.71) 15 52% 0.01
Exposure ascertainment
E-records/trained 1.52 (1.38 to 1.66) 18 59% <0.01 <0.01
Child 1.28 (1.25 to 1.31) 1 0% -
No mention 1.60 (1.11 to 2.31) 3 53% 0.12
Exposure categorisation method
CDC 1.41 (1.30 to 1.53) 13 86% <0.01 <0.01
IOTF 1.61 (1.31 to 1.99) 8 42% 0.10
WHO 1.94 (1.60 to 2.36) 1 - -
Age during diagnosis
Five years and above 1.43 (1.31 to 1.57) 11 69% <0.01 0.05
Mixed (0-19 years) 1.53 (1.30 to 1.80) 11 87% <0.01
Sample size
<1000 1.75 (1.15 to 2.65) 4 49% 0.12 0.07
1000+ 1.46 (1.35 to 1.57) 18 84% <0.01
Study period
<2000 3.39 (1.49 to 7.73) 1 - - 0.03
2000+ 1.47 (1.37 to 1.58) 21 82% <0.01
Study design
Cohort 1.62 (1.35 to 1.95) 6 64% 0.02
Case-control 1.65 (0.45 to 6.1) 2 88% 0.01 <0.01
Cross-sectional 1.46 (1.36 to 1.57) 14 62% <0.01
Number of BMI categories
Two 2.05 (1.42 to 2.95) 1 0% -
Three 1.50 (1.33 to 1.69) 16 56% <0.01 0.01
Four 1.40 (1.26 to 1.56) 5 94% <0.01
Study quality score c
High (7-9/9) 1.47 (1.30 to 1.67) 16 57% <0.01 0.02
Low (≤4/9) 1.40 (1.26 to 1.56) 6 94% <0.01
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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Table 2.17 Subgroup analysis of adjusted odds ratio of wheezing disorders for
obese compared with normal BMI categories
Odds ratio (95% CI) n I2 Pheta Phetb
Outcome terms used
Asthma 1.60 (1.41 to 1.82) 14 50% 0.02 0.25
Wheezing 1.82 (1.30 to 2.54) 1 - -
Outcome ascertainment
Child 1.61 (1.26 to 2.08) 2 0% 0.65 0.57
Parent 1.62 (1.41 to 1.86) 13 55% 0.01
Exposure ascertainment
E-records/trained 1.67 (1.46 to 1.91) 13 46% 0.04 0.07
Parent 1.35 (1.20 to 1.52) 1 - -
No mention 1.35 (0.24 to 7.45) 1 - -
Exposure categorisation method
CDC 1.55 (1.34 to 1.78) 8 52% 0.04 0.22
IOTF 1.76 (1.31 to 2.36) 6 49% 0.08
WHO 1.82 (1.30 to 2.54) 1 - -
Age during diagnosis
Five years and above 1.69 (1.38 to 2.07) 8 58% 0.02 0.10
Under five 2.26 (1.55 to 3.30) 1 - -
Mixed (0-19 years) 1.49(1.29 to 1.71) 6 17% 0.30
Sample size
<1000 1.16 (0.65 to 2.08) 1 - - 0.38
1000+ 1.63 (1.44 to 1.85) 14 51% 0.01
Study design
Cohort 2.06 (1.38 to 3.18) 4 69% 0.02 <0.01
Cross-sectional 1.45 (1.34 to 1.57) 11 0% 0.48
Number of BMI categories
Two 1.56 (1.11 to 2.18) 2 75% 0.05
Three 1.57 (1.37 to 1.81) 9 25% 0.22 0.18
Four 1.90 (1.28 to 2.84) 4 68% 0.02
Study quality score c
High (7-9/9) 1.69 (1.46 to 1.96) 11 52% 0.02 0.02
Medium (5-6/9) 1.36 (1.22 to 1.52) 4 0% 0.69
a P for heterogeneity within subgroups.
b P for heterogeneity between subgroups.
c Sensitivity analysis.
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2.4.3.5 Meta-regression analysis
Body mass index and wheezing disorders
Investigating the sources of between-study heterogeneity in the unadjusted odds
ratios of wheezing disorders for the overweight BMI category showed that none of
the between-study heterogeneity was explained by the a priori selected covariates
(adjusted R-squared=0%, P=0.40), see Table 2.18. When the same analysis was
carried out for the obese group, no significant proportion of the between-study
heterogeneity in the adjusted and unadjusted odds ratios (P=0.57 and P=0.19,
respectively) were explained by the a priori selected covariates or study
characteristics (Table 2.19). No meta-regression analysis was carried out for the
unadjusted underweight risk estimates on childhood wheezing disorders due to not
having enough observations for the models to converge.
Table 2.18 Meta-regression analysis of unadjusted odds ratios of wheezing
disorders for overweight compared with normal BMI categories
Study characteristic Coefficient (95% CI) P-value
Outcome terms used (ref=asthma) 0.12 (-0.28 to 0.52) 0.56
Outcome ascertainment (ref= e-records/trained) -0.03 (-0.18 to 0.13) 0.74
Exposure ascertainment (ref=e-records/trained) 0.05 (-0.08 to 0.16) 0.34
Exposure categorisation method (ref=CDC) -0.11 (-0.27 to 0.05) 0.18
Age during diagnosis (ref=five and above) -0.02 (-0.26 to 0.22) 0.88
Sample size (ref=less than 1000) -0.27 (-0.70 to 0.14) 0.19
Study period (ref=before 2000) -0.49 (-1.60 to 0.64) 0.38
Study type (ref=cohort) -0.03 (-0.14 to 0.08) 0.58
Number of weight categories (ref=two) -014 (-0.30 to 0.12) 0.08
Overall (adjusted R-squared= 0%) 0.40
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Table 2.19 Meta-regression analysis adjusted and unadjusted odds ratios of
wheezing disorders for obese compared with normal BMI categories
Study characteristics Coefficient (95% CI) P-value
Unadjusted odds ratios
Outcome terms used (ref=asthma) 0.18 (-0.66 to 1.02) 0.65
Outcome ascertainment (ref= e-records/trained) -0.14 (-0.37 to 0.09) 0.21
Exposure ascertainment (ref=e-records/trained) 0.004 (-0.19 to 0.20) 0.96
Exposure categorisation method (ref=CDC) 0.16 (-0.20 to 0.52) 0.35
Age during diagnosis (ref=five and above) -0.02 (-0.42 to 0.38) 0.91
Sample size (ref=less than 1000) -0.28 (-0.90 to 0.35) 0.35
Study period (ref=before 2000) 0.46 (-0.82 to 1.73) 0.45
Study type (ref=cohort) 0.04 (-0.16 to 0.24) 0.65
Number of weight categories (ref=two) -0.11 (-0.41 to 0.19) 43
Overall (adjusted R-squared= 0%) 0.57
Adjusted odds ratios
Outcome terms used (ref=asthma) -0.62 (-1.62 to 0.38) 0.18
Outcome ascertainment (ref= e-records/trained) -0.06 (-0.81 to 0.69) 0.85
Exposure ascertainment (ref=e-records/trained) -0.17 (-0.41 to 0.07) 0.13
Exposure categorisation method (ref=CDC) 0.05 (-0.38 to 0.48) 0.78
Age during diagnosis (ref=five and above) -0.21 (-0.53 to 0.12) 0.17
Sample size (ref=less than 1000) 0.96(0.06to 1.87) 0.04
Study type (ref=cohort) -0.39 (-0.66 to -0.12) 0.01
Number of BMI categories (ref=two) -0.11 (-0.52 to 0.29) 0.51
Overall (adjusted R-squared= 10%) 0.19
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2.4.3.6 Investigating biases (small study effects)
Body mass index and wheezing disorders
The funnel plot and bias test results of adjusted and unadjusted risks of wheezing
disorders for different BMI were not consistent. The unadjusted risk estimates of
overweight (P=0.05), showed some evidence of asymmetry but not in the
underweight and obese categories (P=0.92 and P=0.31, respectively), see
Figure 2.14 and Table 2.20. However, the same analysis for the adjusted risk
estimates showed some evidence of asymmetry for the overweight (P=0.02) and
obese (0.04) but not in the underweight (P=0.57), see Figure 2.14 and Table 2.20.
Figure 2.14 Egger’s funnel plots of BMI and childhood wheezing disorder studies
Underweight versus normal BMI (A and D); overweight versus normal BMI (B and E) and obesity versus normal BMI (C and
F) odds ratio funnel plots. Unadjusted odds ratios in A, B and C, and adjusted odds ratios in D, E and F. In all funnel plots, the
middle solid line is the summary odds ratio estimate and the two diagonal dotted lines are the 95% confidence limits around
the summary odds ratio, and the slant solid lines in all figures are the fitted regression lines for Egger’s small-study effect test.
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Table 2.20 Egger’s test of bias for small study effects in BMI and wheezing
disorders studies
Parameter Coefficient (95% CI) P-value
Unadjusted odds ratios for normal versus underweight
Slope -0.16 (-0.31 to -0.001) 0.05
Bias 0.13 (-3.10 to 3.35) 0.92
Adjusted odds ratios for normal versus underweight
Slope -0.15 (-1.01 to 0.70) 0.52
Bias 0.52 (-2.86 to 3.91) 0.57
Unadjusted odds ratios for normal versus overweight
Slope 0.13 (0.10 to 0.16) <0.01
Bias 0.72 (0.01 to 1.43) 0.05
Adjusted odds ratios for normal versus overweight
Slope 0.07 (-0.07 to 0.22) 0.31
Bias 1.14 (0.18 to 2.18) 0.02
Unadjusted odds ratios for normal versus obese
Slope 0.31 (0.27 to 0.35) <0.01
Bias 0.65 (-0.64 to 1.94) 0.30
Adjusted odds ratios for normal versus obese
Slope 0.23 (0.04 to 0.43) 0.02
Bias 1.42 (-0.73 to 0.73) 0.04
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2.4.4 Discussion
2.4.4.1 Key findings
The results of unadjusted and adjusted risk estimates for underweight children are
inconclusive, that is, a significant (unadjusted OR= 0.85, 95% CI: 0.75 to 0.97) and
an insignificant (adjusted OR=0.96, 95% CI: 0.75 to 1.23; P=0.75) decreased risk of
wheezing disorders for the unadjusted and adjusted summary estimates respectively.
However, overweight (unadjusted OR= 1.22, 95% CI: 1.16 to 1.28 and adjusted
OR=1.31, 95% CI: 1.20 to 1.43) and obese (unadjusted OR =1.46, 95% CI: 1.36 to
1.57 and adjusted OR =1.46, 95% CI: 1.36 to 1.57) children have an increased risk
of wheezing disorders when compared with the normal BMI children although there
was a significant between-study heterogeneity and some evidence of small study
effects or publication bias.
2.4.4.2 Results in context of previous reviews and meta-analyses
If meta-analysis was restricted to cohort studies as per Chen et al. (2013) and Egan
et al. (2013) , the summary relative risk estimates for overweight and obesity are
1.21 (95% CI: 1.08 to 1.36) and 1.42 (1.31 to 1.54), respectively. However, the
summary relative risk estimates for only cohort studies may not be comparable to
that of Egan et al. (2013) as the risk estimate definition was not consistent across
the studies included in their meta-analysis. The overweight summary relative risk
estimates for only cohort studies and that reported by Flaherman and Rutherford
(2006) meta-analysis may also not be comparable for the same reasons.
One notable difference between this and the three previous meta-analyses results is
that the summary risk estimates of this meta-analysis have narrower confidence
intervals and are higher than those previously reported. This is likely to be due to the
larger number of participants in this meta-analysis because of data harmonisation,
consistent definition of the risk estimates and BMI categorisation methods were
used.
Based on the subgroup meta-analyses of the unadjusted risk estimate results, it can
be noted that the summary ORs estimates tended to attenuate as the number of BMI
categories used by study authors increased. For example, the summary associated
risk of overweight on wheezing disorders for authors that used two BMI categories
was twice and three times of those which used three and four BMI categories
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respectively (Table 2.14). A similar pattern was also observed in the obesity risk
estimates according to the number of BMI categories used by authors (Table 2.16).
The subgroup meta-analyses by study design also showed that the summary risk
estimates of the cohort and cross-sectional studies are very similar, both for the
overweight and obese BMI categories. This may indicate that cross-sectional studies
can be as credible as cohort studies although the findings need to be validated by
other meta-analyses in other fields or with more data included. Cross-sectional
studies are easier and cheaper to conduct than case-control and cohort studies, and
this can have implication for cost saving and efficiency.
Based on the heterogeneity measures (Q-test and I2), it can be noted that there was a
considerable level of between-study variation in the underweight, overweight and
obesity unadjusted risk estimates although this could also be due to the studies
included in this meta-analysis had high sample size (Rücker et al., 2008). As
illustrated in the forest plots, there were a few studies with large samples and high
precision of risk estimates that can have dominating effects for the between-study
heterogeneities (Figure 2.10 and Figure 2.11). However, except for the obese group,
the same pattern was not observed in the adjusted risk estimates: the between-study
heterogeneities were low in underweight and overweight risk estimates.
2.4.4.3 Strengths and weaknesses
This work has limitations and results should be interpreted cautiously. First, in the
low birthweight and overweight summary risk estimates, there was a significant and
substantial level of between-study variation that was not explained by the a priori
selected covariates. Second, there is also some evidence of funnel plot asymmetry
which may indicate a potential small study effect such as potential publication bias
(Egger et al., 1997). Third, as in any systematic review and meta-analysis, a
possibility of potentially relevant studies being missed cannot be ruled out. Fourth,
the results are based on epidemiologic observational studies and are solely
dependent on the quality of the primary studies included.
The strength of this work is that it was possible to produce consistent risk estimates
due to the use of harmonised data. Combining adjusted risk estimates was a primary
choice among previous authors. This technique may, however, under or
overestimate the association between exposure and outcome variables due to
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exclusion of studies that used non-standard weight categories or combining all
irrespective of the type of exposure categorisation method used. In order to improve
validity of the summary risk estimates, data harmonisation techniques were
implemented and more studies were included than if previous authors’ techniques
were used. The other strength of this work is also that it was possible to extract and
analyse both adjusted and unadjusted risk estimates, which can be used as an
internal validation to each other.
In conclusion, the results suggest that underweight may be associated with reduced
odds of childhood wheezing disorders. Overweight and obese children have
increased odds of wheezing disorders. However, although the findings assert that
overweight/obesity and childhood wheezing disorders are associated, the causality
or their temporal relationship deserves further investigation.
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2.5 Growth patterns and wheezing disorders
2.5.1 Critique of past epidemiologic studies
The effect of early childhood growth on wheezing disorders has not been widely
studied. Results from a handful of previous studies are inconsistent with some
suggesting fast growth predisposes to wheezing disorders (Mamun et al., 2007;
Scholtens et al., 2009; Pike et al., 2010; Zhang et al., 2010; Flexeder et al., 2012;
Magnusson et al., 2012; van der Gugten et al., 2012; Anderson et al., 2013; Rzehak
et al., 2013; Sonnenschein-van der Voort et al., 2014b; Magnus et al., 2015) and
others reporting reduced risk of wheezing disorders (Mai et al., 2005; Sonnenschein-
van der Voort et al., 2012; Sonnenschein-van der Voort et al., 2014b; De Korte-De
Boer et al., 2015).
In addition, all of these studies, with the exception of one (Rzehak et al., 2013),
assumed homogenous growth among children, either used statistical techniques that
can now be improved on or a non-standard growth data analysis that makes
comparison and replication of results very difficult. For example, three (Mamun et
al., 2007; van der Gugten et al., 2012; Magnus et al., 2015) used data-driven
standardised scores (SDS), four (Scholtens et al., 2009; Sonnenschein-van der Voort
et al., 2012; Sonnenschein-van der Voort et al., 2014b; De Korte-De Boer et al.,
2015) used country specific SDS and another one (Flexeder et al., 2012) used non-
standardised weight measurements.
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2.5.2 Sythematic literature review methods
2.5.2.1 Literature Search Strategy
The reviews were carried out in accordance with the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009).
Online searches were carried out using the EMBASE and MEDLINE databases.
Table 2.21 gives the details of terms and phrases used for the literature search.
2.5.2.2 Inclusion criteria
Eligible papers were those published as an article, in English, and reported original
research about the effects of childhood growth patterns on wheezing disorders in
children 0-19 years of age. The literature search included publications until March
2015.
Table 2.21 Terms and phrases used during literature search
Childhood growth
1 Growth
2 Growth trajectory
3 Child growth
4 Childhood growth
5 Growth pattern*
6 Weight change
7 BMI change
8 Weight increase
9 Weight gain
10 BMI increase
11 BMI gain
12 Slow growth
13 Fast growth
14 Rapid growth
15 Wheezing disorders
16 Wheez*
17 Childhood asthma
18 Asthm*
19 1-14/or
20 15-18/or
21 19-20/and
22 Limit 21 to English language
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2.5.2.3 Data extraction
For the studies that were eligible to be included in the meta-analyses, the following
characteristics were extracted:
a) Authors’ name;
b) Year of publication;
c) Country of study;
d) Sample size;
e) Study age group and gender;
f) Diagnosis (outcome) terms;
g) Exposure terms used;
h) Outcome and exposure ascertainment methods; and,
i) Risk estimates.
2.5.2.4 Data standardisation
Exposure variable
No data standardisation was carried out for studies that investigated the effects of
childhood growth on wheezing disorders as there was no loss of information due to
growth data categorisation.
Outcome variables
Study authors used one or multiple outcome terms in their reporting. Again, for
comparability among studies, where authors used a single outcome, for example,
asthma or wheezing, the quoted outcome term by the author and its risk estimate
were assumed for analysis. However, where authors used multiple outcome terms,
the term that was highest in the hierarchy and its risk estimate were assumed for
analysis. For example, if asthma and wheezing were used together, asthma was
preferred over wheezing.
2.5.2.5 Quality assessment
Papers included in the review and meta-analysis were assessed for risks of bias
using the Newcastle-Ottawa quality assessment scale (Wells et al., 2000),
see Appendix A for details on scoring guideline used.
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2.5.2.6 Statistical analysis
Studies were too few and diverse to be combined in a meta-analysis. Thus, no
statistical analysis was planned to produce a quantitative summary of wheezing
disorders risk estimates in relation to childhood growth patterns.
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2.5.3 Results
2.5.3.1 Literature search
The search yielded 2,115 studies with 1,741 of whom screened for eligibility.
Eighteen studies were read in full resulting 15 studies to be included in the review
(Figure 2.15).
The included studies were from Europe (13), America (1) and Oceania (1), see
Table 2.22. Results of these studies were not combined to form a summary estimate
through a meta-analysis. Hence, only a descriptive summary has been presented
(Table 2.24). One study was not included in the descriptive table because the age
range when a second weight measurement occurred was not recorded in the text or
table (Sonnenschein-van der Voort et al., 2014a).
2.5.3.2 Quality of studies
Out of 14 studies, eight scored 7/9, five scored 6/9 and another one study scored 4/9
(Table 2.23)
Figure 2.15 Childhood growth patterns and wheezing disorders literature search
flow chart
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Table 2.22 Characteristics of childhood growth patterns and wheezing disorder studies included in the review
Author , year, region Sample
size
Participants’
age and gender
Outcome
term
Outcome
ascertainment
Exposure
ascertainment
Exposure terms used
Mai et al. (2005), Sweden 74 12 years mixed asthma parent no mention 1 weight SDS increase between 0 and 6 months
Mamun et al. (2007), Australia 3,759 14 years mixed asthma parent trained 1 BMI SDS increase between 5 and 14 years
Scholtens et al. (2009), Netherlands 3,756 8 years mixed asthma parent parent Changes in BMI status between 1 and 7 years
Pike et al. (2010), UK 1,548 3 years mixed wheezing parent trained 1 weight SDS increase between 0 and 12 months
Zhang et al. (2010), USA 285 8 years mixed asthma e-records e-records 0.67 weight SDS increase between 0 and 6 months
Flexeder et al. (2012), Germany 9,086 10 years mixed asthma parent trained Pick weight velocities at 4, 6 or 10 years
Magnusson et al. (2012), Sweden 2,075 12 years mixed asthma parent trained BMI changes between 1 and 7 years
Sonnenschein-van der Voort et al.
(2012), Netherlands
5,125 1-4 years mixed wheezing parent e-records 0.67 SDS increase between 3 and 12 months
van der Gugten et al. (2012),
Netherlands
1,431 1 years mixed wheezing parent no mention 0.67 SDS increase during first 3 months
Anderson et al. (2013), Belarus 12,171 6 years mixed wheezing parent trained Weight velocities between 0 and 60 months of age.
Rzehak et al. (2013), Multi-centre 12,050 6 years mixed asthma parent/trained parent/trained Rapid growth before the age of 2 years
Sonnenschein-van der Voort et al.
(2014b), UK
9,723 17 years mixed asthma parent trained Weight SDS changes during 0-3 and 3-12 months;
1-3, 3-7 and 7-10 years
De Korte-De Boer et al. (2015),
Netherlands
566 3 years mixed wheezing parent e-records Weight SDS changes during 1-7, 7-14, 24-36
months of age.
Magnus et al. (2015), Norway 24,827 7 years mixed asthma parent parent 1 weight SDS change during the first 36 months
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Table 2.23 Risk of bias assessment table using Newcastle-Ottawa quality assessment scale for childhood growth patterns and wheezing
disorder studies included in the review
Author , year, region Study title Selection Comparability Outcome
Mai et al, 2005, Sweden Early rapid weight gain and current overweight in relation to asthma in
adolescents born with very low birth weight.
 
Mamun et al, 2007, Australia Increasing body mass index from age 5 to 14 years predicts asthma
among adolescents: evidence from a birth cohort study
  
Scholtens et al, 2009, Netherlands Overweight and changes in weight status during childhood in relation to
asthma symptoms at 8 years of age
  
Pike et al, 2010, UK Patterns of foetal and infant growth are related to atopy and wheezing
disorders at age 3 years
  
Zhang et al, 2010, USA Early childhood weight status in relation to asthma development in high-
risk children
  
Flexeder et al, 2012, Germany Growth velocity during infancy and onset of asthma in school-aged
children
  
Magnusson et al, 2012, Sweden Early childhood overweight and asthma and allergic sensitization at 8
years of age
  
Sonnenschein-van der Voort et al, 2012,
Netherlands
Foetal and Infant Growth and Asthma Symptoms in Preschool Children   
van der Gugten et al, 2012, Netherlands Rapid early weight gain is associated with wheeze and reduced lung
function in childhood
  
Anderson et al, 2013, Belarus Associations of postnatal growth with asthma and atopy: The PROBIT
Study
  
Rzehak et al, 2013, Multicentre Body mass index trajectory classes and incident asthma in childhood:
Results from 8 European Birth Cohorts—a Global Allergy and Asthma
European Network initiative
  
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Author , year, region Study title Selection Comparability Outcome
Sonnenschein-van der Voort et al, 2014, UK Influence of childhood growth on asthma and lung function in
adolescence
  
De Korte-De Boer et al, 2015, Netherlands Early life growth and the development of preschool wheeze, independent
from overweight: The LucKi Birth Cohort Study
  
Magnus et al, 2015, Norway Peak weight and height velocity to age 36 months and asthma
development: the Norwegian mother and child cohort study
  
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2.5.3.3 Summary of childhood growth patterns and wheezing disorders studies
The measurements and stages of growth investigated were diverse, and those studies
that used the same growth measurements were too few to be combined. Thus, no
meta-analysis was carried out for growth and wheezing disorders studies’ risk
estimates.
Based on the diverse growth measurements and stages, the studies reported an
inconsistent risk of association between growth patterns and wheezing disorders. For
example, three studies reported an insignificant risk reduction (Mai et al., 2005;
Sonnenschein-van der Voort et al., 2012; Sonnenschein-van der Voort et al., 2014b),
five studies reported an insignificant increase (Scholtens et al., 2009; Pike et al.,
2010; Zhang et al., 2010; Magnusson et al., 2012; Anderson et al., 2013), and eight
studies reported a significant increase in the risk of wheezing disorders (Mamun et
al., 2007; Scholtens et al., 2009; Flexeder et al., 2012; Magnusson et al., 2012; van
der Gugten et al., 2012; Rzehak et al., 2013; Sonnenschein-van der Voort et al.,
2014b; De Korte-De Boer et al., 2015; Magnus et al., 2015) for fast growth
(Table 2.24).
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Table 2.24 Summary of studies that investigated the association between childhood
growth patterns and childhood wheezing disorders
Study Growth extent and period Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Mai et al, 2005 1weight SDS increase during the first 6
months
0.49 (0.23 to 1.02)
1weight SDS increase during the first
18 months
0.63 (0.31 to 1.26)
Mamun et al, 2007 1 BMI SDS change between 5 and 14
years
1.14 (1.03 to 1.27) 1.13 (1.02 to 1.25)
Scholtens et al, 2009 between 1- 2 and 6-7 years
early overweight 0.99 (0.73 to 1.34) 1.02 (0.72 to 1.43)
late overweight 1.73 (1.26 to 2.39) 1.77 (1.21 to 2.58)
persistent overweight 1.35 (0.88 to 2.06) 1.40 (0.86 to 2.28)
between 3- 5 and 6-7 years
early overweight 1.13 (0.79 to 1.64) 1.14 (0.72 to 1.80)
late overweight 1.65 (1.15 to 2.38) 1.71 (1.10 to 2.66)
persistent overweight 1.56 (1.10 to 2.23) 1.57 (1.06 to 2.34)
Pike et al, 2010 1 weight SDS increase between 0 and 6
months
1.08 (1.03 to 1.12) 1.05 (1.01 to 1.09)
1 weight SDS increase between 6 and
12 months
1.04 (0.98 to 1.09) 1.06 (1.00 to 1.12)
Zhang et al, 2010 0.67 weight SDS increase between 0
and 6 months
1.16 (0.59 to 2.33) 1.11 (0.50 to 2.51)
Flexeder et al, 2012 velocity of 13kg per year during 1-10
years
1.22 (1.02 to 1.47)*
Magnusson et al, 2012 BMI changes between 1-1.5 and 7
years
early overweight 1.09 (0.64 to 1.87) 1.21 (0.69 to 2.11)
late overweight 2.34 (1.37 to 3.97) 2.51 (1.45 to 4.35)
persistent overweight 1.87 (0,96 to 3.56) 1.89 (0.92 to 3.87)
BMI changes between 4 and 7 years
early overweight 1.17 (0.56 to 2.43) 1.25 (0.58 to 2.67)
late overweight 1.99 (1.06 to 3.73) 2.09 (1.09 to 3.98)
persistent overweight 2.39 (1.38 to 4.13) 2.49 (1.38 to 4.49)
Sonnenschein-van der
Voort et al, 2012
0.67 weight SDS increase during 3and
6 months
0.97 (0.88 to 1.06)
0.67 weight SDS increase during 6 and
12 months
0.95 (0.86 to 1.04)
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Study Growth extent and period Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
van der Gugten et al,
2012
1 SDS increase during the first 3
months
1.26 (1.11 to 1.45) 1.16 (1.01 to 1.34)*
Anderson et al, 2013 1 weight SDS increase per month
during 0 and 60 months
between 0 and 3 months 1.12 (0.95 to 1.32)
between 3 and 12 months 1.15 (0.96 to 1.36)
between 12 and 34 months 1.00 (0.84 to 1.18)
between 34 and 60 months 1.01 (0.80 to 1.28)
Rzehak et al, 2013 1.32 BMI SDS increase per year during
0-2 years
1.22 (1.08 to 1.39) 1.27 (1.06 to 1.51)*
2.5 BMI SDS increase per year during
0-6 years
1.42 (0.90 to 2.27) 1.24 (0.62 to 2.47)
Sonnenschein-van der
Voort et al, 2014
1 weight SDS increase during 0-10
years
between 0 and 3 months 1.18 (1.01 to 1.37)
between 3 and 12 months 0.89 (0.75 to 1.06)
between 1 and 3 years 1.03 (0.87 to 1.23)
between 3 and 7 years 1.04 (0.86 to 1.26)
between 7 and 10 years 0.92 (0.70 to 1.21)
De Korte-De Boer et al,
2015
1 weight SDS increase per year
between 0-3 years
0.89 (0.74 to 1.05) 0.88 (0.73 to 1.05)
1 BMI SDS increase per year between
0-3 years
1.16 (0.99 to 1.36) 1.16 (0.99 to 1.37
Magnus et al, 2015 1 weight SDS increases during the first
36 months
1.14 (1.08 to 1.20) 1.13 (1.07 to 1.20)*
*= relative risk
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2.5.4 Discussion
Until the time of writing up of this thesis, no meta-analysis of previous studies of
childhood growth and wheezing disorders was carried out. Results from previous
epidemiologic studies remain inconsistent. For example, Mai et al reported that there
was an insignificant wheezing disorder risk reduction for 1 weight SDS increase
between birth and six months (Mai et al., 2005). Three other studies also reported an
insignificant risk increases for 1 weight SDS increase between birth and three
months (Pike et al., 2010; Anderson et al., 2013; Sonnenschein-van der Voort et al.,
2014b). However, van der Gugten et al. (2012) reported a significant increase of
wheezing disorders risk for 1 weight SDS increase during the first three months.
Moreover, three other studies that investigated weight SDS increases during longer
follow up periods have reported a significant increase in the risk of wheezing
disorders (Mamun et al., 2007; Rzehak et al., 2013; Magnus et al., 2015), although
another study has also reported an insignificant reduction of the risk (De Korte-De
Boer et al., 2015).
In conclusion, data on childhood growth patterns and childhood disorders is sparse
and results from majority of the studies remain inconclusive (i.e. the risk estimates
included the value of 1). The lack of the use of standardised anthropometric
measurement has also made difficult for results of the studies to be combined for
meta-analyses. Thus, the association between childhood growth patterns and
wheezing disorders needs further investigation.
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CHAPTER 3
METHODS AND MATERIALS
3.1 Chapter overview
This chapter presents a detailed description of the methods and materials used, and
the steps followed during analyses of childhood anthropometric measurements and
wheezing disorders using the Born in Bradford (BiB) cohort data.
In section 3.2, a review of common methodological issues in research, namely:
causality, confounding, missing data and longitudinal data analysis methods is
presented. Novel approaches such as identification of confounders using Direct
Acyclic Graphs (DAGs), maximum likelihood and multiple imputation for missing
data estimation, and statistical techniques for longitudinal data analyses are
discussed.
In sections 3.3-3.9, the study design, ethics statement, data collection and
standardisation, variables for missing data estimation and analyses models are
described in detail. The use of DAGs for selection of confounding variables and the
steps followed are also presented.
Section 3.10 details the statistical methods and software used in the series of
analyses, namely: the incidence and burden of childhood allergic conditions and the
effects of birthweight, weight at the age of 3 years and childhood growth patterns on
wheezing disorders. Latent growth models formulation, models estimation and fit
evaluations techniques are described. Model implementation of non-linear growth
modelling techniques (i.e. polynomials, free-loading, and piecewise), and best model
selection procedures using Mplus software are described in detail.
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3.2 Methodological issues in research
3.2.1 Association and causality
The primary aim of epidemiological research is to establish a valid association
between two variables, known as exposure and outcome. Information on a set of
variables is collected or becomes available for analysis. Then, the putative
association between the two variables is investigated using regression models. The
model variables are broadly categorised into three: exposure, outcome and potential
confounders. However, more often, no clear definition of confounding variables is
assumed and best model selection is based on stepwise selection methods where a
variable is retained if its coefficient is statistically significant (Hernán et al., 2002).
Although a potential association (i.e. statistical relationship) between the exposure
and outcome variables can be established this way, a causal relationship between the
variables can not be implied (Hernán et al., 2002; McNamee, 2003). More
importantly, an indiscriminate inclusion of variables into analysis models may bias
risk estimates (Hernán et al., 2002; Tu et al., 2005; Schisterman et al., 2009). For
example, in a simulation study by Tu et al. (2005), an inclusion of a variable that is
in the causal pathway between the exposure and outcome variables was observed to
cause a spurious association when there is no relationship between exposure and
outcome variables; and, a reversing and exaggerating effect on the estimate when
there is a negative and positive genuine relationship between the exposure and
outcome variables, respectively. In order to avoid risk estimate bias and be able to
infer causality, one has to adopt appropriate definition and tools to identify
confounding variables.
3.2.1.1 Confounding and confounders
Confounding variable is a variable that satisfies three key aspects (McNamee, 2003):
a) be a cause or a proxy cause of a disease;
b) be correlated with the main exposure variable; and,
c) not affected by the exposure variable.
Confounding occurs when an association between an exposure and outcome
variables is due to a causal effect of the exposure on the outcome and sharing of a
common cause variable (Hernán et al., 2002). For example, in Figure 3.1, X and Y
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are statistically associated because: X causes Y, and X and Y share a variable C. In
other words, variable C is confounding the causal association between X and Y so it
is a confounder.
The graph in Figure 3.1 represents a causal assumption about the relationship
between X, Y and C (Greenland et al., 1999; Hernán et al., 2002). A graph becomes
acyclic if there is no directed path in the graph that forms a closed loop, hence,
Direct Acyclic Graph (DAG) (Greenland et al., 1999). The causal relationship and
the temporal precedence assumptions are based on a priori knowledge or speculative
hypothesis about the subject matter, not on the data (Hernán et al., 2002). For
example, in Figure 3.1, it is assumed that X has temporal precedence over Y, and C
has temporal precedence over X and Y
Figure 3.1 Graphical reperesentation of exposure (X), outcome (Y) and a
confounder (C) variable
3.2.1.2 Direct Acyclic Graphs (DAGs)
Direct Acyclic Graphs (DAGs) are valuable tools in visualising the causal structure
of a substantive model and identifying confounding and confounders appropriately
(Greenland et al., 1999; Hernán et al., 2002).
Terminologies in DAG (Greenland et al., 1999): each of the variables are called
nodes or vertices (e.g. C, X, Y, and Z in Figure 3.2). A line or arrow that connects
any of two nodes is called an arc or edge. A node where an arc exits is a parent or
ancestor or a cause, and a node that an arc enters is a child or descendant. For
example in Figure 3.2, C, W and Z are ancestors of a descendant or child X. A path
is the sequence of arcs connecting two or more nodes, e.g., Z—C—X is a path
between Z and X. Two variables are called adjacent if they are directly connected
by an arc, e.g, X and Y are adjacent. A backdoor path is a path, other than the direct
path, from the exposure to the outcome. For example, all paths from X to Y except
the direct path are backdoor paths. A collider is a variable where a path enters and
X Y
C
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exits through arrowheads, e.g. C in Figure 3.2 is a collider. A path is blocked if it
has one or more colliders; otherwise it is unblocked.
Figure 3.2 Direct Acyclic Graph
Identification of confounding and confounders
Potential confounders are qualified using the following algorithm (Greenland et al.,
1999):
a) All single-headed arrows that exit from exposure variable (cause) are
deleted. e.g.: the arrow from X to Y in Figure 3.3a is deleted to form
Figure 3.3b.
b) The presence of any unblocked path from exposure to outcome (disease) in
the new graph is checked, that is, if exposure and disease remain associated
after the exposure effect is removed is examined. In Figure 3.3b, once the
path from X to Y is removed, it can be noted that the two variables share
common ancestors C, W and Z. Thus, C, W and Z are confounders; hence,
there is a confounding.
X Y
C
ZW
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Figure 3.3 Graphical representation of confounders assessment process
Implementing the above two algorithms would result in a sufficient set of variables.
That is, all backdoor paths from X to Y will be blocked by including the set of
variables, known as, confounders. For example, variables C, W and Z in Figure 3.3
are sufficiently enough to block the backdoor path from X to Y. However, including
all three variables in a model as confounders may not be ideal choice for two main
reasons. First, having fewer variables in a model increases the degree of freedom
and model efficiency (Shrier and Platt, 2008). Second, cost of data collection is
directly proportional to the number of variables. Thus, selecting a minimum subset
of variables for adjustment is always preferable (Greenland et al., 1999; Shrier and
Platt, 2008).
The model in Figure 3.3 is not a complex model; selection of minimally sufficient
sets of confounders can be achieved by adding a linking line between two variables
who share a child (i.e. W and Z). Thus, it becomes clear that either C and W or C
and Z would form the minimally sufficient sets of confounding variables.
For complex models, minimally sufficient sets confounders can be identified by a
six step algorithm recommended by Shrier and Platt (2008). However, identifying of
confounders by hand can be very difficult task and errors can arise. Thus, it is much
faster and safer to generate automated results of minimally sufficient sets of
confounders using DAGitty software (Textor et al., 2011) than doing the task by
hand.
W Z
Y
X
X Y
C
ZW
C
a) b)
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3.2.2 Missing data in research
Missing data are inevitable in research but complete cases analyses were more
commonly used to address the problem in the past (Schafer and Graham, 2002;
Wood et al., 2004). However, analyses that are restricted to individuals who have no
missing data in any of the analysis variables have two disadvantages (Royston et al.,
2009; Sterne et al., 2009; White et al., 2011). First, results can be biased if the
remaining data become unrepresentative of the sample population due to an
exclusion of those individuals with missing data in any of the analysis variables.
Second, the exclusion of individuals with missing data in variables may cause a
substantial reduction of sample size which can lead to a loss of study power and
estimate precision. In order to address these concerns, researchers used either ad hoc
(also known as traditional methods) or principled (also known as modern methods)
missing data estimation methods in the past.
Ad hoc methods such as mean substitution (missing values are replaced by the
average of the complete data) and regression imputation (missing values are
replaced by conditional means), hot deck imputation (replacing missing values by a
random draw from the observed values) were widely implemented as alternatives to
case deletion or complete case analysis (Schafer and Graham, 2002; Duncan et al.,
2006c). However, although these methods can estimate the missing values, they
often lead to biased parameter estimates (Schafer and Graham, 2002). Thus, multiple
imputation (Rubin, 1987) and maximum likelihood (Dempster et al., 1977) methods
have been recommended.
3.2.2.1 Multiple imputation
Multiple imputation (MI) is a statistical technique for handling of missing data
where the missing values are replaced by a set of simulated values from the
distribution of observed data (Schafer and Graham, 2002 ; White et al., 2011).
Model parameters estimation using MI is carried out in three stages: imputation of
data sets, statistical analysis of individual sets and combining of results (White et
al., 2011).
Imputation of datasets
At this stage, missing data are filled with m independent simulated sets of values
from the posterior distribution of the missing data conditional on the observed data
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resulting in several completed data sets (White et al., 2011). Imputation can be
carried out using a joint modelling or fully conditional specification, also known as
multiple imputations by chained equations (MICE), the latter being easier and
flexible to implement than the former (van Buuren, 2007).
MICE is carried out through a sequence of regression models (White et al., 2011).
For example, suppose that variables x1, x2 and x3 have incomplete and x4 complete
data. First, x1 is regressed on x2 , x3 and x4 restricted to individuals with information
on x1. Missing values in x1 are replaced by simulated draws from the corresponding
posterior predictive distribution of x1 assuming a vague prior distribution for the
parameters in the regression model. Then, x2 is regressed on x1 , x3 and x4 restricted to
individuals with information on x2 (note that x1 is complete at this stage). Missing
values in x2 are replaced as in x1. The process is repeated for x3 to complete a cycle.
The procedure is repeated for several cycles to produce a single dataset and the
whole procedure is repeated m times to produce m imputed datasets (White et al.,
2011).
In MI, the number of data sets to be imputed (m) depends mainly on the fraction of
missing information (FMI) and White et al recommend that m should be at least
equal to the percentage of incomplete cases (White et al., 2011). Thus, m ≥ 1-p;
where p is the proportion of individuals with complete observation in all of the
variables.
Statistical analysis
This stage is straight forward, each completed dataset is analysed separately by
fitting a regression model. In the end, m sets of parameter estimates are obtained
from separate analyses of m datasets.
Combining of results
At this stage, the m sets of parameter estimates are combined using Rubin’s rules
(Rubin, 1987) incorporating both the within-imputation variability and between-
imputation variability (White et al., 2011). Consistency of results produced from the
m imputed datasets can be checked using Monte Carlo errors from a jackknife
procedure (Royston et al., 2009); if the errors of the beta coefficient (or risk
estimate), test statistic (t-value) and the p-value are less than 10% of the standard
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error, less than 0.1, and less than 0.2 respectively, the consistency is considered to
be adequate (White et al., 2011).
3.2.2.2 Maximum likelihood
Maximum likelihood (ML), unlike MI, does not create datasets but rather estimate
the parameters directly by maximizing the complete data log likelihood function
(Dempster et al., 1977; Enders, 2001a; Schafer and Graham, 2002). There are three
types of ML techniques: Expectation Maximisation, Full Information Maximum
Likelihood and multi-group approach (Enders, 2001b).
The Expectation Maximisation (EM) algorithm uses a two-step iterative procedure
to estimate parameters (Enders, 2001b). In the E step, missing values are replaced
with the conditional expectation of the missing data given the observed data and an
initial estimate of the covariance matrix. In the M step, ML estimates of the mean
vector and covariance matrix are obtained using the sufficient statistics calculated at
the previous E step. Then, the resulting parameter estimates in the M step are used to
derive the new estimates of missing values at the next E step, and the process begins
again. The algorithm repeatedly cycles until convergence is achieved (Enders,
2001b).
Multi-group approach: the sample is divided into G-subgroups based on their
pattern of missing data. That is, observations within each of the G-subgroups have
the same set of variables present and missing. A likelihood function is computed for
each of the G groups, and the group-wise likelihood functions are accumulated
across the entire sample and maximized (Enders, 2001b).
Full Information Maximum Likelihood (FIML): originally developed for factor
analysis, is similar to the multi-group approach although the likelihood function is
calculated at the individual, rather than the group level (Enders, 2001b). However,
the key identifying feature of FIML is that it uses the raw data as input and hence
can use all the available information in the data as opposed to the other ML methods
that use observed covariance matrix which contains less information than the raw
data (Enders and Bandalos, 2001; Schafer and Graham, 2002).
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3.2.2.3 Missing data mechanisms
Modern missing data estimation methods (i.e. MI and ML) are not always the best
option. Implementing the techniques consumes resources and time, and sometimes
there may be no benefit of using them. To avoid unnecessary waste of resources,
analysts are advised to look into the properties or mechanisms of the missing data
prior to executing missing data estimation methods (Collins et al., 2001; Schafer and
Graham, 2002; Sterne et al., 2009). There are three types (mechanisms) of missing
data: missing completely at random, missing at random, and missing not at random
(Collins et al., 2001; Schafer and Graham, 2002; Sterne et al., 2009).
Suppose that we have haemoglobin level as an outcome or dependent variable Y
partly missing, cause of missing variable Z, a missing indicator or missingness
variable R with values of 1 if Y is missing and 0 if Y is not missing, gender as an
explanatory variable X completely observed . Therefore the three missing data
mechanisms can be elucidated as follows (Collins et al., 2001; Schafer and Graham,
2002; Sterne et al., 2009). In missing completely at random (MCAR), the reason for
missingness (Z) on the outcome variable (Y) is entirely unrelated to the outcome
variable itself. For example, some blood haemoglobin levels (Y) are missing due to
contamination of samples (Z); see Figure 3.4a. In missing at random (MAR), the
cause of missingness (Z) may be related to the outcome variable (Y) but only
indirectly through another variable. For instance, missing haemoglobin levels (Y)
may be higher than the non-missing levels but only because women missed the
appointment provided that there is no relationship between missingness and blood
haemoglobin level within men and women groups; see Figure 3.4b. In the case of
missing not at random (MNAR), the outcome variable (Y) itself is associated with
the missingness (R). For example, people with lower blood haemoglobin level
tended to miss appointments (R) because they felt very tired (Z); see Figure 3.4c.
Assessing data for mechanisms of missingness prior to performing analysis has
implication on the decisions to be taken. If the data missingness is MCAR, complete
cases analysis and modern techniques (MI or ML) provide identical results (Wood et
al., 2004) so complete cases analysis may be preferred over MI or ML. However, if
the mechanism of missingness is either MAR or MNAR, analyses based on the
modern missing data estimation methods provide unbiased and more efficient
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parameter estimates than analyses based on ad hoc or case deletion (i.e. complete
cases) methods.
Figure 3.4 Graphical representation of missing data mechanisms; (a) MCAR (b)
MAR and (c) MNAR
3.2.3 Analysis of weight change and childhood growth patterns in
relation to disease outcomes
Childhood weight change and growth patterns have been reported as predictors of
health during childhood and adult life. For example, higher growth rate during
childhood and adulthood has been related to hypertension (Hardy et al., 2004;
Eriksson et al., 2007; Halldorsson et al., 2011 ), chronic heart disease (Baker et al.,
2007; Owen et al., 2009) diabetes (Eriksson et al., 2003), and asthma (Rzehak et al.,
2013). However, except for the method by Rzehak et al. (2013) multiple regression
approaches are prone to collinearity problems caused by the repeated weight
measurements that can lead to biased coefficient estimates (Duncan and Duncan,
2004; Tu et al., 2013).
3.2.3.1 Longitudenal continuous data analysis methods
Based on literature, the statistical techniques used were: generalised estimating
equations (Ballinger, 2004; Hwang and Takane, 2005), multilevel linear models
(Bryk and Raudenbush, 1987; Howe et al., 2013) and latent growth models (Muthen,
2001; Duncan and Duncan, 2004; Muthén, 2004; Duncan et al., 2006b). Generalised
estimating equation (GEE) models were developed by Liang and Zeger for
longitudinal panel data analysis (Liang and Zeger, 1986) and recently have been
proposed for longitudinal continuous data (Hwang and Takane, 2005) although their
X
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use have so far been limited. GEE models are superior to the multiple regression
models as the effects of within-subject correlation are corrected by multiplying of
the variances against the matrix of correlation coefficients (Ballinger, 2004).
Multilevel linear models (MLMs), also known as Hierarchical linear models,
address the issues of correlation between repeated measurements, status and change
over time (Bryk and Raudenbush, 1987) like GEE models. In fact, MLMs and GEEs
can be seen as equivalent except that the random growth factors (i.e. intercept and
slope) are assumed to be Gaussian (normally distributed) in MLMs whereas no such
assumption needs to be made in GEE models (Ballinger, 2004). However, GEE and
MLMs are only capable of deriving a single overall mean growth trajectory, that is,
the growth trajectories of individuals over time are assumed to be homogeneous.
Latent growth models (LGMs) account the within-subject level correlations and
capture individual differences of growth trajectories over time through the
continuous random factors, that is, intercept and slope (Muthén, 2004; Duncan et al.,
2006c), like GEEs and MLMs. However, LGMs more flexible than GEE and MLMs
as the homogeneity assumption can be relaxed and whether the population under
study is made-up of one or sub-groups of population can be tested.
In summary, the difference between GEEs, MLMs, and LGMs depends on the
assumption made about growth trajectories. For example, suppose that we want to
know the growth trajectories of children in a school. In both GEEs and MLMs,
measurement occasions are nested within individuals, who are nested within the
school. The two models will provide only one growth trajectory. In other words,
these models only assume a homogeneous growth among the children and cannot
differentiate between more than one distinct growth trajectories within the school.
However, ignoring the potential variability among individuals can provide biased
estimates (Muthen, 2001; Muthén, 2004; Duncan et al., 2006b). The LGMs on the
other hand, assume that the population under study can be made up of unknown sub-
groups or growth trajectory groups (Duncan et al., 2006c; Gilthorpe et al., 2014).
This assumption then allows us to test if there is more than one distinct growth
trajectory and parameters be estimated accordingly.
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3.2.3.2 Approaches for the analysis of growth trajectories in relation to disease
outcomes
Analysis of growth trajectories in relation to covariates (e.g. disease outcome)
remains to be challenging. Based on literature, researchers have used a variety of
approaches to identify the potential growth trajectory groups in a population and
investigate their relationship with covariates. Broadly, the approaches can be
grouped into one-step and three-step methods (Vermunt, 2010; Asparouhov and
Muthén, 2014).
The one-step method
The one-step approach is a type of analysis where a researcher uses a set of
covariates as predictors of growth trajectories (Vermunt, 2010; Asparouhov and
Muthén, 2014). In this approach, the identification of growth trajectories and their
relationship with covariates are carried out simultaneously. Here, the main interest is
to understand which of the covariates predict the growth trajectories and the model
implementation is straight forward. However, this modelling approach has attracted
criticisms for the following reasons (Vermunt, 2010). First, convergence of models
may become difficult when the number of potential covariates is large. Second, it
introduces additional model building problems, such as whether one should decide
about the number of classes in a model with or without covariates. Third, the
simultaneous approach does not fit with the logic of most applied researchers, who
view building a classification model is a step that comes before introducing
covariates.
The three-step method
Unlike in the one-step method, identification of growth trajectories and investigation
of covariates relationship with the growth trajectories are carried out in separate
steps (Asparouhov and Muthén, 2014). In the first step, the growth trajectories are
estimated using only the repeated weight measurements overtime. In the second
step, the most likely class variable is created using the latent class posterior
distribution obtained during the first step. In the third step, the most likely class is
regressed on covariates, taking into account the misclassification or classification
uncertainty.
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In practice, the three-step modelling approach is also implemented in a
classify-analyse fashion where the growth class memberships of individuals are
estimated using the first two steps of the three-step approach. The class membership
data are then saved and merged with the original data. In step three, a covariate
(distal outcome variable, also known as disease outcome variable) can be regressed
on the categorical latent growth class variable. The drawback of classify-analyse
approach is that the classification uncertainty is ignored and parameter estimates can
be biased as a consequence (Lanza et al., 2013). However, the approach works well
if the classification quality of the classification models (entropy) is greater or equal
to 0.80 (Clark, 2010).
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3.3 Study design and participants
The BiB study is a prospective cohort, mainly bi-ethnic, which examines the impact
of environmental, genetic and social factors on health of the population of Bradford
(Wright et al., 2013). The project’s main aims focus on following up over 13,500
children from childhood up to adulthood life. Further information about the BiB
project is available from the project website
(http://www.borninbradford.nhs.uk/about-the-project/)
Participants were pregnant mothers who attended Bradford Royal Infirmary
antenatal clinic and wished to give birth at the hospital. Recruitment of participants
started in March 2007 and ended in December 2010. A total of 13,776 pregnant
mothers were recruited resulting in 13,857 births. Of the total births, 123 died before
7 days. Thus, data from 13,734 children were used for analyses of incidence and
burden of allergic diseases, and the effects of birthweight on wheezing disorders
(Figure 3.5).
At the time of initial recruitment, pregnant mothers were also asked to join a sub-
cohort known as BiB1000 for regular follow up. A total of 1,735 mothers agreed to
participate resulting in 1,763 babies; 1707 singletons and 28 twins. With the
exclusion of 14 babies due to death before 7 days and another 94 due to being
preterm, a total of 1,598 children were included in the investigation of effects of
weight at the age of 3 years and childhood growth on wheezing disorders. With a
further exclusion of 234 babies who were either minority or unknown (missing value
for) ethnicity, a total of 1,364 Pakistani and white British children were included in
growth patterns analysis of the two ethnicities (Figure 3.5).
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Figure 3.5 Study participants’ recruitment process flow chart for the analyses
carried out using the Born in Bradford cohort
3.4 Ethics statement
Ethics approval for the Born in Bradford project was granted by Bradford Research
Ethics Committee (Ref 07/H1302/112.).
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3.5 Data collection
3.5.1 Incidence and burden of wheezing disorders, eczema and rhinitis
Three data sources were used:
a) Baseline questionnaire for information on ethnicity of the mother (i.e., proxy
for child’s ethnicity);
b) The hospital maternity records for sex, date and outcome of birth; and,
c) Information on wheezing disorders, eczema, and rhinitis drug prescription
from the SystmOne (http://www.tpp-uk.com/products/systmone) primary
care data.
Baseline questionnaire and hospital maternity data were directly available from the
data and research team of the BiB project (http://www.borninbradford.nhs.uk/our-
team/) upon request. However, collection of drug prescription data was conducted in
two steps. First, a list of drug family names and chapters were extracted from the
British National Formulary (BNF) for Children Handbook version 2015 and were
given to the data manager of BiB project. Based on the list of drug names and
chapters the BiB data manager then conducted a SystmOne data query and extracted
the data, which were then available upon request. The list of drug family names and
BNF chapters used are available in Appendix E .
3.5.2 Effects of birthweight and weight at the age of 3 years on wheezing
disorders
Four data sources were used:
a) The hospital maternity records for information on birth weight, gestational
age, gender of a child, number of births, birth outcome;
b) The BiB1000 cohort records for weight at the age of 3 years (36 months);
c) Baseline questionnaire for information on the mother’s ethnicity, smoking
and socioeconomic status; and,
d) SystmOne (http://www.tpp-uk.com/products/systmone) primary care data
for information on wheezing disorders.
All data were available from the BiB project data and research team upon request.
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3.5.3 Describing growth patterns of white British and Pakistani children
The following data sources were used:
a) The hospital maternity records for information on birth weight, gestational
age, gender of a child, number of births, birth outcome;
b) The community health records for weights at 1 and 3 months;
c) The BiB1000 cohort records for weights at 6, 12, 18, 24 and 36 months; and
d) Baseline questionnaire for information on the mother’s ethnicity, smoking
and socioeconomic status.
All data were available from the BiB project data and research team upon request.
3.5.4 The effect of childhood growth patterns on childhood wheezing
disorders
Five data sources were used:
a) The hospital maternity records for information on birth weight, gestational
age, gender of a child, and number of live births, birth outcome;
b) BiB1000 cohort records for weight at 6, 12, 18, 24 and 36 months of age;
c) Community health records for weight at 1 and 3 months of age;
d) Baseline questionnaire for information on the mother’s ethnicity, smoking
and socioeconomic status ; and,
e) SystmOne primary care data for information on wheezing disorders.
Baseline questionnaire, BiB1000 cohort, community health, and hospital maternity
data were available from the BiB project data and research team upon request.
Wheezing disorders drug prescription data were collected as in section 3.5.1.
However, data on disease diagnosis were collected as follows: a list of wheezing
disorder terms and ids were extracted using NHS Clinical Terminology Browser
(http://www.hscic.gov.uk/standards) and were given to the BiB data manager. A
SystmOne primary care data query and extraction were conducted by the BiB data
manager, which were then available upon request. See Appendix E and Appendix F
for the list of drugs and diseases terms used.
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3.6 Data standardisation
Prior to conducting growth patterns analyses, repeated weight measurements of
1,598 BiB1000 children were converted into standardised weight scores (SD score,
SDS). Age-specific and sex-specific weight SDS were derived based on WHO
growth standards (WHO, 2006) in LMSgrowth Microsoft excel add-in software (Pan
and Cole, 2012). However, the WHO growth standards population that were used to
derive the SDS scores was made up of singleton term births. Therefore, multiple and
preterm births were excluded from the growth patterns analyses.
The WHO growth standards included children from Brazil, Ghana, India, Norway,
Oman and USA (WHO, 2006). Therefore, it can be said that it is a representative of
all children in the world, and the BiB cohort in specific.
To facilitate interpretability of the growth trajectories, the weight SDS were then
converted into percentiles using a one-sided normal standard distribution. For
example, weight SDS of -1.64, 0, 1.04, and 1.64 are equivalent to the 5th, 50th, 85th
and 95th centiles, respectively.
Note that the use weight SDS was preferred over raw weight due to two main
reasons. First they are equivalent to BMIs so they become standard comparison tool
for growth of children over time (WHO, 2006). Second, they are convertible to
percentiles which then can be plotted onto the child growth charts in order to assess
growth patterns over time (Pan and Cole, 2012).
Birthweights of 13,734 BiB children were classified into three; based on the CDC
(CDC, 2009) and WHO (WHO, 2014) guidelines where <2.5kg=low, 2.5-
4.0kg=normal and >4.0kg=high.
Weight at the age of 3 years for 1,598 BiB1000 children was first converted into
age-specific and sex-specific weight SDS. Then, weight SDSs were categorised into
underweight (<5th centile), normal (≥5th and <85th centiles), overweight (≥ 85th and
<95th centiles), and obese (≥95th centile) categories based on CDC classification
(CDC, 2014). Weight SDS of -1.64, 1.04, and 1.64 were used cut-off points for the
5th, 85th and 95th centiles, respectively.
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3.7 Outcome definition and ascertainment
3.7.1 Incidence and burden of wheezing disorders, eczema and rhinitis
Incidence of allergic conditions was confirmed through questionnaires and clinician-
diagnosis data in the past. However, these types of data are prone to recall and
reporting bias respectively which are very likely to underestimate the true impact
level of a disease. In order to overcome the potential for the misdiagnoses, a
treatment based algorithm was used to allocate a diagnosis of allergic conditions
where eczema, rhinitis and wheezing disorder cases were ascertained by the
existence of at least two respective drug prescriptions a minimum of one week and
maximum of 12 months apart. Appendix E lists the drugs used to confirm the
diagnosis of eczema, rhinitis and wheezing disorders.
3.7.2 Effects of birthweight, weight at the age of 3 years and growth
patterns on childhood wheezing disorders
Four disease definitions were drawn up based on diagnostic codes and prescribed
medication details entered by general practitioners onto the primary care database.
a) Asthma diagnosis: confirmed by the presence of asthma codes in the record;
b) Wheezing symptoms: confirmed by the presence of wheezing diagnosis codes
in the record;
c) Wheezing disorder diagnosis: it is wheezing disorder based on diagnosis and
was confirmed by the presence of asthma or wheezing diagnosis codes in the
record; and,
d) Wheezing disorder treatment: it is wheezing disorder based on treatment so
was confirmed by the existence of at least two drug prescriptions indicated
for the treatment of asthma a minimum of 1 week and maximum of 12
months apart.
In the process, the following assumptions were made. First, if a drug was prescribed
only once in 12 months, there is a high possibility that the reason for the
consultation was another illness other than wheezing disorders. Second, if two drugs
were prescribed in a week, there is a high possibility that the reason for the two
consultations was the same issue.
Appendix E and Appendix F list the drugs and disease names used to confirm
diagnosis.
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3.8 Variables for analysis
3.8.1 Incidence and burden of wheezing disorders, eczema and rhinitis
Wheezing disorders, eczema and rhinitis were the outcome variables for the analyses
of incidence and prevalence of allergic conditions. Sex, ethnicity and birth year were
used as stratifying variables.
3.8.2 Effects of birthweight and weight at 3 years on childhood wheezing
disorders
3.8.2.1 Exposure variable
Birthweight was classified based on the CDC (CDC, 2009) and WHO (WHO, 2014)
guidelines where <2.5kg=low, 2.5-4.0kg=normal and >4.0kg=high. Weight at the
age of 3 years was categorised into underweight (<5th centile), normal (≥5th and
<85th centiles), overweight (≥ 85th and <95th centiles), and obese (≥95th centile)
categories based on CDC classification (CDC, 2014). Hence, the exposure variables
were categorical forms of birthweight and weight at the age of 3 years.
3.8.2.2 Outcome variables
The outcome variable was wheezing disorder. Four disease definitions of wheezing
disorders were used: asthma diagnosis, wheezing symptoms, wheezing disorders
diagnosis and wheezing disorders treatment; see section 3.7 for details on how these
disease definitions were drawn up.
3.8.2.3 Confounding variables
Selection of confounding variables was carried out in four steps. First, based on a
priori understanding and speculative hypothesis, and a second-person opinion, a list
of variables that believed to be linked with the exposure and/or outcome variables
was constructed. For birthweight (exposure) and wheezing disorders (outcome)
models; ethnicity, family asthma, gender, gestational age, household environment,
maternal smoking, maternal BMI, maternal age, maternal feeding habits, number of
live births, outdoor playing time and parity were listed. For weight at the age of 3
years (exposure) and wheezing disorders (outcome) models, birthweight, breast
feeding, ethnicity, family asthma, gender, gestational age, household environment,
maternal smoking, maternal BMI, maternal age, maternal feeding habits, number of
live births, outdoor playing time and parity were identified.
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Second, causal diagrams were drawn to represent the relationship between main
variables and the other covariates. Note that ‘main variables’ refers to the exposure
and outcome variables. Figure 3.6 illustrates the schematic view of confounding
variables when investigating the effects of birthweight and weight at the age of 3
years on wheezing disorders.
Third, based on DAGs principle (Greenland et al., 1999; Shrier and Platt, 2008),
covariates were retained if they are not affected by but have a direct effect on the
exposure and outcome variables (McNamee, 2003).
Fourth, selection of a minimally sufficient sets of confounding variables using a six-
step algorithm recommended by Shrier and Platt (2008) was attempted initially.
However, owing to the models complexities, DAGitty software (Textor et al., 2011)
was used to generate automated results.
Figure 3.6 Diagrammatic view of the relationship between confounding and main
variables for models that investigated the association of birthweight
and weight at the age of 3 years with wheezing disorders
The three rectangular boxes, populated by the exposure, outcome and confounding variables, represent the nodes
or vertex of the DAGs. The single headed arrows that connect the variables are arcs and indicate that the two
variables are causally related. Note that the confounding variables have two single-headed arrows directed to the
exposure and outcome variables.
Exposure variable:
Birthweight or weight at 3
years of age
Outcome variable:
Wheezing disorders
Set of confounding variables
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3.8.3 Describing the growth patterns of white British and Pakistani
children
The standardised scores of repeated weight measurements, that is, weight SDS, were
the exposure variables and the growth patterns identified by the LGCMs and GMMs
were the outcome variables. The time scores used were: 0, 1, 3, 6, 12, 18, 24 and 36.
The growth class analyses models were adjusted for the following variables that
were known to affect birthweight and childhood growth: mother’s ethnicity (Saxena
et al., 2004), maternal smoking during pregnancy and parity (Ong et al., 2002), and
maternal level of education, that is, as a proxy for SES (Luo et al., 2006)
3.8.4 Effects of growth patterns on childhood wheezing disorders
3.8.4.1 Exposure variables
Two types of exposure variables were assumed for the analyses of the effect of
childhood growth patterns on wheezing disorders.
Velocity
As a starting point, LGCMs were carried out in order to drive growth patterns of the
BiB1000 children between birth and 3 years of age. A piecewise model with two
knots or joint points (i.e. at 3 and 12 months) was fitted to the BiB1000 children’s
growth data resulting in 3 velocities; see section 3.10.2.2 for details about piecewise
models. The velocities (i.e. slopes) were between birth and 3 months, 3 and 12
months, and 12 and 36 months. These velocities are continuous and were used as
exposure variables. The time scores used were 0, 1, 3, 6, 12, 18, 24 and 36.
Growth classes
Growth mixture models were carried out in order to derive growth classes based on
the children’s growth trajectory similarities from birth until the age of 3 years. Each
of the growth classes or group of children would have distinct trajectory
characteristics. For example, a class can be composed of children who grow
consistently, that is, their weight percentiles remain the same starting from birth
until the age of 3 years. A class can also be made up of children who show low
growth percentiles during the first 6 months and very high growth percentiles
between 2-3 years, or vice versa. Collectively, these growth classes make up a single
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categorical variable, that is, the exposure variable. The same time scores were used
as in the LGCMs and GMMs above.
3.8.4.2 Outcome variables
Four disease definitions of wheezing disorders were used as outcome variable,
namely: asthma diagnosis, wheezing symptoms, wheezing disorders diagnosis and
wheezing disorders treatment, see section 3.5.2 for details on how these disease
definitions were drawn up.
3.8.4.3 Confounding variables
Based on the same definition and procedure used in section 3.8.2.3; birthweight,
breast feeding, ethnicity, family asthma, gender, gestational age, household
environment, maternal smoking, maternal BMI, maternal age, maternal feeding
habits, number of live births, outdoor playing time and parity were identified.
Figure 3.7 illustrates the schematic view of adjustment for confounding when
investigating the effects of childhood growth on wheezing disorders. Then, DAGitty
software was used to select minimally sufficient confounding variables.
Figure 3.7 Diagrammatic view of the relationship between confounding and main
variables for models that investigated the association between
childhood growth and wheezing disorders
The three rectangular boxes, populated by the exposure, outcome and confounding variables, represent the nodes or vertex of
the DAGs. The single headed arrows that connect the variables are arcs and indicate that the two variables are causally related.
Note that the confounding variables have two single-headed arrows directed to the exposure and outcome variables.
Exposure variable:
Childhood growth
Outcome variable:
Wheezing disorders
Set of confounding variables
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3.9 Variables for missing data estimation
3.9.1 Growth patterns analyses of two ethnic groups (white British and
Pakistani) and the BiB1000 children
Missing growth data at the 1, 3, 6, 12, 18, 24 and 36 months of age were estimated
using FIML models using weight SDS at birth and the other time points (i.e. 1, 3, 6,
12, 18, 24 and 36 months).
3.9.2 Effects of birthweight, weight at the age of 3 years and growth
patterns on childhood wheezing disorders
Missing data on covariates were estimated in MICE models using analysis variables
(i.e. exposure, outcome and cofounding variables) and two additional variables (i.e.
maternal hypertension and diabetes). For example, for birthweight and wheezing
disorders models: birthweight, sex, ethnicity, smoking, hypertension, diabetes, SES,
parity, number of births, gestational age, asthma diagnosis, asthma treatment,
wheezing disorders treatment and diagnosis were included in the missing data
estimation models.
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3.10 Statistical methods and software
3.10.1 Incidence and burden of wheezing disorders, eczema and rhinitis
Cumulative incidence was defined as the proportion of the cohort of children with
allergic conditions during 0-7 years follow up period which was calculated as the
total incident cases divided by the total number of the cohort of children at risk.
Cumulative incidence rates were defined as the number of new cases of allergic
conditions per the cohort population at risk in a given period calculated as the ratio
of number of children diagnosed with the condition to the total person-years at risk.
Five-year period prevalence was defined as the proportion of the cohort of children
with allergic conditions during 5 years follow up period which was calculated as the
total incident cases divided by the total number of the cohort of children at risk.
Birth year, ethnicity and sex specific incidence rates were calculated as the ratio of
number of children diagnosed with allergic conditions for the particular birth year,
ethnicity and sex to the respective total person-years at risk. Ethnicity and sex
specific incidence rate ratios were defined as incidence rate ratio of Pakistani to
white British and boys to girls respectively.
Analyses were carried out in Stata software version 12 (StataCorp, 2011). To
calculate the cumulative incidence, proportion Stata command was adopted.
stptime and stir Stata commands were used to calculate the incidence rates and
incidence rate ratios, respectively. Five per cent significance levels and 95%
confidence intervals were adopted throughout.
3.10.2 Describing growth patterns of white british and Pakistani children
As described in section 3.2.3, there are three modelling options to address the
problem of collinearity among repeated weight measurements, that is, GEE, MLMs
and LGMs. However, LGMs were preferred over the other modelling techniques
because of their flexibility to estimate missing growth data, test of heterogeneity and
displaying of growth patterns graphically using Mplus software.
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3.10.2.1 Latent growth model formulation
Latent Growth Curve Models (LGCMs) are the basic form of LGMs that assume the
sample under study arises from a homogenous population (Duncan et al., 2006c).
Growth mixture models (GMMs), which are an extension of LGCMs (Gilthorpe et
al., 2014), however, assume that the population under study is made up of unknown
sub-groups or latent classes (Muthen, 2001; Muthén, 2004; Duncan et al., 2006c).
LGCM can be seen as a multilevel model in which, from the LGCM in Figure 3.8;
the individual repeated weight measurements at level one and the latent growth
factors (i.e. intercept and slope) at level two (Duncan et al., 2006d). As such, the
relationship between the growth factors, path coefficients (also known as factor
loadings) and repeated weight measurements of linear LGCM can be expressed in
multilevel notation as follows:
yti = η0i + η1iλti + εti , εti ~N(0,σ2εti) (3.1)
η0i = α0 + ζ0i ,   ζ0i~N(0, σ20i) (3.2)
η1i = α1+ ζ1i  , ζ1i~N(0, σ21i) (3.3)
where yti is the weight measured (e.g. W1 in Figure 3.8) for the ith individual at time
t; η0i and η1i are the latent growth factors, that is, intercept and slope (also known as
velocity), respectively; the λts are time scores; the εti is a composite error term
representing both random measurement error and time specific influence of the ith
individual. α0 (alpha0) is the model estimated overall mean of the initial weight and
α1 (alpha1) is the linear average rate of weight change over time. ζ0i and ζ1i are error
terms representing the variations among individuals in terms of initial weight
measurements and the linear changes over time, respectively. Equation 3.1 is the
within subject model whereas equations 3.2 and 3.3 are the between subject models.
Note that εti is assumed to be normally and independently distributed with its mean
(i.e. equal to zero) and variance (i.e. σ2εti). The ζ0i and ζ1i are normally distributed
with their means (i.e. equal to zero) and their respective variances (i.e. σ20i and σ21i).
ζ0i and ζ1i are possibly correlated but uncorrelated with εti; The variances of εti are
assumed to be equal and uncorrelated across time although these restrictions can be
relaxed (Muthén, 2004).
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With the variations of σ20i and σ21i for the random intercept and linear growth rate,
respectively, a 2x2 variance-covariance matrix (ψ) for a linear LCGM can be 
expressed as follows:
Ψ=  
(3.4)
where σ20i and σ21i are the variances and σ201i is the covariance of the random
intercept and slope (linear growth rate).
Equation 3.1 can be extended further in order to accommodate nonlinear growth
patterns. For example, for a quadratic polynomial LGCM,
yti = η0i + η1iλti + η2iλ2ti+ εti (3.5)
 η2i = α2+ ζ2i (3.6)
where η2i is the quadratic growth rate (also known as acceleration), α2 is the average
quadratic rate change overtime, the ζ2i is the variation between individuals in terms
of quadratic changes overtime, and λ2tis are the quadratic forms of the time scores.
With variations between individuals in terms of intercept, linear growth and
quadratic growth rates, the 3x3 variance/covariance matrix can expressed as follows:
Ψ=  
(3.7)
where σ20i , σ21i and σ21i are the variances, and σ2 01i, σ2 02i and σ2 12i are the covariance
between random intercept and random linear growth rate, random intercept and
quadratic growth rate, and linear growth rate and quadratic growth rate, respectively.
Similarly, equation 3.1 can also be modified to accommodate multiphase growth
patterns. For example, a two phase piecewise LGCM can be formulated as follows
(Duncan et al., 2006d).
σ21iσ201i
σ20i
σ21i
σ201i
σ20i
σ202i 2
σ21i
σ22i
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yti = η0i + η1iλ1ti + η2iλ2ti+ εti (3.8)
η1i = α1 + ζ1i (3.9)
 η2i = α2+ ζ2i (3.10)
where η1i and η2i are the latent growth factors (linear random slopes) for phase 1 and
phase 2, respectively. The λ1t and λ2t are phase 1 and phase 2 time scores, and the ζ1i
and ζ2i are the variations between individuals in linear weight changes overtime for
phase 1 and phase 2, respectively.
Figure 3.8 Schematic view of linear LGCM and GMM
Latent Growth curve (in dotted circle) and Growth Mixture (in solid circle) models schematic view. W1-W8 are
repeated measurements of weight at 0, 1, 3, 6, 12, 24 and 36 months, respectively. E1-E8 are error variances of
W1-W8 respectively. The intercept and slope are two latent (unobserved) growth factors. Arrows from the
intercept factor are path coefficients (or factor loadings) of the intercept on each time measurement and are fixed
at the value of one throughout. Arrows from the slope, represented by lambdas (λ) are path coefficients (or factor
loadings) of the slope on the repeated measurements and are fixed by the time scores. The double headed arrow
between the slope and intercept is the covariance of the latent growth factors. Mi and Ms are the means for the
intercept and slope respectively; Di and Ds are the variances for the intercept and slope, respectively. The latent
classes (C) are the distinct subpopulations/groups to be identified by the model.
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In Figure 3.8, the individual repeated weight measurements and the latent growth
factors (i.e., intercept and slope) are common to both models. Therefore, with the
latent classes (C) at level three, equation 3.1 can be modified into a GMM as follows
(Wang and Wang, 2012a).
ykti = ηk0i + ηk1iλkti + εkti (3.11)
where k is the class number of a latent classes; ykti is the weight measurement for
individual i at time t for the latent class k. The ηk0i and ηk1i are the two class specific
latent growth factors, that is, intercept and slope, respectively. Note also that in
equation 3.9, a single-class GMM is equivalent to the LGCM in equation 3.1.
For a linear GMM, with the variations of σ20i and σ21i for the random intercept and
linear growth rate, respectively, a class-based 2x2 variance-covariance matrix (ψk)
can be expressed as follows:
Ψk =
(3.12)
Where σ20i
k and σ21i
kare the class-based variances and σ201i
k is the class-based
covariance of the random intercept and slope (linear growth rate).
Note that in Equation 3.12, the variance and covariance of the latent growth factors
(i.e. intercept and slope in linear model) are assumed to be different. However, when
these parameters are assumed to be equal or are held equal; the variance-covariance
structure in Equation 3.12 will reduce to variance-covariance matrix in Equation 3.4.
3.10.2.2 Latent growth model estimation
Prior to conducting model estimations, the following parameterisations were
adopted. For a linear LGCM, the intercept factor loadings were fixed at 1, the linear
growth rate (i.e. slope) factor loadings were fixed by the time-scores (i.e. 0, 1, 3, 6,
12, 18, 24, and 36), and the means and variance of the intercept and slope were
estimated freely. For non-linear LGCMs, similar parametrisations were adopted
except that the growth rate factor loadings were fixed by the non-linear form of the
time-scores. For example, for a quadratic polynomial model, the growth rate factor
σ21i
k σ201i
k
σ20i
k
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loadings were fixed by the squared form of the time-scores (i.e. 02, 12, 32, 62, 122,
182, 242, and 362). The same principle was followed for parameterising GMMs.
Growth patterns analyses were performed in Mplus software version 7.11 (Muthén
and Muthén, 2012).
Model building was carried out in several steps. First, linear LGCMs were fit to the
data. Second, in order to account for any nonlinear growth patterns, three nonlinear
modelling options: polynomials, piecewise and free-time score functions (Muthén
and Muthén, 2012; Wang and Wang, 2012b) were explored and the best fitting
function was selected. Third, using the best selected LGCM (e.g. piecewise LGCM),
optimal class determination and estimating the effect of covariates on the growth
classes were carried out using GMMs.
Latent growth curve models
Polynomial models
Polynomial modelling can be seen as increasing the degrees of the linear growth in
order to find the best fit for the observed mean curves. Note that a latent growth
factor of a linear model has a degree of 1 (velocity), that is, the factor loadings are
fixed by the linear form of the time scores. For a quadratic model, the latent growth
has a degree of 2 (acceleration), that is, the factor loadings are fixed by the
quadratic form of the time scores.
Two polynomial functions were explored: quadratic and cubic models. First, a
model with intercept, linear and quadratic slopes was fitted to the growth data—
quadratic model. Second, a model that included intercept, linear slope, quadratic
slope and cubic slope was fitted to the data—cubic model. Then, based on model fit
statistics, a cubic model was found to be more parsimonious or fitted the data better
than the quadratic model and was selected as the best among the two models.
Assuming weight was measured at 0, 1, 3, 6, 12, 18, 24, and 36 months, the two
polynomial models were executed in Mplus software using model commands in
Table 3.1. Polynomial models are easy to implement. However, the latent growth
factor parameters become difficult to interpret and model fit is poor if growth
patterns follow a multimodal shape.
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Table 3.1 Polynomial LGCM commands in Mplus software
Polynomial quadratic model:
USEVAR=zwei0 zwei1 zwei3 zwei6 zwei12 zwei18 zwei24
zwei36; !list of variables used for growth analysis
MODEL:
I S Q| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.6 zwei12@1.2
zwei18@1.8 zwei24@2.4 zwei36@3.6;
!I =intercept; S=linear slope; Q=quadratic slope; and
|=regressed on
Polynomial cubic model:
MODEL:
I S Q C| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.6 zwei12@1.2
zwei18@1.8 zwei24@2.4 zwei36@3.6;
!C=cubic slope
Free-time score (free-loading) models
In comparing free-time score models, two time points were fixed at the time scores
and the rest were left to be estimated by the model. Fixing only two of the time
points and letting the other time points to be estimated by the model would allow the
growth rates (slopes) to be estimated by the model. Initially, the first two time points
(i.e. birth and 1 month) were fixed at the time scores (i.e. 0 and 1) and the rest time
points were left to be estimated by the model. Then, the first and last time points (i.e.
0 and 36 months) were fixed at the time scores (i.e. 0 and 36) and the rest were left
to be estimated by the model. Based on model fit statistics, the model with the first
and last time points fixed (i.e. at 0 and 36 months) performed better than the model
with first and second time points fixed (i.e. 0 and 1 month). See Mplus free time-
score model commands in Table 3.2. Free-time score models are easy to implement,
and the latent growth factor parameters are easy to interpret. However, model
convergence can be problematic due to the increase of free parameters to be
estimated and decrease of degrees of freedom of models.
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Table 3.2 Free-time score LGCM commands in Mplus software
Model with first two time-points fixed
MODEL:
I S | zwei0@0 zwei1@.1 zwei3* zwei6* zwei12* zwei18*
zwei24* zwei36*;
Model with first and last time-points fixed
MODEL:
I S | zwei0@0 zwei1* zwei3* zwei6* zwei12* zwei18*
zwei24* zwei36@3.6;
Piecewise models
For the piecewise models, joints or break points were created in order to get a best
fitting model to the data. Fitting a piecewise model can be seen as a process of
linearization of the growth rates in order to create a flexible predicted line that fits
the data best. Thus, positioning of the joints (also known as knots) is a key in
identifying the best fitting model to the data. In identifying the candidate positions
for the knots, the following strategy was followed. First, a linear model was fit to the
data. Second, a graph that contained the observed and estimated mean curves was
outputted for visual inspection. Third, based on the shape of the observed means
curve, the time-scores located at positions where the curve showed a considerable
change of direction (or bending) were chosen as candidates. Hence, two sets of
candidate position were selected: a) 1, 6, and 18 months; and, b) 3 and 12 months.
Based on the model fit statistics, 3 and 12 months were the better set of positions for
placing the knots. See Mplus piecewise model commands in Table 3.3. Piecewise
models are flexible and the latent growth factor parameters become easy to interpret,
however, model implementation is difficult.
125
Table 3.3 Piecewise LGCM commands in Mplus software
Model with knots at 3 and 12 months
MODEL:
I S| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.3 zwei12@.3
zwei18@.3 zwei24@.3 zwei36@.3;!phase 1 growth
I S1| zwei0@0 zwei1@0 zwei3@0 zwei6@.3 zwei12@.9
zwei18@.9 zwei24@.9 zwei36@.9;!phase 2 growth
I S2| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@0 zwei18@.6
zwei24@1.2 zwei36@2.4;!phase 3 growth
Model with knots at 1, 6 and 18 months
MODEL:
I S| zwei0@0 zwei1@.1 zwei3@.1 zwei6@.1 zwei12@.1
zwei18@.1 zwei24@.1 zwei36@.1;!phase 1 growth
I S1| zwei0@0 zwei1@0 zwei3@.2 zwei6@.5 zwei12@.5
zwei18@.5 zwei24@.5 zwei36@.5;!phase 2 growth
I S2| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@.6
zwei18@1.2 zwei24@1.2 zwei36@1.2;!phase 3 growth
I S3| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@0 zwei18@0
zwei24@.6 zwei36@1.8;!phase 4 growth
Selection of the best LGCM
Once the visual inspection showed that a linear model was not good fitting model,
comparison between the three nonlinear LGCM models (i.e. a cubic polynomial, a
free-time scores model with the first and last times scores fixed, and a piecewise
model with knots positioned at the 3 and 12 months), was carried out. Best non-
linear model was selected based on model fit statistics. See section 4.5 for details.
Fitting of LGCMs to Pakistani and white British growth data
Initially, an overall LGCM was fitted to the data in order to estimate the growth
parameters and mean curves for the 1,364 white British and Pakistani children under
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the assumption of homogeneity of growth patterns in the of population (Duncan et
al., 2006b; Muthén and Muthén, 2012; Wang and Wang, 2012b). Then, a multi-
group LGCM was fitted in order to allow ethnic-specific parameters and mean
curves to be estimated under the assumption of homogeneity of growth patterns in
each ethnic population.
The parameters of the growth variables (i.e., means, variances, and covariances)
were freely estimated, initially. However, the residual variances of one weight
measurement (weight SDS at 36 months) became negative. As a remedy to that, the
variance of the variable was fixed at zero (Chen et al., 2001). There was no dramatic
change of other parameter estimates due to the fixing of this parameter, that is, all
models still converged well.
Fitting GMMs to Pakistani and white British growth data
In GMMs, estimations of parameters during identification of optimal number classes
were performed using two approaches:
a) GMM with growth factors means freely estimated, and growth factors and
error variances freely estimated but held equal across classes; and,
b) GMM with growth factors means and variances, and error variances freely
estimated; no constraints for variance-covariance structure to be equal
across classes.
Using approach (a), the the growth factors means, variances, and covariances were
estimated in two class GMM, initially. However, the residual variances of one
weight measurement (weight SDS at 36 months) became negative. Like in the
LGCMs, the variance of the variable was fixed at zero (Chen et al., 2001), as a
remedy. There was no dramatic change of other parameter estimates due to the
fixing of this parameter, that is, all models with more than two classes still
converged well. See Table 3.4 for a piecewise model command in Mplus software.
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Table 3.4 Piecewise constrained GMM commands in Mplus software
Model with knots at 3 and 12 months
CLASS= C(n); !n is the number of classes
MODEL:
%OVERALL%
I S| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.3 zwei12@.3
zwei18@.3 zwei24@.3 zwei36@.3;!phase 1 growth
I S1| zwei0@0 zwei1@0 zwei3@0 zwei6@.3 zwei12@.9
zwei18@.9 zwei24@.9 zwei36@.9;!phase 2 growth
I S2| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@0
zwei18@.6 zwei24@1.2 zwei36@2.4;!phase 3 growth
In the next step, approach (b) was used to estimate the the growth factors means,
variances, and covariances by relaxing the equality of growth factors variances and
error variances across classes assumption. When a two-classes GMM was fitted to
the data initially, the residual variances of two weight measurement (weight SDS at
3 and 36 months) became negative, the model classification quality (entropy) was
very poor <50%. The two error variances were fixed at zero and model was re-ran.
However, another negative variance emerged and the model classification quality
remained poor. Another attempt was made by increasing the number of random
starts. However, no improvement of model convergence was observed. The
problems persisted for three classes GMM. Thus, approach (b) was abandoned; it
was not used as an option in the determination of optimum number of classes and
further models. See Table 3.5 for a piecewise model command in Mplus software.
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Table 3.5 Piecewise free GMM commands in Mplus software
Model with knots at 3 and 12 months
CLASS= C(n); !n is the number of classes
MODEL:
%OVERALL%
I S| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.3 zwei12@.3
zwei18@.3 zwei24@.3 zwei36@.3;!phase 1 growth
I S1| zwei0@0 zwei1@0 zwei3@0 zwei6@.3 zwei12@.9
zwei18@.9 zwei24@.9 zwei36@.9;!phase 2 growth
I S2| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@0
zwei18@.6 zwei24@1.2 zwei36@2.4;!phase 3 growth
%C#1%
I S S1 S2 zwei0-zwei36;
%C#2%
I S S1 S2 zwei0-zwei36;
.
.
.
.
%C#n%
I S S1 S2 zwei0-zwei36;
Determination of optimal number of classes
First, 2-9 class models were ran to identify a model with the optimal number of
latent classes using a Lo-Mendell-Rubin Likelihood Ratio Test (LMR LRT). Results
were then confirmed using Bootstrapped Likelihood Ratio Test (BLRT) tests.
However, owing to the high computational time needed for BLRT estimation, only
2-5 class models were re-ran and selected for comparison based on Bayesian
Information Criterion (BIC) and classification quality (entropy) values from LMR
LRT results.
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Estimating the effects of covariates on growth classes
Estimating the effects of covariates was carried out in two steps. First, GMMs were
fitted in order to allow for variability (heterogeneity) in the population; see
Figure 3.8 for the schematic view of the LGCM and GMM.
Second, after determining the model with the optimal number of classes, the growth
models were re-ran by including the covariates using a three-step approach
(Vermunt, 2010; Asparouhov and Muthén, 2012) in order to estimate the
multinomial logistic regression coefficients of the latent classes on the covariates
(Table 3.6). See section 3.2.3 for details about the three-step approach.
Table 3.6 Piecewise constrained GMM commands in Mplus software
Model with knots at 3 and 12 months
AUXILIARY=ethnicity(R3STEP)mother_edu(R3STEP)
smoking(R3STEP)parity(R3STEP); !list of covariates
for logistic regression model
CLASS= C(n); !n is the number of classes
MODEL:
%OVERALL%
I S| zwei0@0 zwei1@.1 zwei3@.3 zwei6@.3 zwei12@.3
zwei18@.3 zwei24@.3 zwei36@.3;!phase 1 growth
I S1| zwei0@0 zwei1@0 zwei3@0 zwei6@.3 zwei12@.9
zwei18@.9 zwei24@.9 zwei36@.9;!phase 2 growth
I S2| zwei0@0 zwei1@0 zwei3@0 zwei6@0 zwei12@0
zwei18@.6 zwei24@1.2 zwei36@2.4;!phase 3 growth
3.10.2.3 Missing data estimation
Two missing data estimation approaches were explored: multiple imputation and
maximum likelihood. Growth data of white British and Pakistani children were
analysed using LGCM based on MICE and FIML missing data estimation
techniques and were compared in terms of model fit statistics. The results indicated
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that models based on FIML were more parsimonious than MICE (see Appendix G ).
Therefore, in all subsequent growth pattern analysis models, missing growth data
were estimated using a FIML method in which parameters are estimated based on all
available observations in the dataset (Enders and Bandalos, 2001; Schafer and
Graham, 2002). FIML is implemented as a default in Mplus software unless a user
specifies a list-wise deletion or complete case analysis. Thus, all model estimation
Mplus commands listed above have also missing estimation functionality.
3.10.2.4 Model fit evaluation
Latent growth modelling is a complex process. Usually, combinations of a variety of
model fit statistics are used during model fit assessments (Duncan et al., 2006a). In
fact, there are over 20 available fit indexes to choose from depending on the
statistical software that one uses (Duncan et al., 2006a). Therefore, a combination of
model fit statistics was used based on Mplus software (Muthén and Muthén, 2012).
When evaluating the goodness of LGCM, Comparative Fit Index (Bentler, 1990),
Tucker-Lewis Index (Tucker and Lewis, 1973), Root Mean Square error of
approximation (Browne and Cudeck, 1992), Standardised Root Mean Square
Residual (Muthén and Muthén, 2012), Log-likelihood (LL), Akaike Information
Criterion (Akaike, 1987) and Bayesian Information Criterion (Schwarz, 1978) were
used in combination.
When selecting best fitting GMM and optimal number of classes, the Log-likelihood
(LL), Akaike Information Criterion (Akaike, 1987), Bayesian Information Criterion
(Schwarz, 1978), Bootstrapping Likelihood Ratio Test (McLachlan, 1987) and the
classification quality or entropy (Akaike, 1998) model fit statistics were used in
combination. In addition, interpretability was also considered where models were
rejected if they consist of a class with less ≤1% of the total population. 
Attainment of good GMM convergence or global maxima was assumed if the best
log-likelihood value was replicated at least 5 times, to be conservative, although a
replication of two is also acceptable (Muthén and Muthén, 2012). Where best log-
likelihood did not replicate, number of random starts was increased until global
maxima was attained or replication of the best log-likelihood was achieved. In
significance testing, 5% significance levels and 95% confidence intervals were
adopted.
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3.10.3 Growth patterns of the BiB1000 cohort children
Prior to investigating the association between childhood growth patterns and
wheezing disorders, growth patterns analyses of the BiB1000 children were carried
out. The missing data and model estimation techniques carried out in identifying
growth patterns of white British and Pakistani children in section 3.10.2 were the
basis for the analysis of growth patterns of the BiB1000 children. Therefore,
piecewise LGCM and GMM were preferred over other nonlinear models. Model fit
indices and information criteria were used in combination, and 5% significance
levels and 95% confidence intervals were adopted throughout.
3.10.4 Effects of birthweight, weight at the age of 3 years and childhood
growth patterns on wheezing disorders
3.10.4.1 Missing data estimation
Prior to carrying out imputations, a brief check on the variables of analyses showed
that birthweight, gestational age and outcome variables (i.e. asthma diagnosis,
wheezing symptoms, wheezing disorder treatment and wheezing disorder diagnosis)
were completely observed. To further explore if imputations were necessary or
beneficial, dummy variable (i.e. yes or no) were created as a missing data indicator
for each variable with missing observations.
The missingness indicators and outcome variables were tested for correlations and
the results consistently showed that there were no significant associations between
them which also indicate that complete cases analysis can produce unbiased, albeit
less precise, parameter estimates (Sterne et al., 2009). However, there were
consistent significant associations between the missing indicators and other
confounding variables which also suggest that imputations with inclusion of these
covariates may improve the precision of the parameter estimates (Collins et al.,
2001; Sterne et al., 2009).
In the models that investigated the effects of birthweight and weight at the age of 3
years on wheezing disorder, missing data estimation was carried out in Stata
software using MICE models. Meaning, the ice and mim Stata commands were
used to multiply impute m sets of data and combine results of m analyses using
Rubin’s rules, respectively (Table 3.7).
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Imputations were carried out under MAR assumption that the missingness on
outcome variables does not depend on the outcome variables themselves but can be
explained by (or related to) other variables included in the imputation models
(Collins et al., 2001; Schafer and Graham, 2002; Sterne et al., 2009) In deciding
how many datasets to be imputed, the number of imputations (m) were set to be
greater than the percentage or fraction of incomplete cases (Graham et al., 2007;
Royston and White, 2011).
Table 3.7 Data imputation and analysis commands in Stata software
Model to identify the proportion of individuals with
complete information for all variables:
Ice ethnicity smoking hypertension diabetes///
imdq_national imdq_bradford parity sex n_births///
birthweight gestational_age asthma_diagnosis///
asthma_trt wheez_diagnosis wheez_treatmentt, dryrun///
seed(10011) clear
Imputation model:
Ice ethnicity smoking hypertension diabetes///
imdq_national imdq_bradford parity sex n_births///
birthweight gestational_age asthma_diagnosis///
asthma_treatmentt wheez_diagnosis wheez_treatmentt,///
m(40) cycles (30)/// seed(10011) clear
Individual analysis of 40 datasets and combining each
the results using Rubin’s rules for the birthweight and
asthma diagnosis GLM model as an example:
xi: mim: glm asthma_diagnosis i.birthweight///
i.ethnicity i.sex i.gestational_age i.nbirths///
i.smoking i.parity i.imdq_nat,///
fam(bin) link(log) nolog eform
Monte Carlo errors for parameter consistency test
mim,mcerror
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Imputation models were chosen based on the type of variables to be imputed, that is,
linear regression for continuous variables; logistic regression for binary variables;
multinomial logistic regression for unordered and ordered categorical variables were
adopted (White et al., 2011). However, note that none of the variables to be imputed
was a continuous so no transformation of data was sought to address any non-
normality issues.
In childhood growth and wheezing disorder models, missing data estimation was
carried out in two stages. First, missing growth data on the BiB1000 children were
estimated using FIML (see sections 3.10.2 and 3.10.3) in Mplus software. Then,
estimated latent class membership data were saved and merged with the original
data. Note that the classify-analyse version of the three-step approach was preferred
over the conventional three-step approach used in the analysis of growth classes and
their relationship with covariates for the white British and Pakistani children growth
data in section 3.10.2.2. This was because, the classify-analyse version of the
three-step allowed for missing data on covariates to be estimated and used for
further analyses.
Second, using the merged data, missing data on covariates were estimated using
MICE models in Stata software. That is, the ice Stata command was utilised to
multiply impute m sets of data. Then, analyses of the m datasets and combining of m
results was carried out using mim Stata command (Table 3.7).
3.10.4.2 Model estimation and evaluation
Generalised Linear Models (Nelder and Baker, 1972) were used to derive the
relative risks (RR) where the distribution and link function were specified to be
binomial and log respectively. Models were fitted in Stata software version 12. Five
per cent significance levels and 95% confidence intervals were adopted throughout.
For all models, consistency of results produced from individuals imputed datasets
were assessed using Monte Carlo errors from a jackknife procedure (Royston et al.,
2009); where the errors of the beta coefficient (or risk estimate), test statistic (t-
value) and the p-value are less than 10% of the standard error, less than 0.1, and less
than 0.2 respectively (White et al., 2011), the performances of models were
considered as optimal. The mim,mcerror post-estimation stata command was
utilised to calculate Monte Carlo errors.
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CHAPTER 4
RESULTS
4.1 Chapter overview
This chapter is about the results of a series of analyses using BiB cohort data. In
section 4.2, results of incidence and burden of allergic diseases analyses in the BiB
cohort (13,734 children) are presented and described. Section 4.3 presents results of
effects of birthweight on childhood wheezing disorders analysis using 13,734
children data.
Section 4.4 describes results of effects of weight at the age of 3 years on childhood
wheezing disorders analysis for 1,598 children. In section 4.5, results of growth
patterns analysis of 1,364 children from two ethnic backgrounds (i.e. white British
and Pakistani) are presented and described in detail.
Sections 4.6 presents a detailed description of results from effects of childhood
growth patterns on childhood growth analysis using 1,598 children growth data.
Finally, in section 4.7, comparison between results of complete case and imputed
data analyses of section 4.3, 4.4 and 4.6 are made.
4.2 Incidence and burden of wheezing disorders, eczema and
rhinitis
The cohort consisted of 13,734 children born between April 2007 and June 2011.
There were 5,117 (37.3%) Pakistani and 4,501 (32.8%) white British children; and,
6,917 (50.4%) boys and 6,490 (47.3%) girls (Table 4.1). The cohort yielded a total
follow up period of 74,940 person years. The median follow up period was 5.55
years, ranging from 7 days to 7.6 years.
Of the 13,734 cohort children, 140 had missing information on date of censoring.
The majority of them were white British (41.4%) and boys (47.9%). The proportion
of children with allergic diseases in these 140 children was lower than the overall
cohort (Table 4.2)
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Table 4.1 Cumulative number of incident cases and percentages for 13,734 BiB
cohort children
Number of
children (%)
Allergic conditions (%)
Wheezing disorders Eczema Rhinitis
Overall 13,734 (100) 3,035 (22.1) 7,192 (52.4) 2,646 (19.3)
Ethnicity
Pakistani 5,117 (37.2) 1,150 (22.5) 2,995 (58.5) 1,255 (24.5)
White British 4,501 (32.8) 1,074 (23.9) 2,010 (44.7) 543 (12.1)
Other 1,733 (12.6) 308 (17.8) 948 (54.7) 352 (20.4)
Missing 2,383 (17.4) 503 (21.1) 1,239 (52.0) 495 (20.8)
Sex
Boys 6,917 (50.4) 1,775 (25.7) 3,662 (52.9) 1,445 (20.9)
Girls 6,490 (47.3) 1,190 (18.3) 3,382 (52.1) 1,150 (17.7)
Missing 327 (2.3) 70 (21.4) 148 (45.3) 51 (15.6)
Birth year
2007 2,082 (15.2) 507 (24.4) 1,085 (52.7) 490 (23.5)
2008 3,669 (26.7) 836 (22.8) 1,935 (53.0 779 (21.2)
2009 3,817 (27.8) 872 (22.8) 2,021 (51.8) 725 (19.0)
2010 3,432 (25.0) 693 (20.2) 1,779 (50.7) 551 (16.1)
2011 734 (5.3) 127 (17.3) 372 (50.7) 101 (13.8)
4.2.1 Wheezing disorders
There were 3,035 incident cases (cumulative incidence = 22.1%, 95% CI: 21.4 to
22.8%) of wheezing disorder during the follow up period (Table 4.1). Of these,
1,422 (47%) were diagnosed during the first 12 months (Table 4.3). There was no
significant difference in the cumulative incidence between white British (23.9%;
95% CI: 22.6% to 25%) and Pakistani (22.5%; 95% CI: 21.3% to 23.6%) children.
However, boys (25.7%; 95% CI: 24.6% to 26.7%) were more likely to have been
diagnosed with wheezing disorders than girls (18.3%; 95% CI: 17.4% to 19.3%)
during the follow up period (Table 4.1).
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Table 4.2 Characteristics of 140 BiB cohort children with missing information on
date of censoring
Number of
children (%)
Allergic conditions (%)
Wheezing disorders Eczema Rhinitis
Overall 140 (100) 13 (9.3) 26 (18.6) 2 (1.4)
Ethnicity
Pakistani 22 (15.7) 1 (4.5) 2 (9.1) 0 (0.0)
White British 58 (41.4) 7 (12.1) 12 (20.7) 1(1.7)
Other 20 (14.3) 2 (10.0) 3 (15.0) 0 (0.0)
Missing 40 (28.6.4) 3 (7.5) 9 (22.5) 1 (2.5)
Sex
Boys 67 (47.9) 7 (10.4) 17 (25.4) 2 (3.0)
Girls 42 (30.0) 6 (14.3) 9 (21.4) 0 (0.0)
Missing 31 (22.1) 0 (0.0) 0 (0.0) 0 (0.0)
Birth year
2007 26 (18.6) 3 (11.5) 6 (23.1) 1 (3.8)
2008 31 (22.1) 2(6.5) 4 (12.9) 1 (3.2)
2009 35 (25.0) 3(8.6) 4 (11.4) 0 (0.0)
2010 40 (28.6) 5 (12.5) 10 (25.0) 0 (0.0)
2011 8 (5.7) 0 (0.0) 2 (25.0) 0 (0.0)
The overall incidence rate of wheezing disorders was 40.3 (95% CI: 38.9 to 41.8)
per 1000 person years (Table 4.4). The rate was significantly higher for boys than
girls (incidence rate ratio=1.41; 95% CI: 1.31 to 1.51). However, there was no
significant difference between Pakistani and white British children (Incidence rate
ratio = 0.94; 95% CI: 0.87 to 1.02), see Table 4.4. Although the cumulative
incidence showed substantial decrease between 2007 and 2011 birth years
(Table 4.1), there was a considerable increase in the incidence rate during the same
period (Table 4.4).
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Table 4.3 Cumulative number of incident cases of allergic conditions for 13,734
BiB cohort children based on the age of children when a diagnosis
occurred
Wheezing disorders (%) Eczema (%) Rhinitis (%)
Age in Years
(0-1] 1,422 (46.8) 5,542 (77.1) 839 (31.7)
(1-2] 676 (22.3) 1,044 (14.5) 749 (28.3)
(2-3] 419 (13.8) 348 (4.8) 498 (18.8)
(3-4] 319 (10.5) 146 (2) 339 (12.8)
(4-5] 130 (4.3) 74 (1) 140 (5.3)
(5-6] 49 (1.6) 29 (0.4) 68 (2.6)
>6 20 (0.6) 9 (0.1) 13 (0.5)
Total 3,035 (100) 7,192 (100) 2,646 (100)
4.2.2 Eczema
There were a total of 7,192 (cumulative incidence: 52.4%, 95% CI: 51.5 % to
53.2%) childhood eczema incident cases during the follow up period (Table 4.1).
5,542 (77.1%) of these were diagnosed during their first year (Table 4.3). There
were more incident cases of Pakistani (58.5%; 95% CI: 57.2% to 59.9%) than the
white British children (44.6%; 95% CI: 43.2% to 46.1%). However, there was no
significant difference between boys (52.9%; 95% CI: 51.8% to 54.1%) and girls
(52.1%; 95% CI: 50.9% to 53.3%), see Table 4.1.
The overall incidence rate of eczema was 95.6 (95% CI: 93.4 to 97.9) per 1000
person years. The rate was significantly higher in Pakistani than the white British
(1.31 (95% CI: 1.24 to 1.39), but no significant difference between boys and girls
(Table 4.4).
4.2.3 Rhinitis
There were 2,646 incident rhinitis cases (cumulative incidence: 19.3%; 95% CI:
18.6 to 19.9%) during the follow period (Table 4.1). 31.7% of the cases were
diagnosed during the first 12 months (Table 4.3). There were more cases of rhinitis
of Pakistani and boys than white British and girls, respectively (Table 4.1).
The overall incidence rate of rhinitis in the cohort was 35.3 per 1000 person years
(95% CI: 34.0 to 36.7/1000 person years). The incidence rate was higher in
Pakistani and boys as compared white British and girls, respectively (Table 4.4 )
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Table 4.4 Age, birth year, ethnicity and sex specific person years and incidence
rates of allergic conditions for 13,734 BiB cohort children
Incidence rate per 1000 person years (95% CI)
Wheezing
disorders
Eczema Rhinitis
Overall 40.3 (38.9 to 41.8) 95.6 (93.4 to 97.9) 35.3 (34.0 to 36.7)
Ethnicity
White British 43.7 (41.2 to 46.4) 81.9 (78.4 to 85.6) 22.2 (20.4 to 24.2)
Pakistani 41.2(39.0 to 43.7) 107.4 (103.6 to 111.3) 45.0 (42.6 to 47.6)
Pakistani: white British 0.94 (0.87 to 1.03) 1.31 (1.24 to 1.39) 2.03 (1.83 to 2.25)
Sex
Boys 46.8 (44.7 to 49) 96.5 (93.4 to 99.7) 38.2 (36.3 to 40.2)
Girls 33.3 (31.5 to 35.3) 94.8 (91.7 to 98) 32.3 (30.5 to 34.3)
Boys: girls 1.41 (1.31 to 1.51) 1.02 (0.97 to 1.07) 1.18 (1.09 to 1.28)
Birth Year
2007 34.6 (31.7 to 37.7) 74.0 (69.7 to 78.6) 33.5 (30.7 to 36.6)
2008 36.3 (34.0 to 38.9) 84.1 (80.5 to 88.0) 33.9 (31.6 to 36.4)
2009 43.8 (41.0 to 46.8) 101.7 (97.3 to 106.2) 36.5 (34.0 to 39.3)
2010 46.4 (43.0 to 50.0) 119.2 (113.8 to 124.9) 37.1 (34.2 to 40.2)
2011 46.4 (39.0 to 55.3) 135.3 (122.2 to 149.8) 36.9 (30.4 to 44.9)
4.2.4 Incidence of multiple allergic conditions
Of the overall cohort of 13,734 children, a total of 5,085 were affected by one of the
three allergic conditions; and, a total of 2,682 and 808 children had suffered from
two and three allergic conditions at the same time, respectively. The cumulative
incidence for only one, two and three allergic conditions was 37% (95% CI: 36.2%
to 37.8%), 19.5% (95% CI: 18.9% to 20.2%) and 5.9% (95% CI: 5.5% to 6.3%)
respectively (Figure 4.1 and Table 4.5).
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Figure 4.1 Cumulative incidence of multiple allergic conditions for 13,734 BiB
cohort children
Although Pakistani children were more likely to be diagnosed with one or two
conditions than the white British, they were less likely to have three allergic
conditions simultaneously. Boys and girls were equally to have been diagnosed from
a single condition, but, boys were more likely to be diagnosed from two and three
allergic conditions than girls (Table 4.5).
The overall incidence rate for at least one, two and three allergic conditions was 67.5
(95% CI: 65.7 to 69.4), 35.7 (95% CI: 34.4 to 37.1) and 10.8 (95% CI 10.1 to 11.5)
per 1000 person years respectively. Boys and Pakistanis were more likely to be
affected by multiple allergic conditions than girls and white British children,
respectively (Table 4.6). A consistent increase of trend in the incidence rate of single
and two allergic conditions between 2007 and 2011 birth years was observed
(Table 4.6).
Children without allergic conditions
37.6%
Wheezing disorders
5.9%
28.2%
3.0%
5.9%
9.2%
1.2%
9.1 %
Rhinitis
Eczema
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Table 4.5 Cumulative number of multiple incident cases and percentages for
13,734 BiB cohort children during the follow-up period
Number of
children (%)
Allergic conditions (%)
One
condition
Two
conditions
Three
conditions
Overall 13,734 (100) 5,085 (37) 2,682 (19.5) 808 (5.9)
Ethnicity
Pakistani 5,117 (37.3) 1,963 (38.4) 1,144 (22.4) 383 (4.1)
White British 4,501 (32.8) 1,647 (36.6) 711 (15.8) 186 (7.5)
Other 1,733 (12.6) 628 (36.2) 348 (20) 95 (5.5)
Missing 2,383 (17.4) 847 (35.5) 479 (20.1) 144 (6.0)
Sex
Boys 6,917 (50.4) 2,539 (36.7) 1,456 (21.0) 477 (6.9)
Girls 6,490 (47.3) 2,444 (37.6) 1,174 (18.1) 310 (4.8)
Missing 327 (2.3) 102 (31.2) 52 (15.9) 21 (6.4)
Birth year
2007 2,082 (15.2) 730 (35.1) 457 (22) 146 (7.0)
2008 3,669 (26.7) 1,340 (36.5) 730 (19.9) 250 (6.8)
2009 3,817 (27.8) 1,438 (37.7) 739 (19.4) 234 (6.1)
2010 3,432 (25.0) 1,294 (37.7) 626 (18.2) 159 (4.6)
2011 734 (5.3) 283 (38.6) 130 (17.7) 19 (2.6)
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Table 4.6 Age, birth year, ethnic and sex specific person years and incidence
rates of at least one and multiple allergic conditions
Incidence rate per 1000 person years (95% CI)
One condition Two conditions Three conditions
Overall 67.5 (65.7 to 69.4 ) 35.7 (34.4 to 37.1) 10.8 (10.1 to 11.5)
Ethnicity
White British 67.2 ( 64.0 to 70.5) 29.0 (26.9 to 31.2) 7.6 (6.6 to 8.76)
Pakistani 70.3 (67.3 to 73.5 ) 41.0 (38.7 to 43.5) 13.7 (12.4 to 15.2)
Pakistani: white British 1.05 (0.98 to 1.12) 1.41 (1.29 to 1.56) 1.81 (1.52 to 2.17)
Sex
Boys 66.8 (64.3 to 69.5) 38.4 (36.5 to 40.5) 12.6 (11.5 to 13.8)
Girls 68.5 (65.8 to 71.3) 32.9 (31.1 to 34.9) 8.7 (7.8 to 9.5)
Boys: Girls 1.02 (0.96 to 1.08) 1.17 (1.08 to 1.26) 1.45 (1.25 to 1.67)
Birth Year
2007 49.7 (46.2 to 53.5) 31.3 (28.5 to 34.3) 9.9 (8.4 to 11.7)
2008 58.3 (55.2 to 61.5) 31.7 (29.5 to 34.1) 10.9 (9.6 to 12.3)
2009 72.2 (68.6 to 76.1) 37.2 (34.6 to 40.0) 11.8 (10.4 to 13.4)
2010 86.6 (82.0 to 91.5) 42.0 (38.8 to 45.4) 10.7 (9.2 to 12.5)
2011 102.8 (91.4 to 115.5) 47.5 (40.0 to 56.5) 6.9 (4.4 10.9)
4.2.5 Five-year period prevalence
Of the total 13,734 children, 9,079 (66.1%) had a complete follow-up from birth
until 5 years. Of these, 3,382 (37.2%) were Pakistani and 2,865 (31.6%) were white
British children. 4,590 (50.6%) were boys and 4,298 (47.3%) were girls. Hence,
there was no significant difference between the subset and the overall cohort.
Of those 9,079 children, there were a total of 2,135 (23.5%), 4,867 (53.6%) and
1,939 (21.4%) prevalent cases of wheezing disorders, eczema and rhinitis,
respectively (Table 4.7). Eczema and rhinitis were more prevalent in Pakistani than
the white British children, although there was no significant difference in wheezing
disorders. All three allergic conditions were more prevalent in boys than in girls
(Table 4.7).
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Table 4.7 Five-year period prevalence of allergic conditions in a subset of 9,079
BiB cohort children
Number of
children (%)
Allergic condition prevalence (%)
Wheezing disorders Eczema Rhinitis
Overall 9,079 (100) 2,135 (23.5) 4,867 (53.6) 1,939 (21.4)
Ethnicity
Pakistani 3,382 (37.3) 826 (24.4) 2,041 (60.3) 909 (26.9)
White British 2,865 (31.6) 703 (24.5 ) 1,292 (45.1) 394 (13.8)
Other 1,093 (12.0) 214 (19.6) 617 (56.5) 244 (22.3)
Missing 1,739 (19.1) 392 (22.7) 917 (52.7) 392 (29.1)
Sex
Boys 4,590 (50.6) 1,234 (26.9) 2,489 (54.2) 1,067 (23.2)
Girls 4,298 (47.3) 859 (20.0) 2,288 (53.2) 833 (19.4)
Missing 191 (2.1) 42 (22.0) 90 (47.1) 39 (20.4)
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4.3 Effects of birthweight on childhood wheezing disorders
Demographics
The cohort was made up of 13,734 children that yielded 74,940 person years of
follow-up. In total, 37.3% and 32.8% were Pakistani and white British origin
respectively; 12.6% were minority and 17.3% with missing ethnicity data. In total,
50.4% and 47.3% were boys and girls respectively, and, 2.3% of children had
missing information on sex. In total, 82.6%, 9.1% and 8.3% of the cohort were
‘normal’, ‘high’ and ‘low’ birthweight children respectively (Table 4.8). Data on
birthweight, gestational age, and wheezing disorders were complete. Approximately,
23% of the total children had missing information on at least one covariate
(Table 4.8).
Out of 13,734 children, 841 (6.1%) were diagnosed as asthmatic, 1994 (14.5%) had
wheezing symptoms, 2347 (17.1%) were either diagnosed for asthma or had
wheezing symptoms, and 3035 (22.1%) children were treated with asthma drugs
based on primary care data available up to November 2014 (Table 4.8).
Selecting minimally sufficient sets of confounding variables
DAG model output using DAGitty software resulted in two sets of minimally
sufficient confounding variables (Figure 4.2). That is, each of the two sets contains
minimally sufficient set of confounding variables. Since the list of variables in the
DAG model was constructed retrospectively (i.e. after the BiB cohort data were
collected), comparison between minimally sufficient sets was mainly based on the
availability of data about the variables within each set. That is, a set that has a lowest
number of variables without data was considered to be as the best option. Thus, the
set that contains: ethnicity, family asthma, gender, gestational age, maternal
smoking, number of live births, parity, and SES was selected. However, information
on family asthma was missing from the BiB cohort data so models were not adjusted
for this variable.
Low birthweight and wheezing disorders
There was a significant increased risk of wheezing disorders for low birthweight
children in all four disease definitions (Table 4.9). The unadjusted RRs for asthma
diagnosis, wheezing symptoms, wheezing disorder diagnosis and wheezing disorder
treatment 1.55 (95% CI: 1.27 to 1.89), 1.28 (95% CI: 1.13 to 1.46), 1.28 (95% CI:
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1.14 to 1.45) and 1.27 (95% CI: 1.15 to 1.40). The respective adjusted RRs 1.53
(95% CI: 1.20 to 1.96), 1.29 (95% CI: 1.10 to 1.52), 1.29 (95% CI: 1.12 to 1.50) and
1.25 (95% CI: 1.10 to 1.42).
High birthweight and wheezing disorders
Based on the adjusted risk estimates, there was a consistent but non-significant
reduction of risk in all four wheezing disorders disease definitions for high
birthweight children (Table 4.9). The unadjusted RRs for asthma diagnosis,
wheezing symptoms, wheezing disorder diagnosis and wheezing disorder treatment
were 0.93 (95% CI: 0.73 to 1.19), 0.91 (95% CI: 0.78 to 1.06), 0.92 (95% CI: 0.80
to 1.05) and 1.04 (95% CI: 0.93 to 1.16). The respective adjusted RRs were 0.95
(95% CI: 0.75 to 1.22), 0.90 (95% CI: 0.77 to 1.04), 0.91(95% CI: 0.79 to 1.04) and
0.99 (95% CI: 0.89 to 1.11).
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Figure 4.2 DAG model output of confounding adjustment for models that
investigated the effects of birthweight on wheezing disorders
Key:
=Exposure variable; =Outcome variable; =Ancestor of exposure and outcome;
= Ancestor of outcome; =Causal path; =Biasing path
Minimal sufficient adjustment sets for estimating the total effect of birthweight on
wheezing disorders:
 Ethnicity, family asthma, gender, gestational age, maternal smoking, number of
live births, parity and SES.
 Ethnicity, family asthma, gestational age, maternal smoking, number of live births,
parity, SES and outdoor playing time.
147
Table 4.8 Characteristics of 13,734 children with complete data on wheezing disorders and covariates
Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%)
Birthweight (kg)
Normal (2.5-4.0) 668/10,673 5.9 1,622/9,719 14.3 1,907/9,434 16.8 2,444/8,897 21.6
Low (<2.5) 104/1,035 9.1 209/930 18.3 246/893 21.6 311/828 27.3
High (>4.0) 69/1,185 5.5 163/1,091 13.0 194/1,060 15.5 280/974 22.3
Ethnicity
White British 217/4,284 4.8 586/3,915 13.1 706/3,795 15.7 1,074/3,427 23.9
Pakistani 382/4,735 7.5 857/4,260 16.7 985/4,132 19.2 1,150/3,967 22.5
Others 86/1,647 5.0 207/1,526 11.9 243/1,490 14.0 308/1,425 17.8
Gender
Male 502/6,415 7.3 1,220/5,697 17.6 1,416/5,501 20.5 1,775/5,142 25.7
Female 318/6,172 4.9 742/5,748 11.4 890/5,600 13.7 1,190/5,300 18.3
Gestational age
Term 769/12,100 6.0 1,841/11,028 14.3 2,166/10,703 16.8 2,792/10,077 21.7
Pre-term 72/793 8.3 153/712 17.7 181/684 20.9 243/622 28.1
Number of births
Singleton 803/12,281 6.1 1,923/11,161 14.7 2,262/10,822 17.3 2,911/10,173 22.2
Twins 17/297 5.4 38/276 12.1 43/271 13.7 52/262 16.6
Triplets 0/9 0 1/8 11.1 1/8 11.1 2/7 22.2
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Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%)
Maternal smoking
No 520/7,371 6.6 1,162/6,729 14.7 1,359/6,532 17.2 1,710/6,181 21.7
Yes 167/3,295 4.8 490/2,972 14.2 578/2,884 16.7 823/2,639 23.8
Parity
Primiparous 292/4,823 5.7 686/4,429 13.4 821/4,294 16.1 1,128/3,987 22.1
Multiparous 489/7,311 6.3 1,210/6,590 15.5 1,401/6,399 18.0 1,728/6,072 22.2
IMD 2010 quintile score
1 487/7,048 6.5 1,182/6,353 15.7 1,372/6,163 18.2 1,721/5,814 22.8
2 115/1,939 5.6 253/1,801 12.3 304/1,750 14.8 435/1,619 21.2
3 59/1,196 4.7 148/1,107 11.8 177/1,078 14.1 247/1,008 19.7
4 18/317 5.4 41/294 12.2 53/282 15.8 84/251 25.1
5 8/184 4.2 30/162 15.6 33/159 17.2 49/143 25.5
IMD=index of multiple deprivation at a national level with 1 and 5 indicating the least and most deprived scores respectively.
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Table 4.9 Adjusted relative risks and 95% confidence intervals of covariates using 40 imputed datasets of 13,734 BiB cohort children
Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Birthweight (kg)
Normal (2.5-4.0) 1 1 1 1
High (>4.0) 0.95 (0.75 to 1.22) 0.90 (0.77 to 1.04) 0.91(0.79 to 1.04) 0.99 (0.89 to1.11)
Low (<2.5) 1.53 (1.20 to 1.96) 1.29 (1.10 to 1.52) 1.29 (1.12 to 1.50) 1.25(1.10 to 1.42)
Ethnicity
White British 1 1 1 1
Pakistani 1.36 (1.11 to 1.66) 1.26(1.12 to 1.42) 1.21(1.08 to 1.35) 0.95 (0.87 to 1.05)
Others 0.96 (0.74 to 1.25) 0.93 (0.79 to 1.08) 0.90 (0.78 to 1.04) 0.76 (0.67 to 0.85)
Gender
Male 1 1 1 1
Female 0.67(0.58 to 0.76) 0.64 (0.59 to 0.70) 0.66 (0.61 to 0.72) 0.71 (0.67 to 0.76)
Gestational age
Term 1 1 1 1
Pre-term 1.11(0.83 to 1.48) 1.08 (0.90 to 1.30) 1.09 (0.92 to 1.29) 1.16 (1.01 to 1.34)
Number of births
Singleton 1 1 1 1
Twins 0.68(0.42 to 1.10) 0.71 (0.52 to 0.97) 0.68 (0.51 to 0.90) 0.63 (0.49 to 0.81)
Triplets - 0.57 (0.09 to 3.60) 0.48 (0.08 to 3.03) 0.75 (0.22 to 2.56)
Maternal smoking
No 1 1 1 1
Yes 0.86(0.70 to 1.05) 1.10 (0.98 to 1.24) 1.07 (0.97 to 1.19) 1.05 (0.97 to 1.15)
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Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Parity
Primiparous 1 1 1 1
Multiparous 1.04 (0.91 to 1.20) 1.14 (1.04 to 1.24) 1.10 (1.02 to 1.19) 1.02 (0.95 to 1.08)
IMD 2010 quintile score 0.96 (0.88 to 1.05) 0.95 (0.90 to 1.00) 0.95 (0.91 to 1.00) 0.97 (0.93 to 1.00)
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4.4 Effects of weight at the age of 3 years on wheezing disorders
Demographics
A total of 1,598 BiB1000 singletons, term children were included in this analysis.
They were 778 (48.7%) boys and 820 (51.3%) girls; and 762 (47.7%) Pakistani and
602 (37.7%) white British (Table 4.10). A total of 1,043 (65.3%) had complete
weight data for the 36 months questionnaire. The age of the children ranged between
35.4 and 40.6 months.
The total number of children who had ‘asthma’ diagnosis, ‘wheezing’ symptoms,
‘wheezing disorders’ diagnosis and ‘wheezing disorders’ treatment were 113
(7.1%) , 252 (15.8%), 300 (18.8%) and 369 (23.1%) respectively, slightly higher
than the BiB cohort (Table 4.10).
Selecting minimally sufficient sets of confounding variables
DAG model output using DAGitty software resulted in three sets of minimally
sufficient confounding variables (Figure 4.3). Construction of the list of variables
that go into the DAG model was carried out retrospectively (i.e. after the BiB cohort
data were collected). That is, comparison between minimally sufficient sets was
mainly based on the availability of data about the variables of each set. Thus,
birthweight, breast feeding, ethnicity, family asthma, gender, maternal smoking,
parity, and SES were selected as minimally sufficient set of confounding variables.
However, information on breast feeding and family asthma was not available so
models were not adjusted for these variables.
Weight at the age of 3 years and wheezing disorders
Underweight children had an insignificant reduced risk of wheezing disorders
(Table 4.11). The unadjusted RRs and 95% confidence intervals of underweight for
asthma diagnosis, wheezing symptoms, wheezing disorders diagnosis and wheezing
disorder treatment were 0.58 (0.23 to 1.44), 0.97 (0.60 to 1.57), 0.89 (0.57 to 1.39)
and 0.79 (0.51 to 1.23), respectively when compared with the normal weight
children. The respective adjusted RRs and 95% CI underweight children were 0.55
(0.22 to 1.38), 0.95 (0.59 to 1.53), 0.87 (0.56 to 1.37) and 0.78 (0.50 to 1.21)
Overweight children showed an insignificant increase in the risk of wheezing
symptoms, wheezing disorder diagnosis and wheezing disorder treatment whilst
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insignificant decreased risk of asthma diagnosis when compared with the normal
weight children (Table 4.11). The unadjusted RRs and 95% confidence intervals of
underweight for asthma diagnosis, wheezing symptoms, wheezing disorders
diagnosis and wheezing disorder treatment 0.79 (0.40 to 1.55), 1.32 (0.89 to 1.96),
1.23 (0.86 to 1.76) and 1.14 (0.82 to 1.58). The respective adjusted RRs and 95% CI
were 0.85 (0.43 to 1.65), 1.31 (0.88 to 1.94), 1.23 (0.86 to 1.75) and 1.12 (0.80 to
1.57).
Obese children had an insignificant increased risk of wheezing disorders
(Table 4.11). The unadjusted RRs and 95% confidence intervals of underweight for
asthma diagnosis, wheezing symptoms, wheezing disorders diagnosis and wheezing
disorder treatment were 1.29 (0.66 to 2.50), 0.98 (0.58 to 1.66), 1.10 (0.72 to 1.76)
and 1.14 (0.78 to 1.67). And, the respective adjusted RRs and 95% CI were 1.31
(0.67 to 2.56), 1.01 (0.60 to 1.70), 1.12 (0.73 to 1.70) and 1.14 (0.80 to 1.57).
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Table 4.10 Characteristics of 1,598 BiB1000 children with complete data on wheezing disorders and covariates
Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%)
Birthweight (kg)
Normal (2.5-4.0) 101/1,314 7.1 221/1,194 15.6 264/1,151 18.7 321/ 1,094 22.7
Low (<2.5) 6/64 8.6 14/56 20.0 16/54 22.9 20/50 28.6
High (>4.0) 6/107 5.3 17/96 15.0 20/93 17.7 28/85 24.8
Weight at 3 years
Normal (≥5th and <85th centiles) 66/667 9.0 117/616 16.0 146/587 19.9 185/548 25.2
Underweight (<5th centile) 5/92 5.2 15/82 15.5 17/80 17.5 19/78 19.6
Overweight (≥85th and <95th centiles 9/118 7.0 26/101 20.5 30/97 23.6 35/92 27.6
Obese (≥95thcentile) 10/76 11.6 13/73 15.2 17/80 22.1 25/61 29.1
Ethnicity
White British 24/578 4.0 82/520 13.6 95/507 15.8 141/461 23.4
Pakistani 73/689 9.6 134/628 17.6 164/598 21.5 175/587 23.0
Others 16/216 6.9 36/196 15.5 41/191 17.7 53/179 22.8
Gender
Male 70/708 9.0 159/619 20.4 185/593 23.8 212/566 27.2
Female 43/777 5.2 93/727 11.3 115/705 14.0 157/663 19.1
Maternal smoking
No 90/1,051 7.9 177/964 15.5 213/928 18.7 256/885 22.4
Yes 23/433 5.0 74/382 16.2 86/370 18.9 112/344 24.6
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Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%) Yes/ no Yes (%)
Parity
Primiparous 41/571 6.7 87/ 525 14.2 106/ 506 17.3 144/468 23.5
Multiparous 70/ 892 7.3 163/ 799 16.9 191/ 771 19.9 218/744 22.7
IMD 2010 quintile score
1 83/ 998 7.7 183/898 16.9 217/864 20.1 255/826 23.6
2 19/ 271 6.6 37/253 12.8 45/ 245 15.5 64/226 22.1
3 10/ 158 6.0 23/ 145 13.7 28/140 16.7 36/132 21.4
4 1/34 2.9 3/32 8.6 4/31 11.4 6/ 29 17.1
5 0/24 0 6/18 25.0 6/18 25.0 8/16 33.3
IMD=Index of multiple deprivation at national level with 1 and 5 indicating the least and most deprived scores respectively.
155
Figure 4.3 DAG model output of confounding adjustment for models that
investigated the weight at 3 years and risk of wheezing disorders
Key:
=Exposure variable; =Outcome variable; =Ancestor of exposure and outcome;
= Ancestor of outcome; =Causal path; =Biasing path
Minimal sufficient adjustment sets for estimating the total effect of weight at the age of 3
years on wheezing disorders:
 Birthweight, breast feeding, ethnicity, family asthma, gender, maternal smoking,
parity and SES.
 Birthweight, breast feeding, ethnicity, family asthma, maternal smoking, parity,
SES and outdoor playing time.
 Birthweight, breast feeding, gender, maternal feeding habits, parity and SES.
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Table 4.11 Adjusted relative risks and 95% confidence intervals of covariates using 40 imputed datasets of 1,598 BiB1000 children
Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Weight at 3 years
Normal (≥5th and <85th centiles) 1 1 1 1
Underweight (<5th centile) 0.55 (0.22 to 1.38) 0.95 (0.59 to 1.53) 0.87 (0.56 to 1.36) 0.78 (0.50 to 1.21)
Overweight (≥85th and <95th centiles) 0.85 (0.43 to 1.65) 1.31 (0.88 to 1.94) 1.23 (0.86 to 1.75) 1.12 (0.80 to 1.57)
Obese (≥95thcentile) 1.31 (0.67 to 2.56) 1.01 (0.60 to 1.70) 1.12 (0.73 to 1.70) 1.14 (0.80 to 1.57)
Birthweight (kg)
Normal (2.5-4.0) 1 1 1 1
High (>4.0) 0.83 (0.37 to 1.86) 0.95 (0.60 to 1.50) 0.94 (0.62 to 1.43) 1.04 (0.75 to 1.47)
Low (<2.5) 1.27 (0.57 to 2.83) 1.34 (0.83 to 2.17) 1.28 (0.82 to 2.00) 1.34 (0.91 to 1.97)
Ethnicity
White British 1 1 1 1
Pakistani 2.23 (1.32 to 3.75) 1.37 (1.02 to 1.85) 1.41 (1.08 to 1.85) 1.04 (0.83 to 1.31)
Others 1.65 (0.87 to 3.12) 1.19 (0.81 to 1.74) 1.15 (0.81 to 1.62) 1.01 (0.75 to 1.35)
Gender
Male 1 1 1 1
Female 0.57 (0.39 to 0.82) 0.56 (0.44 to 0.71) 0.59 (0.47 to 0.73) 0.71 (0.59 to 0.85)
Maternal smoking
No 1 1 1 1
Yes 0.97 (0.52 to 1.81) 1.39 (1.01 to 1.91) 1.25 (0.93 to 1.69) 1.17 (0.91 to 1.50)
Parity
Primiparous 1 1 1 1
Multiparous 0.97 (0.66 to 1.41) 1.16 (0.90 to 1.48) 1.10 (0.88 to 1.37) 0.97 (0.81 to 1.17)
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Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
IMD 2010 Quintile score 0.89 (0.69 to 1.14) 0.95 (0.82 to 1.10) 0.95 (0.83 to 1.08) 0.97 (0.87 to 1.09)
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4.5 Describing the growth patterns of white British and Pakistani
children
Demographics
There were a total of 1,364 singletons, term children with 48.5% boys and 51.5%
girls; 44% of white British and 56% of Pakistani origin, that is, 602 white British
children (293 boys and 309 girls), and 762 Pakistani children (368 boys and 394
girls).
Growth characterstics
Over all, missing data was substantial for the ages of 3 and 24 months (Table 4.13).
Although the missing rate for the two ethnicities was similar during the first three
periods of measurements (i.e. birth, 1 and 3 months), it was slightly better during 12,
18 and 24 months but slightly worse during 6 and 36 months for the Pakistani
children when compared with the white British.
The overall observed means at birth, 1 month and 3 months were below the 50th
centile whereas from 6 months onwards above the 50th centile (Table 4.13),
according to the WHO growth standards (WHO, 2006). The correlation among the
repeated weight measurements was between 0.346 and 0.934 (Table 4.13). The
covariance coverage (the proportion of data present in variable x given variable y)
was between 0.089 (9%) and 1.00 (100%). This is a reflection of complete case
covariance matrix. Given that Mplus software was used for analyses of growth
patterns, this information was used for fine tunning of the “coverage” in the analysis
command. The default minimum covariance coverage value in Mplus is 0.10, thus,
the covariance coverage of the GMMs had to be fixed at the lowest covariance
coverage value (i.e. 0.089) of the data. Otherwise, the models would not converge.
Figure 4.4 depicts individual observed growth trajectories of 1,364 children; and
Figure 4.5A and Figure 4.5B illustrate individual growth trajectories of Pakistani
and white British children, respectively. Approximately, 95% of the of the children
had weight SDSs between +2.5 and -3.5 throughout the follow up period
(Figure 4.4). The Pakistani children had a larger range of birthweight (+3.8SDS
to -4.4SDS) than the white British (+3SDS to -3.7SDS) although the difference was
attenuated by the age of three years (Figure 4.5A and Figure 4.5B)
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Table 4.12 Complete weight measurements for 1,364 Pakistani and white British
children
Pakistani (%) white British (%) All (%)
Birth 762 (100) 602 (100) 1364 (100)
1 month 519 (68.1) 426 (70.8) 945 (69.3)
3 months 190 (24.9) 155 (25.7) 345 (25.3)
6 months 425 (55.8) 361 (60.1) 786 (57.6)
12 months 363 (47.3) 262 (43.5) 624 (45.7)
18 months 387 (50.8) 262 (43.5) 649 (47.6)
24 months 257 (33.7) 184 (30.6) 441 (32.3)
36 months 264 (34.6) 270 (44.9) 534 (39.1)
Table 4.13 Observed means, correlations and covariance coverage of repeated
weight SDS measurements of 1,364 Pakistani and white British
children
Months Mean Correlation Matrix
0 1 3 6 12 18 24 36
0 -0.087 1.00
1 -0.426 0.825 1.00
3 -0.412 0.588 0.786 1.00
6 0.015 0.469 0.611 0.853 1.00
12 0.237 0.415 0.514 0.738 0.889 1.00
18 0.252 0.410 0.489 0.688 0.815 0.914 1.00
24 0.272 0.378 0.456 0.656 0.755 0.850 0.934 1.00
36 0.240 0.346 0.447 0.612 0.709 0.795 0.867 0.913 1.00
Covariance coverage
0 1.00
1 0.693 0.693
3 0.253 0.226 0.253
6 0.576 0.420 0.156 0.576
12 0.457 0.328 0.121 0.303 0.457
18 0.476 0.346 0.130 0.309 0.284 0.476
24 0.323 0.231 0.089 0.211 0.183 0.213 0.323
36 0.391 0.284 0.106 0.271 0.223 0.243 0.179 0.391
160
Figure 4.4 Individual observed growth trajectories of 1,364 Pakistani and white
British children
Note: X and Y axes denote age of children when measurtement was recorded and the standardised weight scores, respectively.
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Figure 4.5 Individual observed growth trajectories of Pakistani (A) and white
British (B) children
Note: Both in figre A and B, X and Y axes denote age of children when measurtement was recorded and the standardised weight
scores, respectively.
A
B
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4.5.1 Latent growth curve model
4.5.1.1 The linear model
According to the linear LGCM results (Table 4.14), white British and Pakistani
children had an overall estimated mean of intercept (i.e. birthweight) that fell just
below the 44th centile and shifted up by 0.176 SDS at every subsequent month (i.e.
slope or velocity). The latent growth factors (i.e. slope and intercept) had a
statistically significant inverse relationship (i.e. Covariance = -0.039; P-value =
0.01). However, as can be noted from the model fit statistics results (Table 4.14) and
the graph of sample and estimated means curves (Figure 4.6), the linear LGCM
fitted the data poorly. For example, the chi-squared value was very large (1765, df =
31); the Comparative Fit Index (CFI) and Tucker-Lewis Index (TLI) were lower
than the recommended cut off values; and Root Mean Square Error Approximation
(RMSEA) and Standardised Root Mean square Residuals (SRMR) were above the
cut off values. Likewise, there was a substantial gap (residual) between the
estimated means and sample means lines (Figure 4.6).
Figure 4.6 Sample and estimated mean curves of linear latent growth curve model
Note: X and Y axes denote age of children when measurtement was recorded and the standardised weight scores, respectively.
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Table 4.14 Parameter estimates and model fit statistics of linear latent growth
curve model
Estimate Standard error P-value
Means
Intercept -0.159 0.028 <0.01
Slope 0.176 0.016 <0.01
Covariance
Intercept ↔ slope -0.039 0.014 0.01 
Variances
Intercept 0.712 0.037 <0.01
Slope 0.083 0.013 <0.01
E1 (birth) 0.561 0.044 <0.01
E2 (1 month) 0.407 0.043 <0.01
E3 (3 months) 0.353 0.045 <0.01
E4 (6 months) 0.260 0.027 <0.01
E5 (12 months) 0.211 0.026 <0.01
E6 (18 months) 0.119 0.017 <0.01
E7 (24 months) 0.073 0.018 <0.01
E8 (36 months) 0.224 0.058 <0.01
Model fit statistics
AIC 13,214
BIC 13,282
CFI 0.588
-2LL 13,188
RMSEA 0.203
SRMR 0.0158
TLI 0.628
Chi-squared statistic 1765 (df=31) <0.01
AIC=Akaike Information Criterion; BIC= Bayesian Information Criterion; RMSEA= Root
Mean Square Error Approximation; CFI=Comparative Fit Index; TLI=Tucker-Lewis Index;
SRMR=Standardised Root Mean Square Residuals and -2 LL= -2 X Log-likelihood;
df=degrees of freedom. Recommended cut-off values: CFI>0.95; TLI>0.95; RMSEA≤0.05; 
and SRMR<0.05.
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4.5.1.2 Comparison between non-linear latent growth curve models
Comparison of three modelling techniques showed that a piecewise model with two
joints (i.e. at 3 months and 12 months) performed better than polynomials and free
time score functions (Table 4.15 and Figure 4.7 ). The Log-likelihood, Akaike
information criterion (AIC) and Bayesian information criterion (BIC) were all
optimal, and residuals were relatively smaller, albeit inconsistent, when compared to
the polynomials and free time score functions (Table 4.15 and Figure 4.7). However,
although some improvements were seen when compared to the linear and two
nonlinear models, the RMSEA, CFI, TLI and SRMR values remained suboptimal
(Table 4.15).
Table 4.15 Model fit statistics for non-linear latent growth curve models
Free-time scores model Piecewise model Polynomial model
Fit index
AIC 11,675 11,409 11,753
BIC 11,767 11,517 11,861
RMSEA 0.131 0.106 0.147
CFI 0.86 0.919 0.845
TLI 0.901 0.901 0.811
SRMR 0.084 0.040 0.074
-2LL 11,639 11,367 11,711
Residuals (observed –expected means)
WSDS0 0.145 0.027 0.190
WSDS1 -0.039 -0.231 -0.201
WSDS3 -0.207 -0.056 -0.282
WSDS6 -0.056 0.162 0.024
WSDS12 0.022 -0.034 0.073
WSDS18 -0.004 -0.011 -0.005
WSDS24 -0.002 0.016 -0.018
WSDS36 0.005 -0.002 0.008
WSDS= standardised weight scores; subscripts are age in months.
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Figure 4.7 Sample and estimated mean curves of non-linear latent growth curve
models
Note: x and y axes denote age of children when measurtement was recorded and the standardised weight scores,
respectively.
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4.5.1.3 Piecewise latent growth curve model
According to an overall (one group) growth model, the white British and Pakistani
children had an average birthweight of 3.3kgs (-0.116 SDS) with a significant
downward slope or decrease in velocity (-0.707 SDS) between birth and 3 months, a
significant upward slope or velocity (0.665 SDS) between 3 and 12 months, and a
non significant downward slope (-0.012 SDS) between 12 and 36 months of age
(Table 4.16 and Figure 4.7). The children had significant variations interms of
birthweight and velocities between birth and age of one year (Table 4.17). On
average, low birthweight children had higher growth velocities than the high
birthweight children and vice versa. Likewise, children that had a higher growth
veleocity during the first three months showed a lower growth velocity between the
ages of one and three years than those who had lower velecity during the same
period (Table 4.17).
Table 4.16 Estimated means of latent growth factors for the overall and multi-
group piecewise latent growth curve models
Model Estimate P-value
value 95% CI
Means
Overall (one group) model
Intercept -0.116 -0.174 to -0.058 <0.01
Slope0-3 -0.707 -0.970 to -0.443 <0.01
Slope3-12 0.665 0.583 to 0.748 <0.01
Slope12-36 -0.012 -0.035 to 0.011 0.32
Multi-group model
White British
Intercept 0.119 0.030 to 0.209 <0.01
Slope0-3 -0.881 -1.289 to -0.473 <0.01
Slope3-12 0.578 0.451 to 0.705) <0.01
Slope12-36 -0.057 -0.086 to -0.028 <0.01
Pakistani
Intercept -0.299 -0.377 to -0.221 <0.01
Slope0-3 -0.709 -1.006 to -0.412 <0.01
Slope3-12 0.770 0.684 to 0.857 <0.01
Slope12-36 0.031 -0.003 to 0.066 0.07
Note: subscripts are age in months; Intercept=birthweight; slope=velocity.
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Results from the multi-group model showed that the Pakistani children were
191grams (i.e. 0.498 SDS) lighter than the white British children at birth.
Furthermore, the white British children had statistically significant downward and
upward trends between birth and 36 months (slope0-3 =-0.881 SDS, slope3-12=0.578
SDS, slope12-36=-0.057 SDS), whereas, the Pakistani children had a statistically
significant change of trend between birth and 12 months (slope0-3=-0.709 SDS;
slope3-12=0.770 SDS) but a non-statistically significant change of trend between 12
and 36 months (slope12-36=0.031 SDS), see Table 4.16.
The multi-group analysis results also confirmed that the two ethnicities had distinct
growth curves (Figure 4.8B). According to the estimated latent growth parameter
estimates (Table 4.16), the Pakistani children had a significantly lower birthweight
SDS than the white British, that is, -0.299 SDS and 0.119 SDS, respectively. There
were significant variations among Pakistani and white British children in terms of
birthweight and growth velocities (Table 4.17). In both ethncities, there were
significant inverse relationsships between birthweight and velocities between birth
and 12 months.
168
Table 4.17 Variance and covariance estimates for the overall and multi-group
latent growth curve models
Parameter Estimate Standard error P-value
Overall model
Variances Intercept 1.041 0.052 <0.01
Slope0-3 9.232 0.805 <0.01
Slope3-12 0.465 0.070 <0.01
Slope12-36 0.065 0.006 0.30
Covariance Intercept ↔ slope0-3 -1.484 0.174 <0.01
Intercept ↔ slope3-12 -0.172 0.039 <0.01
Intercept ↔ slope12-36 -0.026 0.042 0.07
Slope0-3 ↔ slope3-12 -0.040 0.159 0.80
Slope0-3 ↔ slope12-36 -0.129 0.042 <0.01
Slope3-12 ↔ slope12-36 -0.002 0.013 0.87
White British
Variance Intercept 0.980 0.083 <0.01
Slope0-3 9.553 1.172 <0.01
Slope3-12 0.588 0.129 <0.01
Slope12-36 0.050 0.006 <0.01
Covariance Intercept ↔ slope0-3 -1.277 0.263 <0.01
Intercept ↔ slope3-12 -0.168 0.054 <0.01
Intercept ↔ slope12-36 -0.015 0.021 0.48
Slope0-3 ↔slope3-12 -0.612 0.272 0.03
Slope0-3 ↔slope12-36 -0.115 0.064 0.07
Slope3-12 ↔ slope12-36 -0.017 0.021 0.43
Pakistani
Variances Intercept 1.001 0.065 <0.01
Slope0-3 8.987 1.037 <0.01
Slope3-12 0.348 0.069 <0.01
Slope12-36 0.077 0.010 <0.01
Covariance Intercept ↔ slope0-3 -1.602 0.224 <0.01
Intercept ↔ slope3-12 -0.129 0.050 <0.01
Intercept ↔slope12-36 -0.017 0.019 0.36
Slope0-3 ↔ slope3-12 0.370 0.162 0.02
Slope0-3 ↔ slope12-36 -0.137 0.058 0.02
Slope3-12 ↔ slope12-36 -0.001 0.016 0.93
Note: subscripts are age in months.
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Figure 4.8 Estimated mean curves of overall (A) and multi-group (B) latent growth
curve models
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4.5.2 Piecewise growth mixture model
4.5.2.1 Determination of optimal class number
The goodness fit indices for the classification models did not agree (Table 4.18).
However, none of the model fit indices favoured one class (i.e. equivalent to the
LGCM). While the log-likelihood and AIC favoured the highest class model, the
sample size adjusted BIC indicated that the three classes model was optimal.
According to simulation studies by Nylund et al. (2007) and Yang (2006), BIC and
sample size adjusted BIC were found to be superior to all Information Criteria
indices. Of the two likelihood ratio tests (i.e. Lo-Mendell-Rubin Likelihood Ratio
Test (LMR LRT) and Bootstrapped Likelihood Ratio Test (BLRT)), the BLRT was
discovered to be superior (Nylund et al., 2007). In line with the recommendation of
these simulation studies, both the adjusted and non adjusted LMR LRTs rejected the
K and K+1 (i.e. K is class number) class models consistently. The selection of the
optimal number of classes was, therefore, guided mainly by sample size adjusted
BIC and BLRT values. Owing to the high computational time needed for BLRT
estimation, only 2-5 class models were run and selected for comparison based on
ABIC and classification quality (entropy) values of the classes.
Table 4.18 Model fit results for selection of optimal number of classes of growth
mixture model
Model fit Criterion Classification
quality
Likelihood ratio test
-2LL AIC ABIC df Entropy BLRT (-2LL diff; df diff;
and P-values)
1 class 11,886.2 11,928.2 11,971.1 21 N/A N/A
2 classes 11,839.8 11,891.9 11,945.0 26 0.92 46.34; 5; <0.001
3 classes 11,805.4 11,867.5 11,930.7 31 0.91 34.42; 5; 0.002
4 classes 11,786.6 11,858.6 11,932.1 36 0.89 18.80; 5; 0.070
5 classes 11,766.6 11,848.7 11,932.4 41 0.70 19.85; 5; 0.065
6 classes 11,749.6 11,841.5 11,935.4 46 0.70 -
7 classes 11,731.8 11,833.6 11,937.7 51 0.69 -
8 classes 11,716.6 11,828.6 11,942.9 56 0.64 -
9 classes 11,702.6 11,824.6 11,949.2 61 0.66 -
LL= Log-likelihood; AIC=Akaike Information Criterion; ABIC= sample size adjusted Bayesian Information Criterion;
BLRT= bootstrapped likelihood ratio test; -2LL diff=2 times the Log-likelihood difference, df=degrees of freedom (number of
free parameters); df diff= difference in the degree of freedom.
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Based on class numeration results (Table 4.18), the BiB1000 children had three
optimal classes (Figure 4.9). In Table 4.19, the average latent class assignment
probabilities of individuals in each of the three classes are outputted. These figures
are indicators of classification quality of the model’s class assignment. A
classification model with main diagonal matrix values closer to 1 is considered to be
more reliable; the recommended cut-off point is 0.70 (Nagin, 2005). For example,
the average probability of individuals in latent class 1 to be correctly assigned to
their most likely class (i.e. class 1) was 0.975 (97.5%). In other words, on average,
there was a 2.5% of class assignment error in class 1. Likewise, the average
probabilities of individuals in latent class 2 and class 3 to be correctly assigned to
their respective latent classes were 81.3% and 86.3%, that is, the class assignment
errors in class 2 and 3 were 19% and 16%, respectively. The classification quality
(entropy) for the three classes model was 0.91 (Table 4.18) which is above the
recommended adequate cut-off point of 0.80 (Clark, 2010).
Table 4.19 Average latent class probabilities for most likely latent class
membership (row) by latent class (column)
Class 1 Class 2 Class 3
Class 1 0.975 0.015 0.010
Class 2 0.171 0.813 0.016
Class 3 0.137 0.000 0.863
Class 1, which comprised 95.9% of the sample population, were characterised by
consistent growth from birth until the age of 3 (Figure 4.9). This group of children
had a birthweight SDS (intercept) of -0.095; and, statistically significant downward
slope0-3 (-0.726 SDS, 95% CI: -0.977 to -0.474), upward slope3-12 (0.646 SDS, 95%
CI: 0.571, 0.721), and an insignificant downward slope12-36 (-0.022 SDS, 95% CI: -
0.047 to 0.002), see Table 4.20. Based on the growth patterns, the group can be
classified as ‘normal growth’ group. Generally speaking, the means weight SDS
(i.e., from birth to 36 months) of this group of children were within the 38th and 61st
centile range when compared to the WHO growth standards (WHO, 2006).
Latent class 2, which comprised 2.5% of the population, had the lowest mean
birthweight SDS and showed the fastest growth from three months until 12 months
when compared to the other two classes (Figure 4.9). The group had an estimated
172
mean birthweight SDS (intercept) of -0.746. Between birth and 3 months, the group
showed a non-statistically significant drop (slope0-3= -2.344 SDS, 95% CI: -7.975 to
3.287), then significant change to an upward trend (Slope3-12=3.547 SDS, 95% CI:
2.438 to 4.655) between 3 and 12 months, and then a non-significant downward
trend (slope12-36 SDS=-0.151, 95% CI: -0.504 to 0.202) until the age of 3 years
(Table 4.20). When compared to the WHO growth charts, the group’s estimated
mean standardised weight at birth was 22nd centile. Then by the age of three months,
the estimated mean was at the 7th centile, and by the age of one year, it was at the
96th centile (WHO, 2006). This group can be categorised as ‘fast growth’ group that
were observed to be overweight from 1 to 3 years of age.
The children in class 3, comprising 1.6% of the population, are those who showed a
consistent downward trend from birth until 12 months, that is, slope0-3=-2.434 SDS
(95% CI: -5.496 to 0.628) and slope3-12=-0.692 SDS (95% CI: -1.790 to 0.406).
Between 12 and 36 months, they showed a significant upward trend (slope12-
36=1.050 SDS, 95% CI: 0.534 to 1.565). Subsequently, they consistently gained
weight until 3 years. When compared with the WHO growth charts, their estimated
mean birthweight was just above the 25th centile. By the age of 12 months, this
dropped to the 2nd centile, and then at the age of 3, their mean sharply increased to
the 69th centile (WHO, 2006). Generally speaking, the group can be categorised as
‘slow growth’ group.
Figure 4.9 Estimated mean curves of three classes GMM for 1,364 Pakistani and
white British children
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Collectively, children in all classes had significant variations in terms of birthweight
(i.e, intercept) and growth velocities (i.e. slope0-3, slope3-12 and slope12-36).
Furthermore, birthweight had a statistically significant inverse relationship with the
velocity of growth between birth and three months (i.e. slope0-3), and between three
and twelve months (i.e. slope3-12), see Table 4.20. Note that the variance and
covariance were held equal across the three classes.
When the probabilities of the two ethnicities were compared respective to the three
classes (reference=class 1), the Pakistani children had a higher probability of being
in the ‘faster growth’ and ‘slow growth’ groups than the white British, that is, ORs
of 2.90 (95% CI: 0.91 to 9.25) and 15.63 (95% CI: 1.06 to 230) for the ‘fast growth’
and ‘slow growth’ respectively (Table 4.21).
174
Table 4.20 Parameter estimates of latent growth factors of growth mixture model
of Pakistani and white British children
Estimate P-value
value 95% CI
Means
Class 1 Intercept -0.095 -0.164 to -0.025 <0.01
Slope0-3 -0.726 -0.977 to -0.474 <0.01
Slope3-12 0.646 0.571 to 0.721 <0.01
Slope12-36 -0.022 -0.047 to 0.002 0.07
Class 2 Intercept -0.746 -1.641 to 0.149 0.10
Slope0-3 -2.344 -7.975 to 3.287 0.42
Slope3-12 3.547 2.438 to 4.655 <0.01
Slope12-36 -0.151 -0.504 to 0.202 0.40
Class 3 Intercept -0.660 -1.551 to 0.230 0.15
Slope0-3 -2.434 -5.496 to 0.628 0.12
Slope3-12 -0.692 -1.790 to 0.406 0.22
Slope12-36 1.050 0.534 to 1.565 <0.01
Variances*
Intercept 1.014 0.903 to 1.126 <0.01
Slope0-3 8.938 7.394 to 10.482 <0.01
Slope3-12 0.297 0.206 to 0.387 <0.01
Slope12-36 0.057 0.047 to 0.067 <0.01
Covariance*
Intercept ↔ slope0-3 -1.448 -1.789 to -1.108 <0.01
Intercept ↔ slope3-12 -0.157 -0.258 to -0.057 <0.01
Intercept ↔ slope12-36 -0.015 -0.043 to 0.012 0.27
Slope0-3 ↔ slope3-12 0.018 -0.319 to 0.356 0.92
Slope0-3 ↔ slope12-36 -0.128 -0.210 to -0.046 <0.01
Slope3-12 ↔ slope12-36 0.012 -0.009 to 0.034 0.27
*= Parameter estimates were held equal across classes; subscripts are age in months.
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Table 4.21 Results of categorical latent variable multinomial logistic regressions
using 3-step procedure for the three classes of Pakistan and white
British children
*= reference is class 1 (the normal growth)
Odds ratio (95% CI) P-value
Class 2 (fast growth)*
Ethnicity (ref=white British) 2.90 (0.91 to 9.25) 0.072
Smoking (ref=yes) 0.23 (0.04 to 1.29) 0.095
Mother’s education(ref=5 GSCEs) 1.87 (0.87 to 4.01) 0.111
Parity(ref=primiparous) 0.30 (0.08 to 1.21) 0.092
Class 3 (slow growth)*
Ethnicity (ref=white British) 15.63 (1.06 to 230) 0.045
Smoking (ref=yes) 0.15 (0.02 to 1.01) 0.051
Mother’s education(ref=5 GSCEs) 1.03 (0.53 to 2.01) 0.934
Parity(ref=primiparous) 1.42 (0.17 to 11.88) 0.747
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4.6 Effects of childhood growth patterns on wheezing disorders
The BiB1000 follow-up cohort consisted of 1,598 children that contributed a total of
8,683 person years of follow-up. The overall observed means at birth, 1 month and 3
months were below the 50th centile whereas from 6 months onwards above the 50th
centile (Table 4.22 ), according the WHO growth standards (WHO, 2006). The
correlation among the repeated weight measurements was between 0.342 and 0.936
(Table 4.22). The covariance coverage (the proportion of data present in variable x
given variable y) was between 0.085 (~9%) and 1.00 (100%). There was a
substantial amount of missing weight data for the ages 3 , 24 and 36 months
(Table 4.23 ).
Table 4.22 Means, correlations and covariance coverage of repeated weight SDS
measurements of 1,598 BiB1000 children
Months Mean* Correlation Matrix
0 1 3 6 12 18 24 36
0 -0.103 1.00
1 -0.428 0.851 1.00
3 -0.404 0.588 0.770 1.00
6 0.006 0.472 0.613 0.861 1.00
12 0.220 0.411 0.506 0.735 0.879 1.00
18 0.238 0.399 0.480 0.694 0.814 0.913 1.00
24 0.253 0.374 0.443 0.654 0.762 0.850 0.936 1.00
36 0.209 0.342 0.428 0.613 0.710 0.788 0.863 0.911 1.00
Covariance coverage
0 1.00
1 0.681 0.681
3 0.250 0.220 0.250
6 0.569 0.409 0.152 0.569
12 0.452 0.317 0.118 0.298 0.452
18 0.477 0.343 0.130 0.303 0.280 0.477
24 0.315 0.223 0.085 0.205 0.174 0.206 0.315
36 0.391 0.282 0.105 0.270 0.220 0.245 0.174 0.391
* = observed values
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Table 4.23 Complete weight measurements for 1,598 BiB1000 children
Measurement period Complete data (%)
Birth 1,598 (100)
1 month 1,092 (68.3)
3 months 399 (25)
6 months 910 (56.9)
12 months 722 (45.2)
18 months 763 (47.7)
24 months 504 (31.5)
36 months 625 (39.1)
After estimating missing growth data using FIML, 1.6% of the BiB1000 children
had missing information on at least one covariate. Fewer than 2% and 10% of the
children were diagnosed with or treated for wheezing disorders during the first three
months and the first six months, respectively (Table 4.24). The total number of
children who had ‘asthma’ diagnosis, ‘wheezing’ symptoms, ‘wheezing disorders’
diagnosis and ‘wheezing disorders’ treatment were 113 (7.1%) , 252 (15.8%), 300
(18.8%) and 369 (23.1%) respectively, slightly higher than the whole BiB cohort
(Table 4.10).
Table 4.24 Period of diagnosis or treatment initiation of 1,598 BiB1000 children
Period in months
First 3 months First 6 months First 9 months First 12 months
Wheezing disorders diagnosis 1.3% 8.3% 17.0% 27.7%
Wheezing disorders treatment 2.1% 16.8% 33.1% 46.1%
Asthma diagnosis 0% 1.8% 2.7% 4.4%
Wheezing symptoms 1.59 7.9% 19.8% 31.8%
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4.6.1 Piecewise LGCM for 1,598 BiB1000 children
4.6.1.1 Describing growth velocities
Based on the LGCM, the BiB1000 children had an average birthweight of 45th
centile (SDS =-0.128) based on the WHO growth charts (WHO, 2006). Overall, the
children showed a significant downward trend during the first 3 months (velocity0-
3=-0.761) and upward trend between 3 and 12 months (velocity3-12=0.684).
There was a significant variation among 1,598 children on birthweight and velocities
between birth and 36 months. Birthweight was inversely related with the velocity of
growth, that is, children who had a higher birthweight were seen to have lower
velocity of growth and vice versa (Table 4.25 and Figure 4.10). While there was a
significant inverse relationship between velocities of the first 3 months and after 1
year, no significant association was observed between any of the velocities
(Table 4.25).
Although RMSEA and SRMR values are just at the border, CFI and TLI values are
slightly lower than the recommended (Table 4.25). This may indicate that LGCM is
not the optimal model for the BiB1000 children’s growth data.
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Table 4.25 Parameter estimates and model fit statistics of a piecewise latent
growth curve model of 1,598 BiB1000 children
Parameter Estimate Standard error P-value
Means
Birthweight -0.128 0.027 <0.01
Velocity0-3 -0.762 0.112 <0.01
Velocity3-12 0.684 0.035 <0.01
Velocity12-36 -0.020 0.011 0.08
Variances
Birthweight 1.009 0.047 <0.01
Velocity0-3 9.180 0.726 <0.01
Velocity3-12 0.503 0.065 <0.01
Velocity12-36 0.066 0.006 <0.01
Covariance
Birthweight ↔ velocity 0-3 -1.401 0.157 <0.01
Birthweight ↔ velocity3-12 -0.176 0.035 <0.01
Birthweight ↔ velocity12-36 -0.027 0.013 0.03
Velocity0-3 ↔ velocity3-12 -0.081 0.147 0.58
Velocity0-3 ↔ velocity12-36 -0.120 0.040 <0.01
Velocity3-12 ↔ velocity12-36 -0.009 0.013 0.47
Residual Variances (errors)
E1 (birth) 0.059 0.029 0.04
E2 (1 month) 0.229 0.022 <0.01
E3 (3 months) 0.073 0.033 0.03
E4 (6 months) 0.165 0.017 <0.01
E5 (12 months) 0.079 0.016 <0.01
E6 (18 months) 0.070 0.012 <0.01
E7 (24 months) 0.106 0.011 <0.01
E8 (36 months) 0.013 0.027 0.62
Fit indices
AIC 13,836
BIC 13,949
-2LL 13,794
RMSEA 0.05
SRMR 0.05
CFI 0.89
TLI 0.86
Note: subscripts are age in months; birthweight=Intercept; Velocity=Slope; AIC=Akaike Information Criterion; BIC=
Bayesian Information Criterion; RMSEA= Root Mean Square Error Approximation; CFI=Comparative Fit Index;
TLI=Tucker-Lewis Index; SRMR=Standardised Root Mean Square Residuals and -2 LL= -2 X Log-likelihood;
df=degrees of freedom. Cut-off values: CFI>0.95; TLI>0.95; RMSEA≤0.05; SRMR<0.05. 
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Figure 4.10 Individual observed growth curves and estimated mean (A) and sample
and estimated mean curves (B) of 1,598 BiB1000 children
Note: Red line in A is the estimated mean curve and the black lines are individual oberved curves. The solid and
dashed lines in B are estimated and sample (observed) mean curves. Both in A and B, the X and Y axes denote
age of children when measurtement was recorded and the standardised weight scores, respectively.
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Selection of minimally sufficient sets of confounding variables
Based on the DAG model output, three sets of minimally sufficient sets of
confounding variables were eligible for selection. The set that contained birthweight,
ethnicity, family asthma, breast feeding, gender, maternal smoking, parity, and SES
was selected as ‘minimally sufficient’ set of confounding variables (Figure 4.11).
However, information on family asthma and breast feeding was not available so
childhood growth and wheezing disorder models were not adjusted for these
variables.
Figure 4.11 DAG model output of confounding adjustment for models that
investigated the effects of childhood growth on wheezing disorders
Key:
=Exposure variable; =Outcome variable; =Ancestor of exposure and outcome;
= Ancestor of outcome; =Causal path; =Biasing path
Minimal sufficient adjustment sets for estimating the total effect of childhood growth on wheezing
disorders:
 Birthweight, breast feeding, ethnicity, family asthma, gender, maternal smoking, parity and
SES.
 Birthweight, breast feeding, ethnicity, family asthma, maternal smoking, parity, SES and
outdoor playing time.
 Birthweight, breast feeding, gender, maternal feeding habits, parity and SES.
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4.6.1.2 Effects of growth velocities on risk of wheezing disorders
When the velocities of growth were assessed for wheezing disorders risk, a slow
growth during the first 3 months and fast growth between three and 12 months were
associated with significant increased risk of all four wheezing disorders irrespective
of adjusting for confounding variables (Table 4.26). For example, for every 1SDS
decrease between birth and three months had an associated 5% risk of wheezing
disorder diagnosis (adjusted RR= 1.05, 95% CI: 1.04 to 1.07). The respective
increased risk for the upward velocity between 3 and 12 months was 26% (RR=
1.26, 95% CI: 1.18 to 1.35).
Table 4.26 Adjusted and unadjusted relative risks and 95% confidence intervals of
velocities between birth and 36 months from 10 imputed datasets of
1,598 BiB1000 children
Unadjusted RR
(95% CI; p-value)
Adjusted RR
(95% CI; p-value)
Velocity (-1SDS) between birth and 3 months
Asthma diagnosis 1.09 (1.07 to 1.12; 0.04) 1.08 (1.05 to 1.11; <0.01)
Wheezing symptom 1.06 (1.06 to 1.08; <0.01) 1.07 (1.05 to 1.08; <0.01)
Wheezing disorder diagnosis 1.06 (1.05 to 1.07; 0.01) 1.05 (1.04 to 1.07; <0.01)
Wheezing disorder treatment 1.05 (1.04 to 1.07; 0.01) 1.05 (1.04 to 1.07; <0.01)
Velocity(+1SDS) between 3 and 12 months
Asthma diagnosis 1.49 (1.34 to 1.66; <0.01) 1.39 (1.24 to 1.56; <0.01)
Wheezing symptom 1.29 (1.20 to 1.39; <0.01) 1.29 (1.19 to 1.39; <0.01)
Wheezing disorder diagnosis 1.28 (1.20 to 1.36; <0.01) 1.26 (1.18 to 1.35; <0.01)
Wheezing disorder treatment 1.19 (1.13 to 1.26; <0.01) 1.20 (1.13 to 1.27; <0.01)
Velocity(-1SDS) between 12 and 36 months
Asthma diagnosis 1.35 (0.96 to 1.88; 0.08) 0.91 (0.64 to 1.29; 0.60)
Wheezing symptom 0.68 (0.54 to 0.84; <0.01) 0.54 (0.43 to 0.68; <0.01)
Wheezing disorder diagnosis 0.79 (0.65 to 0.97; 0.02) 0.64 (0.52 to 0.78; <0.01)
Wheezing disorder treatment 0.83 (0.70 to 0.99; 0.04) 0.78 (0.65 to 0.94; <0.01)
All models were adjusted for birthweight, ethnicity, gender, maternal smoking, parity and maternal SES;
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4.6.2 Piecewise GMM for BiB1000 children
4.6.2.1 Growth patterns analysis
According to the optimal number of class determination results, a four class model
was best (Table 4.27). However, a three class model was preferred on an
interpretability basis.
Table 4.27 Model fit results for selection of optimal number of classes of 1,598
BiB1000 children
Model fit Criterion Classification
quality
Likelihood ratio test
-2LL AIC ABIC df Entropy BLRT (-2LL diff; df
diff; and P-values)
1 class 13,794 13,836 13,883 21 N/A N/A
2 classes 13,752 13,805 13,862 26 0.94 42; 5; <0.01
3 classes 13,724 13,785 13,853 31 0.90 29; 5; <0.01
4 classes 13,698 13,770 13,849 36 0.88 24; 5; 0.02
5 classes 13,680 13,763 13,853 41 0.88 17; 5; 0.70
Based on class numeration results (Table 4.27), the BiB1000 children had three
optimal classes (Figure 4.12). Based on the average latent class assignment result,
the probability of individuals to be correctly assigned to class 1, class 2 and class 3,
was 97%, 80% and 86%, respectively (Table 4.28). In other words, on average, there
was a 3%, 20% and 24% of class assignment error in class 1, class 2 and class 3,
respectively. However, the average latent class probability were above minimum the
recommended cut-off point is 0.70 (Nagin, 2005). The classification quality
(entropy) for the three classes model was 0.90 (Table 4.27) which is above the
recommended adequate cut-off point of 0.80 (Clark, 2010).
Table 4.28 Average latent class probabilities for most likely latent class
membership (row) by latent class (column)
Class 1 Class 2 Class 3
Class 1 0.974 0.014 0.012
Class 2 0.188 0.804 0.007
Class 3 0.000 0.242 0.758
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Class 1 (95.8%) was composed of children whose mean birthweight was at the 46th
centile and were just over the 60th centile at the age of 1 year and stayed around 60th
centile afterwards according to WHO growth standards (WHO, 2006). Class 2
(2.2%) was composed of children whose mean weight at birth was on the 28th centile
then increased to the 96th centile at one year of age and persisted to be overweight
until the age of three. Class 3 (2.0%) were a group of children whose mean
birthweight was on the 29th centile, who subsequently showed very slow growth,
their mean weight reaching the 3rd centile at the of 1 year, then 56th centile by the
age of three years. Class 1, class 2 and class 3, could be characterised as ‘normal’,
‘fast’ and ‘slow’ growth respectively (Table 4.29 and Figure 4.12).
Table 4.29 Estimated mean and percentiles of the three class piecewise growth
mixture model for 1,598 BiB1000 children
Growth classes
Class 1 Class 2 Class 3
Birth 46th (-0.11 SDS) 28th (-0.59 SDS) 29th (-0.56 SDS)
1 month 43rd (-0.18 SDS) 19th (-0.89 SDS) 23rd (-0.75 SDS)
3 months 38th (-0.31 SDS) 7th (-1.48 SDS) 13th (-1.13 SDS)
6 months 45th (-0.12 SDS) 34th (-0.40 SDS) 8th (-1.39 SDS)
12 months 61st (0.27 SDS) 96th (1.75 SDS) 3rd (-1.91 SDS)
18 months 60th (0.25 SDS) 94th (1.57 SDS) 8th (-1.40 SDS)
24 months 59th (0.23 SDS) 92nd (1.39 SDS) 19th (-0.88 SDS)
36 months 58th (0.20 SDS) 85th (1.02 SDS) 56th (0.14 SDS)
Based on the latent growth factors parameter estimates, the BiB1000 children had a
significant variation in terms of birthweight (i.e. intercept) and velocity of growth
between birth and the age of three years (Table 4.30). The results also showed that
birthweight and growth velocities between birth and age of 1 year were inversely
related.
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Figure 4.12 Estimated mean curves of three class pricewise growth mixture model
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Table 4.30 Latent growth factor parameter estimates of three class piecewise
growth mixture model
Mean/variance/covariance Estimate and 95% CI P-value
Class 1 Birthweight –0.111 (–0.170 to –0.053) <0.01
Velocity 0-3 –0.671 (–0.903 to –0.439) <0.01
Velocity 3-12 0.645 (0.578 to 0.712) <0.01
Velocity12-36 –0.028 (–0.053, –0.003) 0.03
Class 2 Birthweight –0.594 (–1.305 to 0.117) 0.10
Velocity 0-3 –2.956 (–7.838 to 1.925) 0.24
Velocity 3-12 3.588 (2.850 to 4.326) <0.01
velocity 12-36 –0.302 (–0.993 to 0.390) 0.39
Class 3 Birthweight –0.564 (–1.146 to 0.018) 0.06
Velocity 0-3 –1.878 (–3.980 to 0.225) 0.08
Velocity 3-12 –0.871 (-1.950 to 0.208) 0.11
Velocity 12-36 0.856 (0.266 to 1.446) <0.01
Variances * Birthweight 0.994 ( 0.897 to 1.090) <0.01
Velocity 0-3 8.945 (7.534 to 10.356) <0.01
Velocity 3-12 0.330 (0.224 to 0.437) <0.01
Velocity 12-36 0.057 (0.046 to 0.067) <0.01
Covariance* Birthweight ↔ velocity 0-3 -1.387 (-1.70 to -1.075) <0.01
Birthweight ↔velocity 3-12 -0.171(-0.247 to -0.94) <0.01
Birthweight ↔ velocity 3-12 -0.020 (-0.045 to 0.006) 0.13
Velocity 0-3 ↔ velocity 3-12 -0.003 (-0.304 to 0.298) 0.98
Velocity 0-3 ↔ velocity 12-36 -0.117 (-0.196 to -0.039) <0.01
Velocity 3-12↔ velocity 12-36 0.016 (-0.015 to 0.046) 0.31
Note: subscripts are age in months; *=parameter estimates were held equal across classes.
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4.6.2.2 Effect of growth patterns on the risk of wheezing disorders
When the risk of wheezing disorders was compared among the growth classes, the
slow growth group had an insignificant decreased risk when compared with the
normal growth group. For example, the adjusted RRs of ‘wheezing’ symptoms,
‘wheezing disorder’ diagnosis and ‘wheezing disorders’ treatment were 0.72 (95%
CI: 0.20 to 2.62), 0.60 (95% CI: 0.16 to 1.95) and 0.81 (95% CI: 0.29 to 2.25)
respectively, see Table 4.31.
The fast growth group also showed an inconsistent risk of association for the four
diseases definitions. For example, the adjusted RRs of the ‘fast’ compared to the
‘normal’ growth group for ‘asthma’ diagnosis, ‘wheezing’ symptoms, ‘wheezing
disorder’ diagnosis and ‘wheezing disorders’ treatment were 0.81 (95% CI: 0.12 to
5.46), 1.59 (95% CI: 0.67 to 3.71), 1.30 (95% CI: 0.56 to 3.06) and 0.77 (95% CI:
0.20 to 2.51), respectively (Table 4.31).
Table 4.31 Adjusted and unadjusted relative risk and 95% confidence intervals
using 10 imputed datasets of the BiB1000 cohort
Unadjusted RR
(95% CI; p-value)
Adjusted RR (95% CI;
p-value)
Class 2
(fast growth)
Asthma diagnosis 0.82 (0.12 to 5.56; 0.84) 0.81 (0.12 to 5.46; 0.83)
Wheezing symptom 1.50 (0.62 to 3.56; 0.36) 1.59 (0.68 to 3.71; 0.29)
Wheezing disorder diagnosis 1.25 (0.53 to 2.97; 0.61) 1.30 (0.56 to 3.06; 0.54)
Wheezing disorder treatment 0.76 (0.27 to 2.14; 0.60) 0.77 (0.28 to 2.17; 0.63)
Class 3
(slow growth)
Asthma diagnosis 1 1
Wheezing symptom 0.80 (0.21 to 2.93;0.73) 0.72 (0.20 to 2.63; 0.29)
Wheezing disorder diagnosis 0.67 (0.18 to 2.45; 0.54) 0.60 (0.16 to 2.18; 0.44)
Wheezing disorder treatment 0.81 (0.29 to 2.25; 0.68) 0.81 (0.29 to 2.25; 0.69)
Note: models were adjusted for birthweight, ethnicity, gender, maternal smoking, parity and maternal SES; class
1 was a reference group.
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4.7 Comparison between complete cases and imputed datasets
analyses
4.7.1 Birthweight and the risk of wheezing disorders
The complete cases analysis for birthweight and wheezing disorders retained 10,623
out of the 13,734 BiB cohort children. The adjusted RRs of low and high
birthweight for wheezing disorders from the complete cases analysis were similar
but less efficient (wider confidence intervals), and inconsistent and less efficient
respectively as compared to the imputed data results (Table 4.32). The similarity
between complete cases and imputed data analyses results was expected given that
all the outcome variables were completely observed and the missing indicator
variables for the incomplete covariates did not have strong relationship with the
outcome variables.
The unadjusted RRs of wheezing disorders (in all four definitions) for low and high
birthweight using the complete cases data are also exactly the same with the imputed
data results as expected provided that birthweight was completely observed
(Table 4.9 and Table 4.32).
4.7.2 Weight at age of 3 years and the risk of wheezing disorders
The complete case analysis was based on 1,027 (64.2%) of the total 1,598 BiB1000
children. The adjusted RRs for the underweight, overweight, obese compared to the
normal weight group using the complete cases analysis are similar to but less precise
than the imputed data analyses results as expected (Table 4.11 and Table 4.33). The
respective unadjusted RRs are also similar to but less efficient than the imputed data
analysis results (Table 4.11 and Table 4.33).
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Table 4.32 Relative risks and 95% confidence intervals of birthweight using complete data of 10,623 BiB cohort children
Asthma diagnosis Wheezing symptoms wheezing disorder diagnosis wheezing disorders treatment
Unadjusted model
Normal (2.5-4.0kg) 1 1 1 1
High (>4.0kg) 0.93 (0.73 to 1.19) 0.91 (0.78 to 1.06) 0.92 (0.80 to 1.05) 1.04 (0.93 to 1.16)
Low (<2.5kg) 1.55 (1.27 to 1.89) 1.28 (1.13 to 1.46) 1.28 (1.14 to 1.45) 1.27 (1.15 to 1.40)
Adjusted model †
Normal (2.5-4.0kg) 1 1 1 1
High (>4.0kg) 0.88 (0.63 to 1.22) 1.01 (0.84 to 1.21) 0.97 (0.82 to 1.14) 1.03(0.90 to1.18)
Low (<2.5kg) 1.63 (1.24 to 2.14) 1.26 (1.05 to 1.51) 1.30 (1.10 to 1.53) 1.22 (1.06 to 1.41)
† =model was adjusted for ethnicity, sex, gestational age, number of live births, maternal smoking, parity, and SES
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Table 4.33 Relative risks and 95% confidence intervals of weight at the age of 3 years using complete data of 1,027 BiB1000 children
Asthma diagnosis Wheezing symptoms Wheezing disorder diagnosis Wheezing disorder treatment
Unadjusted model
Normal (≥5th and <85th centiles) 1 1 1 1
Underweight (<5th centile) 0.57 (0.24 to 1.39) 0.97 (0.59 to 1.59) 0.88 (0.56 to 1.39) 0.78 (0.51 to 1.18)
Overweight (≥85th and <95th centiles 0.78 (0.40 to 1.54) 1.28 (0.88 to 1.88) 1.19 (0.84 to 1.67) 1.09 (0.80 to 1.49)
Obese (≥95thcentile) 1.29 (0.69 to 2.41) 0.95 (0.56 to 1.60) 1.11 (0.72 to 1.69) 1.15 (0.81 to 1.64)
Adjusted model ‡
Normal (≥5th and <85th centiles) 1 1 1 1
Underweight (<5th centile) 0.56 (0.23 to 1.36) 0.96 (0.59 to 1.59) 0.88 (0.57 to 1.38) 0.75 (0.49 to 1.15)
Overweight (≥85th and <95th centiles 0.86 (0.44 to 1.67) 1.31 (0.90 to 1.93) 1.23 (0.87 to 1.73) 1.06 (0.77 to 1.46)
Obese (≥95thcentile) 1.20 (0.62 to 2.32) 1.01 (0.59 to 1.73) 1.11 (0.72 to 1.38) 1.06 (0.73 to 1.55)
‡ = model was adjusted for birthweight, ethnicity, sex, maternal smoking, parity, and SES
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4.7.3 Childhood growth patterns and the risk of wheezing disorders
4.7.3.1 Piecewise latent growth curve model
The complete case analyses retained 1,572 of the 1,598 children. The results showed
that for a decrease of 1SDS between birth and 3 months there was a moderate
associated risk of wheezing disorders (i.e. both adjusted and unadjusted RRs of all
four disease definitions), see Table 4.34. For an increase of 1SDS between 3 and 12
months, the unadjusted and adjusted RRs for complete case analysis did not
completely agree (Table 4.34). There was a significant and insignificant risk of
wheezing disorders if models were unadjusted and adjusted for covariates,
respectively. However, there was an insignificant reduction of wheezing disorders
risk for a decrease of 1SDS between 12 and 36 months. Overall, the relative risks of
wheezing disorders for velocities between birth and 12 months of the complete cases
analyses were almost the same although slightly imprecise when compared with
results of imputed dataset results in Table 4.26.
Table 4.34 Adjusted and unadjusted relative risks and 95% confidence intervals of
velocities between birth and 36 months using complete data of 1,572
BiB1000 children
Unadjusted RR
(95% CI; p-value)
Adjusted RR
(95% CI; p-value)
Velocity (-1SDS) between birth and 3 months
Asthma diagnosis 1.09 (1.02 to 1.17; 0.01) 1.08 (1.00 to 1.16; 0.04)
Wheezing symptom 1.07 (1.02 to 1.12; <0.01) 1.07 (1.02 to 1.12; <0.01)
Wheezing disorder diagnosis 1.06 (1.02 to 1.10; 0.01) 1.05 (1.01 to 1.10; 0.01)
Wheezing disorder treatment 1.05 (1.02 to 1.09; <0.01) 1.05 (1.01 to 1.10; 0.01)
Velocity (1SDS) between 3 and 12 months
Asthma diagnosis 1.49 (1.03 to 2.15; 0.03) 1.36 (0.92 to 2.01; 0.13)
Wheezing symptom 1.29 (1.01 to 1.64; 0.04) 1.23 (0.95 to 1.59;0.10)
Wheezing disorder diagnosis 1.28 (1.03 to 1.59; 0.03) 1.20 (0.95 to 1.51; 0.11)
Wheezing disorder treatment 1.19 (0.98 to 1.44; 0.07) 1.15 (0.94 to 1.41; 0.16)
Velocity (-1SDS) between 12 and 36 months
Asthma diagnosis 1.35 (0.44 to 4.08; 0.60) 0.83 (0.26 to 2.64; 0.75)
Wheezing symptom 0.68 (0.32 to 1.41; 0.29) 0.55 (0.26 to 1.18; 0.12)
Wheezing disorder diagnosis 0.79 (0.41 to 1.54; 0.49) 0.62 (0.32 to 1.23; 0.17)
Wheezing disorder treatment 0.83 (0.47 to 1.49; 0.54) 0.78 (0.43 to 1.43; 0.42)
All models were adjusted for birthweight, ethnicity, gender, maternal smoking, parity and maternal SES
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4.7.3.2 Piecewise growth mixture model
Similar to the piecewise LGCM, 1,572 children contributed to the complete cases
analyses. The adjusted RRs of the ‘fast’ growth group compared to the ‘normal’
growth group for ‘asthma’ diagnosis, ‘wheezing’ symptom, ‘wheezing disorder’
diagnosis and ‘wheezing disorders’ treatment were 0.84 (0.13 to 5.60), 1.26 (0.46 to
3.48), 1.03 (0.38 to 2.85) and 0.55 (0.15 to 2.02) respectively. And, the adjusted RRs
of the ‘slow’ growth group compared to the ‘normal’ growth group for ‘asthma’
symptoms, ‘wheezing disorder’ diagnosis and ‘wheezing disorder’ treatment were
0.72 (95% CI: 0.20 to 2.60), 0.59 (95% CI: 0.16 to 2.15) and 0.81 (95% CI: 0.29 to
2.25), respectively (Table 4.35).
These results of complete cases analyses were very close to the imputed data
analyses as expected given that all the outcome variables were completely observed
and the missing indicator variables for the incomplete covariates did not have strong
relationship with the outcome variables.
Table 4.35 Adjusted and unadjusted relative risks and 95% confidence intervals of
growth patterns using complete data of 1,572 BiB1000 children
Unadjusted RR
(95% CI; p-value)
Adjusted RR
(95% CI; p-value)
Age based weight SDS
Class 2
(fast growth)
Asthma diagnosis 0.82 (0.12 to 5.55; 0.84) 0.84 (0.13 to 5.60; 0.86)
Wheezing symptom 1.50 (0.63 to 3.55; 0.36) 1.26 (0.46 to 3.48; 0.65)
Wheezing disorder diagnosis 1.25 (0.53 to 2.97; 0.61) 1.03 (0.38 to 2.85; 0.95)
Wheezing disorder treatment 0.76 (0.27 to 2.13; 0.60) 0.55 (0.15 to 2.02; 0.37)
Class 3
(slow growth)
Asthma diagnosis 1 1
Wheezing symptom 0.80 (0.22 to 2.92;0.73) 0.72 (0.20 to 2.60; 0.61)
Wheezing disorder diagnosis 0.67 (0.18 to 2.44; 0.54) 0.59 (0.16 to 2.15; 0.42)
Wheezing disorder treatment 0.81 (0.29 to 2.25; 0.68) 0.81 (0.29 to 2.25; 0.68)
All models were adjusted for birthweight, ethnicity, gender, maternal smoking, parity and maternal SES; class 1
was a reference group in both models.
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CHAPTER 5
DISCUSSION
5.1 Chapter overview
This chapter presents a critical discussion of results, description of limitation and
strengths of results, and conclusions drawn from the series of analyses using the BiB
cohort data, namely: the incidence and burden of childhood allergic conditions and
the effects of birthweight, weight at the age of 3 years and childhood growth
patterns on wheezing disorders.
5.2 Incidence and burden of childhood allergic conditions in the
BiB cohort
In this prospective cohort study, the results indicate that 1 in 2 children have
suffered from eczema, and 1 in 5 children have suffered from wheezing disorders
and rhinitis sometime between 0 and 7 years of age. Almost 2 in 5, 1 in 5 and 1 in16
children have suffered from one, two and three allergic conditions, respectively.
While there was no significant difference for eczema by gender, boys were more
likely to suffer from wheezing disorders and rhinitis than girls. Furthermore, while
no difference was observed for wheezing disorders, Pakistani children were more
likely to suffer from eczema and rhinitis than white British children. Boys and
Pakistani children were more likely to suffer from multiple allergic conditions than
girls and white British children, respectively.
The five-year prevalence estimates suggest that 1 in 5 children will have been
diagnosed with a wheezing disorder and rhinitis, when they reach the age of 5 years;
and, 1 in 2 of the cohort have had eczema during the same period. Eczema and
rhinitis were more prevalent in Pakistani than white British children, whilst all three
allergic conditions were more prevalent in boys than girls.
In a meta-analysis and systematic review of studies conducted in the UK by
Netuveli et al. (2005), it was reported that 12-months period prevalence of asthma
was lower in south Asian children (prevalence: 7.6%; 95% CI: 3.7 to 11.4%) as
compared with black (prevalence: 15%; 95% CI: 3.5 to 26.5%) and white
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(prevalence: 10.6; 95% 4.6 to 16.7%) children. These figures are significantly lower
than any of the five-year prevalence (i.e. overall or ethnicity based figures) in this
study which could be due to difference in the ethnic composition of the population,
diagnosis terms used (i.e. ‘asthma’ versus ‘wheezing disorders’) and the prevalence
period. It was also reported that in Pakistan, the prevalence of asthma, wheezing,
eczema and rhinitis in school children of Karachi was 15.8%, 11.7%, 21.8% and
28.5% respectively (Hasnain et al., 2009). The prevalence figures for rhinitis are
similar to the BiB Pakistani group results although it must be noted that the authors
defined ‘wheezing’ and ‘asthma’ as separate terms and used questionnaires to
confirm diagnoses of allergic conditions.
Punekar and Sheikh (2009), who used the national General Practice Research
Database (GPRD) data, reported lower incidence rates and lifetime prevalence than
the BiB cohort’s findings. The incidence rates for eczema, asthma and rhinitis were
22.7, 13.7 and 6.1 per 1000 person years, respectively. The 18-year prevalence
figures reported by the authors are also significantly lower for eczema (36.5%, 95%
CI: 35.9 to 37.2%) and rhinitis (11.4%, 95% CI: 11.0 to 11.8%) while similar for
wheezing disorders (22.9%, 95% 22.3 to 23.4%) when compared with the five-year
prevalence of BiB cohort. These could be for two reasons. First, the authors used
clinician-diagnosed allergic conditions and ‘asthma’ instead of ‘wheezing
disorders’. However, drugs can be prescribed for some period of time as a trial
without any formal diagnosis (GINA, 2015). If the condition is transient, the child
may not be formally diagnosed so this would underestimate the true burden of
allergic diseases. Second, the GPRD data reflects the UK population and regions,
but, the BiB data were composed of mainly Pakistani and white British who live in
the district of Bradford. The district of Bradford has higher infant mortality
(BDIMC, 2007), and air pollution has been a major concern in the community
(Wright et al., 2013). Hence, the higher incidence of allergic conditions in the BiB
cohort than national level could be due to either difference in ethnic composition or
higher environmental pollution.
Although similar in direction, the cumulative incidence of wheezing disorder figures
from the BiB cohort are moderately lower and higher than the Health Survey for
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England (HSE) figures for wheezing occurrence and doctor diagnosed asthma
respectively. The HSE reported 30% and 23% cumulative incidence of wheezing
occurrences in boys and girls respectively; and, 17% and 12% of cumulative
incidence of doctor-diagnosed asthma for boys and girls respectively, in 0-15 year
old children (Boodhna and Hall, 2011). The disparities could be due to longer follow
up and the use of questionnaires to confirm wheezing occurrences and doctor-
diagnosed asthma in HSE’s analysis report.
In a recent study that used data from the Millennium Cohort study
(http://www.cls.ioe.ac.uk/page.aspx?sitesectionid=851) the lifetime prevalence at
age 7 for eczema, wheeze and asthma were 42.9%, 25.8% and 15.1% respectively
(Panico et al., 2014). Another recent study that used data from the Avon
Longitudinal Study of Parents and Children (ALSPAC) cohort
(http://www.bristol.ac.uk/alspac/) and the Manchester Asthma and Allergy Study
(MAAS) cohort (http://www.maas.org.uk/) also reported that the prevalence of
eczema, wheeze and rhinitis at five years of age were 24.4%, 18.4% and 2.3%,
respectively, for ALSPAC cohort; and, 32.4%, 22.5% and 28.1, respectively, for
MAAS cohort (Belgrave et al., 2014). The 5-years prevalence figures from the BiB
cohort were slightly higher than the prevalence reported from the Millennium
Cohort; and, moderately higher than the ALSPAC and MAAS cohort results. The
variations in prevalence of allergic diseases between the BIB and the other UK
cohorts could be due to the difference in ethnic composition and the use of
questionnaire based data.
From the cumulative incidence rates analysis of the BiB cohort based on the birth
years, it can be noted that there was no significant change in the incidence rate of
rhinitis during 2007-2011 (Table 4.4). However, there were substantial increases in
the incidence rates of eczema during every subsequent birth year. The same pattern
was also observed in the incidence rate of wheezing disorders although it plateaued
between 2009 and 2011 birth years (Table 4.4). These results may indicate that
either the impact of allergic conditions has increased during those birth years
(Ghouri et al., 2008; Simpson et al., 2009; Turner et al., 2009) or there may have
been changes in clinicians’ prescribing habits.
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5.3 Effects of birthweight on childhood wheezing disorders
Results from the analyses of the effects of birthweight on wheezing disorders using
the BiB cohort (13,734 children) showed that, based on unadjusted and adjusted risk
estimates, low birthweight was significantly associated with wheezing disorders
(Table 4.9). However, the evidence about the effect of high birthweight on wheezing
disorders remains inconclusive. Based on the adjusted risk estimates, there is a
insignificant reduced risk of wheezing disorders (i.e. using all four disease
definitions). Based on the unadjusted risk estimates, whilst there was an
insignificant reduced risk of asthma diagnosis, wheezing symptoms, and wheezing
disorder diagnosis, there was an insignificant increased risk of wheezing disorders
treatment for being high birthweight compared to normal birthweight children
(Table 4.9).
The findings for the effects of low birthweight on wheezing disorder diagnosis and
treatment are in line with the findings of the meta-analysis and systematic review in
chapter two that showed a 37% increase in wheezing disorders risk for low
birthweight (unadjusted OR=1.37, 95% CI: 1.05 to 1.79), see Figure 2.4 . However,
the finding of the effect of high birthweight on wheezing disorders is slightly
different from the figure of the meta-analysis in chapter two (unadjusted OR=1.02,
95% CI: 0.99 to 1.04), see Figure 2.5. Only wheezing disorders treatment disease
definition agreed with the meta-analysis finding (unadjusted RR=1.04; 95% CI: 0.93
to 1.16)
Although both results (i.e. the meta-analysis of previous epidemiologic studies in
Chapter 2 and the BiB cohort data analysis) confirm that low birthweight is
associated with wheezing disorders, the mechanism of this relationship remains
unclear. However, some studies have reported that low birthweight is associated
with an increased risk of childhood lower respiratory infection (Jackson et al., 2013;
Lu et al., 2013). Low birthweight children can also experience more viral respiratory
infection than normal birthweight children due to altered immune function (Raqib et
al., 2007).
The contribution of respiratory viral infections (e.g. respiratory syncytial virus and
rhinovirus) is two fold. First, in chronic infections, the virus-infected epithelium and
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airway leukocytes release cytokines and mediators that increase airway
inflammation (Singh et al., 2007; Sly et al., 2008). Second, recurrent infection can
also damage the epithelial cells of the airways that cause constriction and stiffness of
the mucosal muscles (Balfour-Lynn, 1996; Roche and Jeffery, 2002), hence,
resulting in wheezing disorder symptoms.
The results indicate that low birthweight is a modifiable risk factor for childhood
wheezing disorders. This implies that by implementing policy measures that
enhance birthweight could result in the reduction of childhood wheezing disorders.
However, some studies have reported that although South Asian children have lower
birthweight than Caucasians or white European origin, they have higher adiposity at
birth (Yajnik et al., 2002; Yajnik et al., 2003; West et al., 2013) and during
childhood (Krishnaveni et al., 2005; Bansal et al., 2008; Whincup et al., 2010).
It was also reported that although South Asians were lighter, they had higher levels
of type-2 diabetes precursors (i.e. glycated haemoglobin (HbA1c) and triglyceride
concentrations) levels than white European children. This may suggest that
increasing birthweight may lead to diabetes and cardiac disease in South Asian
children (Whincup et al., 2010; West et al., 2013). Increasing birthweight may not
have adverse effects on the white British and other ethnicities of the Bradford
children; however, it may not be so for the South Asians in general and Pakistani in
specific. Thus, policies that aim at enhancing birthweight in the Bradford
community could be beneficial if they also incorporate measures to tackle high
birthweight problems at the same time.
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5.4 Weight at the age of 3 years and associated risk of wheezing
disorders
Based on 1,598 BiB1000 children data, those who were underweight at the age of 3
years had a reduced risk of wheezing disorders (in all four disease definitions, and
unadjusted and adjusted risk estimates) although not statistically significant
(Table 4.11). The results also showed that overweight and obesity are associated
with an insignificant increase in the risk of wheezing disorders (Table 4.11). The
direction of these risks is in agreement with the results from a meta-analysis of past
observational epidemiologic studies in chapter two; adjusted OR and 95%
confidence intervals for underweight, overweight, and obese children when
compared to normal weight children were 0.96 (0.75 to 1.23), 1.31 (1.20 to 1.42),
1.60 (1.42 to 1.80), respectively.
It can be noted that, unlike results from the meta-analysis in chapter two, analyses
results based on 1,598 children data are all insignificant so the evidence is weak.
This is likely due to a lack of statistical power of the tests to detect the risk of
wheezing disorders given that the sample size was not so large for an exposure
variable with four categories. In fact, post estimation power calculation (Fleiss et al.,
2003) results showed that all tests that compared the unadjusted wheezing disorders
risk between normal and the other weight groups (i.e. overweight, obese, and
underweight) had a power less than 30%.
From the results of the meta-analyses and systematic reviews (see chapter two) and
analysis of the risk of association between weight at the age of 3 years and wheezing
disorders, high BMI/weight percentile is associated with wheezing disorders.
However, the temporal relationship between BMI and wheezing disorders may not
be apparent based on these findings. This is because, overweight or obesity, due to
increased pressure on the airways, can have restrictive effect on breathing and can
also cause gastro-oesophageal reflux that leads to transient asthmatic signs and
symptoms (Sontag, 2000). In addition, in overweight or obese people, there are
excess pro-inflammatory hormones that can trigger asthmatic symptoms (Guler et
al., 2004; Castro-Rodríguez, 2007; Farah and Salome, 2012 ). At the same time, it is
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also understood that children with respiratory symptoms can be less physically
active that can lead to obesity (Lucas and Platts-Mills, 2006).
In a recent Mendelian Randomisation study, it has been reported that
overweight/obesity precedes childhood wheezing disorders (Granell et al., 2014).
However, the authors did not investigate the reverse direction, that is, if wheezing
disorders cause overweight/obesity or not. Therefore, the possibility of reverse
association can not be discredited as the current evidence stands.
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5.5 Describing the growth patterns of white British and Pakistani
children
Based on LGCM results, Pakistani children were lighter than the white British by
191 grams at birth. Although there was no difference in the change of weight in the
first three months, Pakistani children showed faster growth than their white British
counterparts between 3 and 36 months. It was reported that the prevalence of low
birthweight in Pakistan was among the highest countries in the world (WHO, 2004).
A study in the UK also reported that there is no significant difference of birthweight
between first (i.e. mothers born abroad) and second generation (mothers born in the
UK) South Asian (i.e. Bangladeshi, Indian or Pakistani) babies (Margetts et al.,
2002; Harding et al., 2004). In addition, West et al. (2014) recently reported that
Pakistani pregnant mothers had lower BMI and height than the white British
mothers. Thus, it can be speculated that the disparity in birthweight between the two
ethnic origin babies is due to diet and lifestyle of mothers.
Another recent study that used BiB1000 cohort data also reported that Pakistani
children consumed more ‘commercial sugar-sweetened baby meals’ such as sweet
drinks and chips than the white British during the age of 12-18 months (Sahota et
al., 2015). The effect of sugary food and drinks is well documented suggesting that
high consumption of sugar leads to obesity and high weight gain during childhood
(Malik et al., 2006; Vartanian et al., 2007). Thus, it can be hypothesised that the
faster growth during the age of 3-36 months seen in Pakistani children could be due
to feeding habits.
The LGCM results also illustrate that Pakistani and white British children both
tended to grow consistently slowly until 3 months of age when compared to the
WHO growth standards (Figure 4.8A and Figure 4.8B). Although the WHO growth
standards population represents all children in the world, it was made up of healthy
breastfed children with no known health or environmental constraints to growth, and
whose mothers were willing to follow WHO feeding recommendations, not smoking
and not from low socioeconomic background (WHO, 2006). In the BiB1000 cohort
population, however, no such constraint was imposed during selection of the
participants. Therefore, it can be speculated that the slow growth observed in this
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study’s population could be due to difference in life-style and child feeding habits of
mothers.
Based on GMM results, the sub population of BiB1000 children (i.e. only white
British and Pakistani) had three distinct growth patterns: ‘normal growth’ (95.9%),
‘fast growth’ (2.5%) and ‘slow growth’ (1.6%). The Pakistani children were more
likely to be in either the ‘fast’ or ‘slow growth’ group than the white British. The
‘slow growth’ group are similar to the growth trajectories shown by Eriksson et al.
(2007) who also reported that low birthweight coupled with fast catch-up growth
was associated with adulthood hypertension although the authors did not use WHO
growth standards as a reference. However, a study by Rzehak et al. (2013) that used
the same standardisation method as in this study had reported that children who
persistently grew faster (i.e. similar to the fast growth groups in this study) as
compared to those who grew normally have an increased risk of asthma by 30%.
The growth patterns results using the LGCM are similar to those reported by Fairley
et al. (2013) who used multilevel spline modelling approach although the shape of
the growth trajectories are not identical with this study’s findings. The difference
could be due to the use of different modelling parameterisations and the fact that the
authors assumed MCAR during their analyses. In this thesis, however, FIML was
used to estimate missing growth data.
Fairley et al. (2013) reported that the Pakistani children were lighter at birth and
grew faster, during 9-24 months age, than the white British children which agrees
with the findings of this study. However, the model fit statistics values in the
determination of a model with optimal number of classes showed that a model with
three classes was more parsimonious than a model with one class. In other words,
the GMM fitted the data better than the LGCM. This indicates that LGCM and
multilevel splines may not be the optimal choices for growth patterns analysis of the
BiB1000 data.
The choice between multilevel spline and LGM depends mainly on the depth of
information that one wants to derive from the data and the number of repeated
measurement points. LGM (i.e. GMM) provides extra information (e.g., distinct
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growth trajectories) about the study population and estimates the missing growth
data using a FIML method. However, if the repeated measurement points are too
many, parameter estimations using LGM can have more convergence problems than
the multilevel spline models. In addition, the number of optimal classes and growth
trajectories generated by the GMM may not agree with the initial hypothesis where a
researcher may opt for the most interpretable number of classes despite the model
identifying a different number of optimal classes. Therefore, there is a trade-off
when choosing between the two modelling techniques.
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5.6 The effects of growth patterns on childhood wheezing disorders
Based on the LGCM using growth data of 1,598 BiB1000 children, the results
showed that every decrease of 1SDS during the first three months was associated
with 5% increase in the risk of wheezing disorder diagnosis or treatment. 1SDS
increase between 3 and 12 months was also associated with 26% increase in the risk
of wheezing disorder diagnosis (Table 4.26). These results are in agreement with
previous studies that reported a positive association between velocity of growth and
wheezing disorders (Mamun et al., 2007; Pike et al., 2010; Zhang et al., 2010; van
der Gugten et al., 2012; Anderson et al., 2013; Sonnenschein-van der Voort et al.,
2014b; Magnus et al., 2015) but not so with some other studies that reported an
inverse relationship (Mai et al., 2005; Sonnenschein-van der Voort et al., 2012; De
Korte-De Boer et al., 2015).
Analyses of growth patterns using the 1,598 children’s growth data using GMM
showed inconclusive results for the group classified as ‘fast’ growth. While there
was a non-significant increased risk of diagnosis for wheezing disorders, there was a
non-significant reduced risk of receiving wheezing disorders treatment (Table 4.31).
However, the results showed that the ‘slow’ growth group have an insignificant
reduction for both wheezing disorders diagnosis and treatment when compared to
the ‘normal’ growth group (Table 4.31). The growth patterns’ associated risks are
similar to Rzehak et al. (2013) who used GMM and reported hazard ratios of 1.22
(95% CI: 1.08 to 1.39) and 1.43 (95% CI: 0.90 to 2.27) for groups of children
exhibiting rapid growth until 2 years and persistent rapid growth, respectively. The
authors’ rapid growth trajectory until 2 years group and its risk estimates are similar
to the fast growth group of the BiB1000 children.
In the growth patterns and wheezing disorders analyses, on average, the children
with lower birthweight SDS showed significant growth changes during the first 6
months (Figure 4.12 and Table 4.29) and were more likely to have experienced
wheezing disorder conditions (Table 4.31). It can also be noted that children with
the lowest birthweight SDS were more likely to be obese and to have experienced
wheezing disorder conditions (Figure 4.12 and Table 4.31). Given that a very small
proportion of wheezing disorders or treatment cases were identified in the first three
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and six months (Table 4.24), during which changes in growth occurred, it may
suggest that low birthweight coupled with rapid change in growth during the first six
months is a risk factor for wheezing disorders.
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5.7 Study strengths and limitations
The study has certain weaknesses and results need to be interpreted cautiously. First,
in the analysis of incidence and burden of childhood allergic conditions, there was a
moderate proportion of missing information on ethnicity (17.4%) which could
possibly have impacted the ethnic-specific incidence rate and ratio results. The
follow-up period for the cohort was also short (a maximum of 7 years) which could
have impacted the incidence rate and ratio results as well as comparability with
results from other cohorts that used longer follow-up periods.
Second, although the sample size for the effects of birthweight on wheezing
disorders analysis was sufficiently large, study participants were those who were
born at a single centre: the Bradford Royal Infirmary (BRI) maternity hospital.
Births in the regional tertiary centre, home births and births in smaller hospitals
outside Bradford will have been excluded. The participation in the sub-cohort
(BiB1000) of growth patterns was also mainly driven by the mothers’ willingness to
participate and so there is likely to be further selection bias. In fact, if the
socioeconomic status of the cohort population is considered, 55% of the BIB
(Table 4.8) and 68% of the BiB1000 (Table 4.10) population had come from the
least deprived part of the Bradford community (i.e. national IMD Quintile score=1)
although it has been widely claimed that the Bradford district is among the most
deprived areas of the country (BDIMC, 2007; BDIMC, 2014). Thus, BiB cohort
population may not be a representative sample of the community so results must be
read with a caution.
Third, the classes identified by GMM contained a small proportion of children that
resulted in having less precise risk estimates. In fact, a post estimation power
calculation (Fleiss et al., 2003) revealed that the tests had a very weak statistical
power to detect the risk effect. For instance, from the 1,598 cohort children, 31
children were classified as ‘fast’ growth with 30% of whom diagnosed for wheezing
disorders. In the ‘normal’ growth group, there were 1,531 children and 23% of them
were diagnosed for wheezing disorders. The post estimation power test of a model
based on these proportions was only 12.3% percent. For the model to have 80%
power, the ‘fast’ growth group needed to be at least 414 children, that is, ‘fast’
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growth to ‘normal’ growth ratio of 0.27. Likewise, results for weight at the age of
three years were based on a relatively small sample for a categorical exposure
variable with four categories.
Fourth, missing levels of growth data at some ages and visits was substantial.
Although the thesis has used FIML to address the growth data missing problem, the
extent of bias was not explored using simulations. However, the extents of bias due
to missing data on covariates of regression models was investigated by a series of
comparisons between complete cases and multiply imputed data analyses.
Information on maternal asthma and breast feeding was also missing so the models
were not adjusted for these potential confounding variables. However, the lack of
adjustment may not have had a drastic effect on birthweight and BMI risk estimates
as there were only slight differences between the unadjusted and adjusted summary
ORs of wheezing disorders for birthweight and BMI studies (Figure 2.2, Figure 2.3,
Figure 2.10, Figure 2.11, Figure 2.12 and Figure 2.13). Likewise, the direction of the
risk estimates of unadjusted and adjusted models for those studies that investigated
the association between childhood growth patterns and wheezing disorders was the
same but slight difference in magnitude (Mamun et al., 2007; Scholtens et al., 2009;
Pike et al., 2010; Zhang et al., 2010; Magnusson et al., 2012; Sonnenschein-van der
Voort et al., 2012; van der Gugten et al., 2012; Rzehak et al., 2013; De Korte-De
Boer et al., 2015; Magnus et al., 2015). Thus, the lack of adjusting for breast feeding
and family asthma in childhood growth patterns model outcomes may not be
substantial due to the same reason.
Fifth, during the investigation of the effects growth patterns on wheezing disorders
using GMMs, classify-analyse approach was implemented. This would mean that
the classification uncertainty was not incorporated into the models that investigated
the effects of growth trajectory classes on wheezing disorders. The average class
assignment error for 3 class growth models was 3%, 20% and 24% (class 1, class 2
and class 3, respectively) (Table 4.28). Thus, although the average latent class
probability were above the minimum recommended cut-off point of 0.70 (Nagin,
2005) and the classification quality (entropy) for the three classes model was 0.90
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(Table 4.27) which is above the recommended adequate cut-off point of 0.80 (Clark,
2010), the results must be interpreted with caution.
Nonetheless, this study has several strengths. First, this study was based on a
contemporary prospective cohort data that anthropometric measurements were
collected by trained workers (Raynor, 2008; Wright et al., 2013).
Second, clinical records were used in identifying cases of allergic conditions.
Clinical records have minimal errors in excluding cases as opposed to questionnaires
and clinical diagnosis data. The drug and prescription data need to be recorded for
reimbursement which is an incentive for records to be accurate. In addition, unlike
12-months period or point prevalence which measure the disease burden during a
limited period, lifetime prevalence figures provide a clearer picture about the
absolute burden of disease and are therefore more helpful for health policy makers.
Third, during the analyses of childhood growth pattern, a more advanced analytic
technique (latent growth modelling) was used to analyse life-course growth
trajectories. Unlike mixed effects regression and multilevel spline models which
both assume homogenous growth within a group, latent growth models allow for
individuals to vary according to their distinct growth trajectories. These growth
trajectories may provide greater insight in predicting the risk of childhood or early
adulthood diseases in life-course studies.
Fourth, the application of FIML in missing data estimation to minimise parameter
estimate biases was also an advantage as compared to list-wise and pair-wise
deletion methods under missing data at random assumptions (Enders, 2001a; Enders
and Bandalos, 2001). Likewise, the use of multiple imputations was also an
advantage when compared to a complete cases analysis.
Fifth, the use of age-specific and sex-specific standardised weight scores have the
advantage of clearly depicting the growth patterns of children in reference to the
standard growth reference (WHO, 2006). The standard scores are convertible to
percentiles (Pan and Cole, 2012) which can then be compared with the growth charts
used by clinicians or growth monitoring workers in their daily practice.
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Sixth, in the birthweight and wheezing disorders analyses, the sample size was
reasonably large, in which the risk estimates were precise in the case of low
birthweight.
Seventh, all modelling process throughout the thesis were informed by DAGs using
DAGitty software, techniques that reduce potential bias due to confounding
variables (Greenland et al., 1999; Tu et al., 2005; Textor et al., 2011).
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5.8 Conclusion
The study shows that the burden of allergic conditions in the BiB cohort is higher
than previously reported by earlier studies. Boys are more likely to suffer from
wheezing disorders, rhinitis and multiple allergic conditions than girls. Pakistani
children are more likely to suffer from eczema, rhinitis and multiple allergic
conditions than white British children.
The study also confirmed that Pakistani and white British children have distinct
growth patterns, that is, Pakistani children are lighter at birth and have a faster
growth than White British children between birth and 3 years. More importantly, the
study also showed that the children displayed heterogenous growth, that is, three
distinct growth patterns although the size some of the growth classes was very small.
However, the growth patterns may provide better insight in predicting the risk of
childhood or early adulthood diseases in life course research.
There is a strong evidence to suggest that low birthweight is associated with
increased risk of childhood wheezing disorders whilst there is a weak evidence to
suggest that high birthweight children are associated with a reduced risk. Thus,
increasing birthweight may reduce the impact of wheezing disorders in the Bradford
community. However, by enhancing birthweight, there is also a possibility of
increasing the likelihood of other health problems such as diabetes and cardiac
diseases in South Asian children so health policies may also have to incorporate
measures to tackle high birthweight problem at the same time.
Although results of BMI and growth based on the BiB1000 data remain
inconclusive, keeping physical fitness of children may reduce the impact of
childhood wheezing disorders and other diseases in the community of Bradford. In
addition, maintaining optimal prenatal and postnatal growths may also reduce a risk
of childhood wheezing disorders in the Bradford population.
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CHAPTER 6
SUMMARY
6.1 Chapter overview
The purpose of this chapter is to summarise the findings of all previous chapters in
order to make coherent recommendations mainly about the effects of birthweight,
BMI and childhood growth patterns on childhood wheezing disorders.
6.2 Thesis overview
The thesis is made up of four parts. Part 1 consisted of Chapter 1, and provided a
gentle introduction to childhood allergic diseases and childhood wheezing disorders
in particular. Hypothetical mechanisms by which childhood wheezing disorders can
be associated with childhood anthropometric measurements (i.e. birthweight, BMI
and growth patterns) are also described. Then, the motivations of this thesis are
discussed.
Part 2 (Chapter 2) investigated the association between childhood anthropometric
measurements and childhood wheezing disorders using past epidemiologic studies.
It described methods of systematic review and meta-analysis used along with meta-
analyses results using random effects models, and included discussions and
conclusions of the findings in detail.
Part 3 (Chapters 3, 4, and 5) mainly investigated the effect of birthweight, weight at
the age of 3 years, and childhood growth patterns on wheezing disorders using BiB
cohort data and novel statistical analyses techniques. Analysis variables were
selected using DAGs and missing data were appropriately estimated using FIML and
MI. LGMs were used for growth patterns analyses. Results from the series of
analyses are described and discussed in detail.
The fourth and final part of this thesis consists of the present chapter, in which it
summarises the results of the findings from past epidemiologic studies and the BiB
cohort data. It also discusses what the implications of the findings are and the areas
for further research.
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6.3 Summary of past epidemiologic studies and BiB cohort results
This thesis has analysed and presented results from past epidemiologic studies and
using a contemporary cohort data about the effects of birthweight, BMI, and
childhood growth on wheezing disorders. In addition, the thesis also presented and
discussed the results of the incidence and burden of allergic disease analyses using
the BiB cohort data.
6.3.1 Past epidemiologic studies
The key findings from the systematic reviews and meta-analyses of past
epidemiologic studies data can be summarised as follows:
a) Based on unadjusted and adjusted summary risk estimates, low birthweight
children have significantly higher risk of childhood wheezing disorders.
b) Based on unadjusted summary risk estimates, high birthweight children have
insignificant higher risk of wheezing disorders than normal birthweight
children.
c) Based on unadjusted and adjusted summary risk estimates, overweight and
obese children have significantly higher risk of childhood wheezing
disorders than normal BMI children.
d) The effect of underweight on childhood wheezing disorders is inconclusive;
that is, there is a significant and insignificant reduction of risk based on
unadjusted and adjusted risk estimates, respectively.
e) The effect of childhood growth patterns on childhood wheezing disorders
remains inconclusive; no summarising of risk estimates was conducted.
6.3.2 Born in Bradford cohort data
The key findings from the series of analyses using the birth cohort data can be
summarised as follows:
a) Boys are more likely to suffer from wheezing disorders, rhinitis and multiple
allergic conditions than girls.
b) Pakistani children are more likely to suffer from eczema, rhinitis and
multiple allergic conditions than white British children.
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c) Low birthweight children have significantly higher risk of childhood
wheezing disorders, whilst there is a weak evidence for associated decreased
risk for being high birthweight.
d) Overweight and obese children have an insignificant higher risk of wheezing
disorders, whilst, underweight children have an insignificant reduced risk.
e) Pakistani children are lighter at birth but grow faster than white British
children after birth until the age of three years.
f) Low birthweight is associated with faster growth until the age of 3 years.
g) Slow growth during the first 3 months is associated with higher risk of
wheezing disorders
h) Fast growth between 3 and 12 months of age is associated with increased
risk of wheezing disorders.
i) Slow growth between 12 and 36 months of age is associated with decreased
risk of wheezing disorders.
6.4 Areas for further research
The important limitation of this thesis is that it was not possible to produce
conclusive evidence about the effect of growth trajectories on childhood wheezing
disorders. Producing a quantitative summary risk estimate from past epidemiologic
studies was not possible; and, the GMMs using BiB cohort data produced
inconsistent results. Meta-analysis is one way of enhancing the statistical power of
analysis by combining data from different studies. However, there could be another
way of aggregating data from different birth cohorts by using harmonisation
methods. Analyses based on harmonised data can then have enough statistical power
to detect any risk of wheezing disorders associated with childhood growth
trajectories. Thus, further researches can be done using harmonised data of birth
cohorts in order to explore the effect of growth trajectories on childhood wheezing
disorders.
The thesis has not investigated the potential childhood wheezing disorder
phenotypes in the BiB cohort. It could be of interest to examine this and possibly
investigate its relationship with childhood anthropometric measurements in further
research. Although missing extent on BMI and growth data of the BiB1000 (1,598
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children) is substantial, birthweight and wheezing disorders of BiB cohort (13,734
children) are complete which would give enough statistical power for further
analyses.
6.5 Discussion
Results from the past observational epidemiologic studies (i.e. through a systematic
review and meta-analysis) and BiB cohort data agree that there is a strong evidence
to suggest that low birthweight is associated with increased risk of childhood
wheezing disorders. The two findings also agree that there is a weak evidence to
suggest that there is increased (based on meta-analysis of studies) or decreased
(based on BiB cohort data) risk of childhood wheezing disorders for high
birthweight.
The summary estimates of wheezing disorders indicate that overweight and obesity
are strongly associated with childhood wheezing disorders, although this was not
replicated by the BiB1000 cohort results. This is probably due to lack of power in
the BiB cohort data analyses. However, given that the meta-analyses results were
based on more than 1 million children and the fact that the adjusted and unadjusted
risk summary risk estimates agreed, it can be suggested that overweight and obesity
are strongly associated with increased risk of childhood wheezing disorders.
The evidence for the effect of underweight on wheezing disorders has been
inconclusive. Based on unadjusted summary risk estimates from 7 studies (>700 000
children), there is strong evidence for a reduced risk of the disease, whilst the
adjusted summary estimates from 4 studies (<100 000 children) indicated that the
evidence is weak (i.e. insignificant). However, risk estimates (adjusted and
unadjusted) based on the BiB1000 cohort data of 1,598 children indicate that there is
a weak evidence for reduced risk of childhood wheezing disorders.
The evidence about the effect of childhood growth remains inconclusive due to two
main reasons. First, it was not possible to produce summary risk estimates of past
epidemiologic studies as the weight measurements and developmental stages of
children were diverse. Second, analyses for the effect of growth trajectory classes on
childhood wheezing disorders using the BiB1000 cohort data lacked statistical
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power to detect the risk. However, results based on the cohort data indicate that
there is strong evidence to suggest that a decrease of 1SDS during the first 3 months,
an increase of 1SDS between 3 and 12 months and between 12 and 36 months is
associated with increased risk of wheezing disorders.
6.6 Conclusions
This thesis has confirmed that low birthweight, overweight and obesity are risk
factors for childhood wheezing disorders. It has added that not only fast growth but
also slow growth during early age can predispose to childhood wheezing disorders.
In addition, it indicates that whilst boys are more likely to suffer from wheezing
disorders, rhinitis and multiple allergic conditions than girls, Pakistani children are
more likely to suffer from eczema, rhinitis and multiple allergic conditions than
white British children.
Thus, if low birthweight and overweight/obesity are modifiable risk factors for
childhood wheezing disorders, policies that aim at increasing birthweight,
maintaining optimal childhood growth and keeping physical fitness could
significantly reduce treating and caring cost of childhood wheezing disorders.
However, it must be noted that enhancing birthweight in South Asian children may
lead to diabetes and cardiac diseases. This indicates that, although increasing
birthweight may not have adverse effects on the white British and other ethnicities
of the Bradford children, it may not be so for the South Asians in general and
Pakistani in specific. Therefore, policies that aim at enhancing birthweight in the
Bradford community could be beneficial if they also incorporate measures to tackle
high birthweight problems at the same time.
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Appendix A Quality assessment scale for cohort studies
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE
COHORT STUDIES
Note: A study can be awarded a maximum of one star for each numbered item within the
Selection and Outcome categories. A maximum of two stars can be given for
Comparability
Selection
1) Representativeness of the exposed cohort
a) truly representative of the average _______________ (describe) in the community

b) somewhat representative of the average ______________ in the community 
c) selected group of users eg nurses, volunteers
d) no description of the derivation of the cohort
2) Selection of the non exposed cohort
a) drawn from the same community as the exposed cohort 
b) drawn from a different source
c) no description of the derivation of the non exposed cohort
3) Ascertainment of exposure
a) secure record (eg surgical records) 
b) structured interview 
c) written self report
d) no description
4) Demonstration that outcome of interest was not present at start of study
a) yes
b) no
Comparability
1) Comparability of cohorts on the basis of the design or analysis
a) study controls for _____________ (select the most important factor) 
b) study controls for any additional factor  (This criteria could be modified to
indicate specific control for a second important factor.)
Outcome
1) Assessment of outcome
a) independent blind assessment 
b) record linkage 
c) self report
d) no description
2) Was follow-up long enough for outcomes to occur
a) yes (select an adequate follow up period for outcome of interest) 
b) no
3) Adequacy of follow up of cohorts
a) complete follow up - all subjects accounted for 
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ %
(select an adequate %) follow up, or description provided of those lost) 
c) follow up rate < ____% (select an adequate %) and no description of those lost
d) no statement
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Appendix B Quality assessment scale for case-control studies
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE
CASE CONTROL STUDIES
Note: A study can be awarded a maximum of one star for each numbered item within the
Selection and Exposure categories. A maximum of two stars can be given for
Comparability.
Selection
1) Is the case definition adequate?
a) yes, with independent validation 
b) yes, eg record linkage or based on self reports
c) no description
2) Representativeness of the cases
a) consecutive or obviously representative series of cases 
b) potential for selection biases or not stated
3) Selection of Controls
a) community controls 
b) hospital controls
c) no description
4) Definition of Controls
a) no history of disease (endpoint) 
b) no description of source
Comparability
1) Comparability of cases and controls on the basis of the design or analysis
a) study controls for _______________ (Select the most important factor.) 
b) study controls for any additional factor  (This criteria could be modified to
indicate specific control for a second important factor.)
Exposure
1) Ascertainment of exposure
a) secure record (eg surgical records) 
b) structured interview where blind to case/control status 
c) interview not blinded to case/control status
d) written self report or medical record only
e) no description
2) Same method of ascertainment for cases and controls
a) yes
b) no
3) Non-Response rate
a) same rate for both groups 
b) non respondents described
c) rate different and no designation
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Appendix C Quality assessment scale for cross-sectional studies
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE
(adapted for cross-sectional studies)
Selection: (Maximum 3 stars)
1) Representativeness of the sample:
a) Truly representative of the average in the target population.  (all subjects or
random sampling)
b) Somewhat representative of the average in the target population.  (non-
random sampling)
c) Selected group of users.
d) No description of the sampling strategy.
2) Non-respondents:
a) Comparability between respondents and non-respondents characteristics is
established, and the response rate is satisfactory. 
b) The response rate is unsatisfactory, or the comparability between respondents
and non-respondents is unsatisfactory.
c) No description of the response rate or the characteristics of the responders and
the non-responders.
3) Ascertainment of the exposure (risk factor):
a) Validated measurement tool. 
b) Non-validated measurement tool, but the tool is available or described.
c) No description of the measurement tool.
Comparability: (Maximum 2 stars)
1) The subjects in different outcome groups are comparable, based on the study design or
analysis. Confounding factors are controlled.
a) The study controls for the most important factor (select one). 
b) The study control for any additional factor. 
Outcome: (Maximum 2 stars)
1) Assessment of the outcome:
a) Independent blind assessment. 
b) Record linkage. 
c) Self report.
d) No description.
2) Statistical test:
a) The statistical test used to analyze the data is clearly described and
appropriate, and the
measurement of the association is presented, including confidence intervals and the
probability level (p value). 
b) The statistical test is not appropriate, not described or incomplete.
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Appendix D Summary of studies that investigated the effect of
birthweight on wheezing disorders using non-
standard birthweight categories
Author and year Comparison Unadjusted odds
ratio (95% CI)
Adjusted odds
ratio (95% CI)
Gold et al, 1999 <3.2kg Vs 3.2-3.8kg 1.43 (0.86, 2.39)
>3.8kg Vs 3.2-3.8kg 0.61 (0.33, 1.13)
Yuan et al, 2003 <3.2kg Vs 3.2-3.8kg 1.13 (0.86, 1.49)
>3.8kg Vs 3.2-3.8kg 1.00 (0.79, 1.27)
Sin et al, 2004 <2.5kg Vs 2.5-4.5kg 1.00 (0.90, 1.11)*
>4.5kg Vs 2.5-4.5kg 1.16 (1.04, 1.29)*
Mai et al, 2007 <2.9kg Vs 2.9-4.2kg 1.70 (1.19, 2.43) 1.47 (0.87, 2.49)
>4.2kg Vs 2.9-4.2kg 1.27 (0.86, 1.87) 1.18 (0.74, 1.87)
Garcia-Marcos et al,
2008
<2.0kg Vs 2.0-3.5kg 0.52 (0.12, 2.22)
>3.5kg Vs 2.0-3.5kg 1.04 (0.65, 1.69)
Davidson et al, 2010 <3.0kg Vs 3.0-4.0kg 1.17 (1.08, 1.26) 1.21 (1.13, 1.30)
>4.0kg Vs 3.0-4.0kg 1.10 (0.97, 1.24) 1.05 (0.93, 1.18)
Jeong et al, 2010 <2.8kg Vs 2.8-3.3kg 0.29 (0.09, 0.92) 0.56 (0.16, 1.96)
>3.3kg Vs 2.8-3.3kg 0.45 (0.17, 1.22) 0.29 (0.05, 1.59)
Brew and Marks, 2012 <3.27 kg Vs 3.28-3.7kg 1.95 (1.07, 3.54)
>3.71kg Vs 3.28-3.7kg 0.91 (0.47, 1.75)
Lu et al, 2012 <3.0 kg Vs 3.0-4.0kg 1.94 (1.78, 2.11) 1.24 (1.16, 1.33)
>4.0kg Vs 3.0-4.0kg 1.54 (1.33, 1.77) 0.93 (0.82, 1.06)
Mathew et al, 2012 <2.7kg Vs >=2.7kg 1.88 (1.08, 3.29) 1.79 (1.08, 2.98)
Mathew et al, 2012 <2.7kg Vs >=2.7kg 1.51 (0.94,2.42) 1.09 (0.54, 2.20)
Nuolivirta et al,2012 <3.0kg Vs 3.0–4.0kg 0.65 (0.13, 3.16)
>4.0kg Vs 3.0–4.0kg 2.95 (1.04, 8.37)
*=Relative risk
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Appendix E List of drug names and British National Formulary
chapters used to confirm diagnoses of allergic
conditions
Drug class names (BNF chapters) Drug family names
Asthma
Antimuscarinic bronchodilators (3.1.2) IPRATROPIUM BROMIDE
Selective beta-2 agonists (3.1.1) FORMOTEROL FUMARATE
SALBUTAMOL
SALMETEROL
TERBUTALINE SULPHATE
Leukotriene receptor antagonist (3.3) MONTELUKAST
ZAFIRLUKAST
Inhaled Corticosteroids (3.2) BECLOMETASONE DIPROPIONATE
BUDESONIDE
CICLESONIDE
FLUTICASONE PROPIONATE
MOMETASONE FURATE
SODIUM CROMOGLICATE
Eczema
Emollients (13.2.1) Proprietary emollient preparations
Non- Proprietary emollient preparations
Preparations containing urea
Emollient bath and shower preparations
Topical corticosteroids (13.4) ALCLOMETASONE DIPROPIONATE
BECLOMETASONE DIPROPIONATE
BETAMETHASONE ESTERS
CLOBETASOL PROPIONATE
CLOBETASONE BUTYRATE
DIFLUCORTOLONE VALERATE
FLUDROXYCORTIDE
FLUOCINOLONE ACETONIDE
FLUOCINONIDE
FLUOCORTOLONE
FLUTICASONE PROPIONATE
HYDROCORTISONE
HYDROCORTISONE BUTYRATE
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Drug class names (BNF chapters) Drug family names
MOMETASONE FUROATE
TRIAMCINOLONE ACETONIDE
Ichthammol (13.51) ICHTHAMMOL
Rhinitis
Nasal corticosteroids (12.2.1) AZELASTINE HYDROCHLORIDE
BECLOMETHASONE DIPROPIONATE
BETAMETHASONE SODIUM
PHOSPHATE
BUDESONIDE
FLUNISOLIDE
FLUTICASONE PROPIONATE
MOMETASONE FUROATE
SODIUM CROMOGLICATE
TRIAMCINOLONE ACETONIDE
Antihistamines (3.4.1) ACRIVASTINE
ALIMEMAZINE TARTRATE
BILASTINE
CETIRIZINE HYDROCHLORIDE
CHLORPHENAMINE MALEATE
DESLORATADINE
FEXOFENADINE HYDROCHLORIDE
HYDROXYZINE HYDROCHLORIDE
KETOTIFEN
LEVOCETIRIZINE HYDROCHLORIDE
LORATADINE
MIZOLASTINE
PROMETHAZINE HYDROCHLORIDE
RUPATADINE
Nasal decongestants (12.2.2) EPHEDRINE HYDROCHLORIDE
XYLOMETAZOLINE
BNF= British National formulary
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Appendix F List of disease terms and Read Codes used to
confirm diagnosis of wheezing disorders
Name List of terms Read Code Term ID
Wheezing
Expiratory polyphonic wheeze Xa83N YaVc1
Expiratory wheeze Xa7uu YaVQZ
Expiratory wheezing Xa7vA YaVQt
Inspiratory wheeze Xa7ut YaVQY
Inspiratory wheezing Xa7v9 YaVQs
Mild wheeze XaX5K Yaty9
Moderate wheeze XaX5L YatyA
Nocturnal wheeze/cough 173B. YM1gs
Severe wheeze XaX5M YatyC
Very severe wheeze XaX5N YatyE
Viral wheeze XaMe7 YapfP
Wheeze - rhonchi X76If Y7DxZ
Wheezing XE0qs Y7DuF
Wheezing symptom XM0Ci YM1is
Wheezy XE0qs Y7DuF
Asthma
Acute asthma Xa9zf YaYk2
Allergic asthma XE0YT Y108G
Asthma H33.. Y107p
Asthma NOS XE0YX Y1080
Asthma unspecified H33z. Y107y
Asthmatic bronchitis Xa0lZ Y108e
Brittle asthma Ua1AX YMFVN
Childhood asthma X101t Y107w
Chronic asthmatic bronchitis H3120 Y108g
Mild asthma 663V1 YaY1o
Moderate asthma 663V2 YaY1p
Nocturnal asthma XaLPE Y1084
Non-allergic asthma XE0YT Y108G
Occasional asthma 663V0 YaY1n
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Appendix G Model fit statistics results of FIML and MICE
missing data methods
Fit criterion FIML MICE
Overall
model
Multi-group
model
Overall
model
Multi-group
model
AIC 11409 11319 16635 16555
BIC 11517 11535 16748 16781
RMSEA 0.106 0.105 0.180 0.187
CFI 0.919 0.924 0.931 0.927
TLI 0.901 0.907 0.912 0.907
SRMR 0.040 0.043 0.045 0.048
-2LL 11,367 11,234 16,590 16,466
